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Abstract

i

Magnetic resonance imaging (MRI) is a medical imaging technique that provides
high-resolution images used for diagnostic medicine while maintaining a superior safety
profile compared to other radiative techniques. The administration of gadolinium-based
contrast agents (GBCAs) improves the diagnostic power of MRI and have been used
clinically for over three decades. Although GBCAs are effective at improving the contrast
in the image, their detection limits are high and require a large dose to generate an
observable effect. This high dose is the consequence of the current available designs of
clinical GBCAs; their structures are not tuned to generate optimal efficacy. Efficacy of
GBCAs is defined as relaxivity; how effectively the agent increases the T1 relaxation rate
constant of protons on water. The isoelectric structure of the f-orbitals of Gd3+ yields it an
effective relaxivity agent. However, Gd3+ is toxic and insoluble in vivo, and is therefore
bound as a low molecular weight hydrophilic chelate. The ligand which forms the most
kinetically inert and safest GBCA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate
(DOTA).
Parameters defined by Solomon, Bloembergen, and Morgan (SBM) describe
different factors that influence relaxivity of a GBCA. Two of which have been
demonstrated to dramatically influence efficacy: chelate tumbling and water exchange
rates. A drawback to current ligand systems are low molecular weight; relaxivity increases
with slower tumbling chelates. Current GBCAs have a tumbling rate that is much too rapid
to achieve high relaxivities. Secondly, while this value is predominating, it is difficult to
ascertain the contribution of other SBM parameters. It had been originally hypothesized
that to improve relaxivity, water exchange rate needs to be fast. However, research in our
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group has demonstrated that a chelate which exchanges water too rapidly suffers from a
reduction in its hydration state. The implication of this reduction in hydration state on
relaxivity has yet to be fully appreciated.
The importance of the influence of SBM parameters on relaxivity is realized when
advancements in GBCA technology are applied. The non-specific nature of GBCAs means
they cannot directly diagnose pathology. One promising approach to reduce detection
limits by increasing specificity in vivo is through bifunctional chelators (BFCs). These
ligands have two components: a metal chelating group to bind gadolinium (DOTA), and a
reactive moiety that couples with a targeting vector to bind desired biological receptors.
This allows for defined bioaccumulation in vivo, resulting in improved diagnostics and
lower detection limits. But with several BFCs available commercially, each positioning the
vector attachment differently on the DOTA scaffold, the ideal scaffold for BFC design
while including the influence of SBM is yet to be established.
The three most common strategies of targeting vector attachment are off the
tetraaza macrocycle, through a monoamide pendant arm, or off an -carbon on the acetate
pendant arm. A thorough investigation of these three strategies was explored herein, in
which BFC precursors were synthesized, and their structures analyzed relaxometrically. It
was found that the attachment strategy significantly impacted water exchange parameters
and molecular tumbling, which in turn greatly influenced relaxivity. The experiments
conducted herein presented compelling new evidence in the way we define water exchange
and hydration state. Studies into derivatives of the macrocycle substituted chelate NBDOTA presented the impact an extremely rapidly exchanging chelate has on hydration
state and its effect on relaxivity. Synthesis and analysis of a new tetra -carbon substituted
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chelate, DOTFA, yielded an exceedingly high relaxivity, as well as an interesting and novel
impact on water exchange; there is strong evidence that DOTFA chelates exchange water
in a mechanism that is not purely dissociative. Finally, studies into amide substituted
chelates provided the expected low relaxivity associated with slow water exchange. Yet, it
was demonstrated that changing the type of coordinating monoamide pendant arm, water
exchange can be tuned to slightly more optimal values. These systematic studies provided
novel insight how the most effective targeted GBCA can be designed, synthesized, and
analyzed, as well as presented new evidence into the impact functionalization strategies
have on relaxometric values.
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CHAPTER 1
INTRODUCTION
1.1. Medical Imaging History
1.1.1. Introduction
Before the invention of imaging technology, diagnostic medicine was based on a
patient’s symptoms and a physician’s ability to decipher disease from the presented signs.
This changed in 1895 when German physicist Dr. Wilhelm Röntgen discovered the X-ray,
and for the first time physicians were able to peer inside the human body without the aid
of a scalpel.1 This invaluable advancement ignited a new field of medical technology in
which physicians looked towards modalities that glean anatomy without invasive surgery.
In 1942 utilizing technology created by Pierre Curie in 1880, neurologist Karl
Dussik used ultrasonic waves to generate the first image of a human brain. This imaging
modality was perfected by physicist John Wild in the late 1940s and ultrasound has
remained largely unchanged to this day.
The next major leap in medical imaging was in the field of nuclear medicine. In
1960 physician William Oldendorf filed for the first patent entitled “Radiant Energy
Apparatus for Investigating Selected Areas of the Interior of Objects Obscured by Dense
Material” and subsequently published his findings in 1961.2,3 Then in 1967, electrical
engineer Sir Godfrey Hounsfield invented the first computed axial tomography (CAT)
scanner used clinically.
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In 1971, physician Raymond Damadian published a seminal paper in Science which
described the differentiation between healthy and malignant tissue based on relaxation
times in nuclear magnetic resonance spectroscopy (NMR).4 Two years later, chemist Dr.
Paul Lauterbur was able to translate the data provided by NMR into an image.5 Combining
the important discoveries by Damadian and Lauterbur, physicist Dr. Peter Mansfield
employed the use of gradients, which resulted in the first practical method for magnetic
resonance (MR) imaging in humans.6 These discoveries led to the first MR image
generated in 1977, and a Nobel prize for Lauterbur and Mansfield.
The field of nuclear medicine was expanded with the advent of positron emission
tomography (PET). This imaging modality detects gamma rays from radioactive decay of
an injected radioactive tracer. Following the foundational research into radioisotopes by
the Manhattan Project, many scientists sought to develop radioactive materials that were
inert to humans. In 1975, graduate student Louis Sokoloff developed a radioactive 2deoxyglucose, a competitive inhibitor for glucose-6-phosphate, utilizing 14C and the first
radiotracer for imaging was born.7 Sokoloff expanded his research with the development
of [18F]fluoro-2-deoxy-D-glucose (FDG), which remains as the most clinically used
radiotracer. This allowed physicians to glean insight into metabolic processes, in addition
to the generation of discrete images.
1.1.2. Comparison of Imaging Modalities
While there are many benefits to the myriad of imaging techniques a physician has
available, each has their own set of inherent drawbacks. Comparing these modalities helps
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to understand the advantages and limitations of each, as well as determining which imaging
technique works best for each purpose.
1.1.2.1. X-ray
X-ray imaging is an inexpensive and accessible modality that does not require
specialized building setup. Furthermore, new technology has allowed X-ray imaging to be
portable, thus allowing diagnosticians to image in a variety of settings. X-rays are a type
of electromagnetic radiation, where the high energy of an X-ray photon is transferred to
any electrons it encounters. This interaction results in the atom ejecting the energized
electron, resulting in a net positive charge on the atom, thus X-ray radiation is termed
ionizing radiation. Although the energy transfer and electron ejection results in a
destabilization of the molecular structure of the object the X-ray hits, infrequent short
exposure to X-ray radiation does not generally result in long lasting detrimental effects.
The amount of X-ray radiation an object can absorb is dependent on its density and
atomic makeup. High atomic number containing matter will absorb X-rays more easily
because there is a higher probability of an encounter with an electron. Thus, dense matter
such as bone, which is primarily composed of calcium, will absorb X-rays better than soft
tissue which is primarily constituted of lower atomic number elements. As a result, X-ray
is an excellent modality for analyzing the skeleton, and not very effective at differentiating
against soft tissue. Another limitation of this imaging modality is that it only analyzes the
patient from a two-dimensional configuration. When taking an X-ray, the area being
imaged is placed against a photographic or fluorescent film. The X-ray is passed through
the afflicted area; dense material absorbs the X-ray radiation, preventing the X-rays from
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hitting the film. The X-rays pass through the soft tissue and are deposited on the film,
turning it black.
X-ray can also employ the use of a contrast enhancing agent, typically a compound
which contains high atomic elements such as barium or iodine. This allows for certain
anatomical information that is typically dark on the image to appear bright. Thus, features
such as the circulatory system or digestive tract can be imaged with good detail. However,
neither of these contrast agents are specific; they either circulate through the bloodstream
non-specifically or travel through the digestive tract via peristalsis, and thus cannot directly
diagnose pathology.
1.1.2.2. Ultrasound
Ultrasound imaging has the benefit of being inexpensive, extremely portable, and
simple to use. Ultrasound devices are transducers comprised of piezoelectric crystals that
vibrate when an electrical current is applied through the crystal array. This vibration results
in the generation of high frequency ultrasonic waves. When ultrasonic waves are emitted
into the body, they encounter tissues of different densities, resulting in characteristic
vibrational echoes that are detected by the transducer. The signals of these echoes are
measured based on the time it takes for them to travel back to the transducer. The varied
signals are then translated into electrical currents that are computationally resolved into a
colorimetric spectrum. The color spectrum produced is like that of MRI, where strong
signals are encoded as bright and weak signals are encoded as dark. The differentiation in
color intensity is what gives rise to the image produced. A major benefit to ultrasound is
its ability to display real-time motion, such as that of a heart valve opening, or movement

CHAPTER 1. Introduction

5

of fluid, by exploiting the Doppler effect. This allows diagnosticians to determine
physiological information that is typically missed in many other imaging modalities. The
main drawback to ultrasound imaging is its inability to image past a certain depth. Because
ultrasound utilizes the movement of sound waves the transducer does not have high enough
sensitivity to detect waves that travel deep into the body. As a result, deeper tissues and
organs cannot be imaged. Patients who have a large amount of subcutaneous fat are also
poor candidates for ultrasound for this reason.
Contrast agents in ultrasound are limited due to the nature of the imaging modality.
The main source of improving contrast in ultrasound is implementing microbubbles; these
are insoluble gas cores made up of fluorinated compounds enveloped in an insoluble
material, typically a lipid or polymer. They facilitate the enhancement of the acoustic
contrast ratio in the generated image and are used primarily in cardiological imaging.
Ultrasound can move, expand, or divide microbubbles through insonation, which requires
their stability to be robustly studied. As a result, microbubbles have been thoroughly
evaluated to ensure patient safety.8
There has been research in recent years to increase the utility of microbubbles by
implementing them as therapeutic agents. Ultrasound can control the oscillation of the
microbubbles to alter the walls of blood vessels, which would facilitate the delivery of a
therapeutic drug.9 Although preliminary studies are promising, there are limitations to this
technology; microbubbles cannot overcome the flow of blood through the cardiovascular
system, resulting in dissipation of the drug. There has been research to increase specificity
of microbubbles, by altering the chemical surface of the encapsulating material. However,
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efforts to create a stable, uniform, specific material is still underway. Most importantly, the
extremely low resolution observed in ultrasound imaging cannot be overcome regardless
of the specificity of the targeted agent.
1.1.2.3. CT
Computed tomography (CT) is a high sensitivity imaging modality that alleviates
the major limitation of X-ray imaging: inability to spatially resolve images. CT operates
under the same principle as X-ray imaging; however, it utilizes a rotating source of X-rays,
generated from a tungsten ring. A continuous source of X-rays is simultaneously received
through a detection ring that also encircles the patient. This allows for cross-sectional slices
of the body to be imaged. These images can then be computationally rendered through
projection-reconstruction to create a three-dimensional image and allows physicians to
glean detailed anatomical information that a traditional X-ray does not provide. A major
benefit of this modality is the speed with which images are produced. X-rays are detected
instantaneously, and a full CT imaging session can take less than 10 minutes. The images
generated are perpendicular to the patient’s body, and thus CT is sometimes referred to as
computational axial tomography (CAT). The major limitation to this imaging modality is
the same as X-ray: the patient is being exposed to ionizing radiation and at a higher
exposure rate due to the ring of X-rays being shot at the patient. The amount of radiation a
patient is exposed to is not minimal, and CT imaging is typically performed to monitor
progress of treatment. Thus, the patient could receive multiple scans in a short period of
time, increasing their ionizing radiation exposure.
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Contrast agents are commonly used during CT image acquisition. The most used
contrast agent in CT is an iodinated compound; typically, an aromatic organic structure
decorated with multiple iodine atoms. Although these agents are quite effective at
increasing the contrast on the image, they require a high dose to be effective, in the range
of 30 g – 50 g of organo-iodine per dose.10 The high detection limits of iodinated contrast
agents means that the structure in which iodine is bound must be robust, as excess free
iodine can cause irreversible damage to the endocrine system.11 Secondly, it has been
reported that iodinated contrast agents, even when effectively bound in their organic
frameworks, can trigger an allergic response in up to 14% of patients.10 With dose and
toxicity aside, a major issue within the use of iodinated CT agents is their lack of
specificity. They are typically used to enhance circulatory imaging; however, they do not
selectively highlight areas of damage or distress, thus it is up to the radiologist to carefully
analyze the image to diagnose pathology.
1.1.2.4. PET
Positron emission tomography (PET) utilizes a radionuclide-labeled sugar, to
monitor metabolism inside a tumor cell. Once the radiopharmaceutical is taken up by the
tumor, the radioactive component decays and emits a positron. The positron then collides
with an electron, and the annihilation event results in the emission of two photons of
−radiation emitted in opposite directions. The relative position of the emitted  particles
can then be detected in a circular detector around the patient, to highlight important
metabolic information.
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One major benefit to PET imaging is its ability to examine metabolism inside tumor
cells and other soft tissues by monitoring the uptake of the radiopharmaceutical. This
allows for PET to be a quantitative imaging modality that directly diagnoses pathology.
However, there are some drawbacks to this imaging methodology. Like CT, the PET decay
of the radiotracer results in the patient being exposed to ionizing radiation; albeit a much
lower dose than that produced in X-ray or CT imaging. Unlike CT, the mechanism of a
PET scan does not provide anatomical information. Secondly, certain patients are unable
to undergo PET imaging; those who are pregnant or diabetic are contraindicated, due to
risk associated with exposure to a radioactive material or a sugar-containing substance,
respectively. Another major drawback to PET is the extremely low resolution of the images
produced by this modality. Although PET is considered a high sensitivity modality due to
the mechanism of detecting photons, the images produced are difficult to interpret. Thus,
PET has the ability to monitor metabolic activity that could potentially provide important
information about pathology; however, the resolution is much lower than that of CT or
MRI. Lastly, PET imaging is expensive, requires specialized equipment, and a dedicated
lab-space capable of synthesizing and disposing of the radiotracer.
1.1.2.5. MRI
Magnetic Resonance Imaging (MRI) is a unique diagnostic tool in that it provides
high resolution images without exposing the patient to ionizing radiation like its X-ray,
CT, and PET counterparts. The mechanism of action for MRI is the same principle as
NMR: a large external magnet is utilized to align the orientation of the magnetic vector of
an NMR-active nucleus. The external field perturbs the magnetic moments of these nuclei
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so the net magnetic vector aligns with a slight bias in the orientation of the magnetic field.
Once aligned, the system is not static; the net magnetic vector precesses about the applied
magnetic field at a rate specific to the nucleus in question. However, the signal generated
by this precession of spins is of a much lower magnitude than that of the applied magnetic
field and is therefore unable to be detected. Thus, through a series of radiofrequency pulses,
the bulk magnetic moment is translated to the transverse plane where the signal can be
detected by receiver coils. The primary difference from NMR to MRI is the utilization of
gradient magnetic fields which encode spatial resolution of the signal to generate an image.
Although MRI is an excellent tool to differentiate between tissue types, the time it
takes for nuclei to relax to equilibrium results in low temporal resolution. Furthermore,
MRI is limited in its ability to image metabolic processes. Another drawback to current
MRI practices is the cost; because scanners utilize superconducting magnets, they need to
be cooled to near absolute zero to reduce electrical resistance. This requires the use of
liquid cryogenics, which are finite resources, to maintain the superconducting nature of the
magnet. Finally, the cost associated with maintaining, and the facilities required to house
MRIs are limiting factors for many hospitals and medical centers. Because MRIs are
permanent fixtures in these settings, their utility is limited to mostly urban centers.
1.1.3. Multi-Modal Imaging Technologies
Combining two advanced imaging modalities allows physicians to glean greater
insight into the pathology of disease. PET imaging provides important metabolic
information but suffers from resolution and is therefore unable to provide anatomical
information. CT and MR can generate in high resolution images of anatomy, but do not
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provide the metabolic information of PET. There is a great demand for combining a
metabolic imaging modality with an anatomical one. Thus, PET-CT and PET-MRI are the
predominant multimodal imaging modalities. The differences in the dual images they
produce are shown in Figure 1.1.

Figure 1.1. Dual-modal imaging performed on a 58-year-old male patient with
nasopharyngeal carcinoma. (A) PET/CT dual image. (B) PET image (C) CT image (D) T1weighted PET/MR dual image. (E) T1-weighted image. (F) T2-weighted image.12

The dual-modal technology of PET-CT allows for metabolic and anatomical
information to be obtained simultaneously.13 Because CT is an advanced form of X-ray
imaging, it provides highly detailed images of bone and other dense material. However,
one major drawback to a dual-modal PET-CT scan is the high dose of ionizing radiation:
both the CT scanner and PET radiotracer result in the production of ionizing radiation, thus
increasing the patient’s exposure. Yet, this dual imaging modality has become increasingly
popular for physicians who need information on a metabolic process with high resolution
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images. PET-CT continually proves utility due to its lower cost in comparison with MR
imaging, and quick acquisition time. Conversely, PET-MRI is an attractive dual-modal
imaging modality due to reduced patient exposure to ionizing radiation. A major advantage
of a dual PET-MRI is its ability to take simultaneous images in one session.14 This allows
for real-time imaging of a metabolic process, while maintaining the high-resolution
imaging power of MRI. Secondly, a combined imaging probe can be utilized to act as a
radiotracer as well as contrast agent. One drawback of PET-MRI is its inability to
effectively image dense material such as bone. Another detriment of PET-MRI is the
expense associated with imaging.
1.1.4. Summary
The individual and combined imaging techniques presented each have their
inherent benefits as well as drawbacks. No one imaging modality has a major advantage
over another in current clinical practice. The major goal in the future of medical imaging
is to develop tools that provide more specific information about pathology. Currently, each
modality can overcome high detection limits, low sensitivity, or poor resolution by
implementing a contrast enhancing agent, yet none of these agents facilitate direct
diagnosis. Thus, the field needs a modality that provides high resolution images, low
detection limits while maintaining a superior safety profile.
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1.2. Magnetic Resonance Imaging (MRI)
1.2.1. Generating Contrast
The weak magnetic field of the earth causes any nucleus with an odd number of
protons, neutrons, or both, to have a net magnetic moment. These moments, or spins, are
randomly positioned in space with no bias towards any orientation. However, when they
are placed in an external magnetic field such as an NMR or MRI, the external field induces
a bias in the net magnetic moment according to the Boltzmann distribution of individual
spins. The distribution of spins is nearly split between aligning with (-state), or against
(-state) the applied magnetic field, with only parts per one million more spins aligned
with the lower energy -state. This slight excess of bias of spin distribution is the result of
the field frequency of the NMR being much higher than the net magnetic field of the earth
and generates the net magnetic moment (Mz) that is probed in an NMR experiment.
𝜔0 = −𝛾𝐵0
Equation 1.1. The definition of Larmor frequency in which 0 is the Larmor frequency in
rad‧s-1,  is the gyromagnetic ratio of the nucleus, and B0 is the magnetic field strength.

B0 causes Mz to precess at a specific frequency called Larmor as shown in Equation
1.1. The gyromagnetic ratio, , is a specific property of the nucleus and affects the rate of
Larmor precession, which is linearly dependent on field strength. To glean information
about the chemical environment, torque is applied to Mz via an excitation radiofrequency
(RF) pulse (B1) at the Larmor frequency of the nucleus being probed. This transfers the
magnetization into the transverse plane where the precession of Mz produces a signal. Once
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the RF pulse is turned off, the spins will return to equilibrium through two simultaneously
occurring mechanisms.
Once the RF pulse is turned off, the spins lose coherence across the transverse
plane, where they no longer act as a bulk property (Mxy) but decay into individual spins;
this is caused by local magnetic fields generated by spins on each other, Bloc. Concurrently,
they will return to alignment with B0. The loss of coherence is denoted transverse relaxation
(characterized by the time constant T2) and occurs faster than the return to the z-axis, called
longitudinal relaxation (denoted by the time constant T1). These processes are described in
Figure 1.2.

Figure 1.2. Rotating frame depiction of the two relaxation mechanisms that occur in an NMR
experiment. The magnetic sum of spins is depicted as a bulk property, large pink arrow, and
are aligned with the applied magnetic field, B0. After a RF pulse is applied, the spins are tilted
into the transverse plane. Once the pulse is turned off, the spins lose coherence (T2 relaxation),
and return to alignment with B0 (T1 relaxation).
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Once the RF pulse is turned off, the simultaneous relaxation mechanisms result in
a loss of signal generated by the magnetic flux in the form of a free induction decay (FID).
The FID then goes through a receiver coil where it is amplified. This amplified signal is
then digitized to convert the FID signal into a series of data points. Through a Fourier
transform, these data points are converted to a frequency spectrum for an NMR experiment.
An MRI scan utilizes the same principles as an NMR experiment; however, there
are some major differences in data acquisition. With a spin quantum number of ½, the
hydrogen nucleus has a small magnetic moment that will generate a weak signal in an NMR
experiment. Thus, it is important to have a high concentration of nuclei to probe to generate
a strong signal. In the context of MRI, the protons of water provide the greatest signal; the
human body is approximately 60% water, and with two hydrogen atoms per water
molecule, it is the most abundant NMR-active nucleus to probe. However, the water
molecules within the human body are all in vastly different chemical environments and
these environments impart different magnetic characteristics that can be exploited to allow
for differentiation in the image contrast produced.
To maximize the effect of signal intensity differences, an MRI scan employs the
use of three magnetic field gradients. The orientation of the slice selection gradient
determines the plane of the image, which allows for specific area in the anatomy to be
selected for the image along the x-, y-, and z-axes. Each slice has a thickness and contains
volume, so each cross-sectional image is comprised of all three axes, denoted as voxels. A
phase encoding gradient is applied to the slice along one axis to cause the Bloc of each
region of the slice to be different, and once turned off, cause each section of spins to be out
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of phase. Finally, a frequency encoding gradient is applied to the slice along the opposite
axis to change each voxel to have a different rate of precession. What results is a slice with
each voxel producing a signal in which the frequency and phase are unique. Each voxel is
assigned a grayscale value based on the strength of its Bloc signal. A strong signal, arising
from quickly relaxing material appears bright, and a weak signal appears dark.
1.2.2. Amplifying the Signal Produced – The Spin Echo
To maximize the contrast generated in an MR image, different pulse sequences can
be implemented to weight the relaxation rate of one tissue type versus another. The pulse
sequence used in an MR image is slightly different than that produced in an NMR
experiment. A spin-echo pulse sequence is typical of an MR imaging pulse sequence: it
applies two consecutive RF pulses, producing a spin echo rather than an FID. This process
allows for the dephasing that occurs during transverse relaxation to be refocused to
generate a stronger signal. A spin echo pulse sequence is described in Figure 1.3, where
the time between each 90° excitation pulse is called the repetition time (TR), and the time
between the 90° pulse and the echo produced is called the echo time (TE). To maximize
the contrast generated in an image, TE and TR are altered.

Figure 1.3. Pulse sequence to obtain an MR image. 90° and 180° refer to RF pulses of that
strength. TE is the echo time, and TR is the repetition time.
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The T1 relaxation time for free-flowing water is approximately 3 – 4 s, and its T2
relaxation time is slightly shorter. The different chemical environments of water in vivo
lead to different relaxation properties: these differences in relaxation time constants are
exploited in designing an MR spin echo pulse sequence.
1.2.2.1. Echo Time (TE)
The time between the 90° pulse and maximum height of the echo (TE) can be
manipulated in the echo pulse sequences to alter the signal sensitivity to transverse
relaxation, which is deemed T2* in MR imaging due to complications caused by field
inhomogeneity, magnetic susceptibility in the human body, and the gradients required for
spatial resolution. Nevertheless, when TE is much shorter than the T2 of the desired tissue
being imaged, the spins are effectively rephased and thus transverse relaxation effects are
minimized. But when TE is much longer than tissue T2, the spins dephase and cannot be
effectively refocused: the differing T2* relaxations occurring in two different tissues are
amplified and this allows for different color assignments in the image. A short TE typically
refers to a value that is much shorter than T2, whereas a long TE is ~3 – 5 times greater
than T2.
1.2.2.2. Repetition Time (TR)
The time between 90° pulses (TR) can also be shortened or lengthened to amplify
or minimize the effect of local differences in longitudinal relaxation. If TR is made several
times longer than the T1 of the tissue being imaged, then the nuclei have time to completely
return to equilibrium along the Zeeman alignment, thus two tissues with differing T1 values
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will not be exaggerated. Conversely, if TR is made short, tissues with short T1 values will
relax to equilibrium faster than those with a longer T1. This means that more signal will be
obtained with longer T1 values; the differences in T1 relaxation in two different tissues is
emphasized. As with TE, a short TR refers to a value that is much shorter than T1, whereas
a long TR is ~3 – 5 times greater than T1.
1.2.2.3. Weighted Imaging
Favoring one relaxation process over another is known as weighting, and it is the
result of altering TR, TE, or both. Altering TR mostly impacts T1 effects, whereas the major
influence on T2 effects is altering TE. These effects on signal intensity are described in
Equation 1.2.
𝑆 = 𝐾[𝐻](1 − 𝑒 −𝑇𝑅/𝑇1 )𝑒 −𝑇𝐸/𝑇2
Equation 1.2. The determination of signal intensity (S) from a pulse sequence where K is a
scaling factor, [H] is the proton density.

Dense stationary tissue such as fat and protein will return to equilibrium along B 0
quickly and will therefore appear bright on the T1-weighted image. Free flowing tissue such
as cerebrospinal fluid (CSF) and edema retain transverse magnetization longer, and return
to equilibrium along B0 more slowly, resulting in a weak signal that translates to a dark
color in a T1-weighted image. A short TR and short TE results in a T1-weighted image as
shown in Figure 1.4 Top Left.
In contrast, a T2-weighted imaging pulse sequence has greater time between pulses
and nuclei with a short T2 lose coherence completely. Free flowing tissue that loses
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coherence quickly, such as CSF and edema will result in a strong signal and appear bright
on the image, where dense stationary tissue like fat and protein dephase slowly and appear
dark. A long TR and long TE results in a T2-weighted image as shown in Figure 1.4 Bottom
Right.
The last type of echo pulse sequence that is relevant clinically is proton density
(PD). Because shortening TE minimizes T2 effects, and lengthening TR minimizes T1
effects, an echo pulse sequence that employs short TE and long TR results in a PD image.
This sequence is used to determine the actual density of protons in a tissue. As a result,
CSF as well as fat provide a high signal in PD imaging, whereas cartilage produces a low
signal. This is highlighted in Figure 1.4 Top Right.
It is possible to use a spin echo pulse sequence that employs a long TE and short
TR. However, this would result in poor signal from T1 as well as T2 effects. This is because
a short TR maximizes T1 effects and minimizes T2 effects, whereas a long TE maximizes
T2 effects and minimizes T1 effects, essentially canceling out the weighted advantage of
both. This is shown in Figure 1.4 Bottom Left.
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Figure 1.4. Pulse sequence techniques used to alter TR and TE to result in T1-weighted (T1W), T2-weighted (T2-W), and Proton Density (PD) images.15

1.3. MRI Contrast Agents (CAs)
To improve the diagnostic power of MRI, physicians can employ a contrast
enhancing agent (CA). Within a biological system, a contrast agent works by binding free
water molecules and shortening their T1, or T2 relaxation time constant. All contrast agents
shorten both T1 and T2, but the implementation of weighted imaging favors one relaxation
process over another and the most used contrast agents are T1-enhacing agents. After
interacting with a water molecule and effectively reorienting the magnetic moment of those
proton nuclei, the molecule will exchange with the bulk. This process is repeated resulting
in the transfer of relaxation to the bulk water. In a T1-weighted image, protons that relax
quickly will appear bright on an image and those that relax slowly will appear dark. The
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differences between a T1-weighted image with and without contrast is highlighted in Figure
1.5. It is the difference of the increased relaxation rate of the water molecules that is
highlighted in an image enhanced by contrast.

Figure 1.5. T2-weighed image (Left), T1-weighted image (Center), and T1-weighted image with
gadolinium-based contrast agent administered (Right).16

1.3.1. Non gadolinium-based Contrast Agents
1.3.1.1. Iron-Based Superparamagnetic Agents
Superparamagnetic nanoparticles of iron (II) oxide have been used clinically as
contrast enhancing agents. Iron oxide nanoparticles have a large magnetic moment, which
allows them to shorten both T1 and T2 relaxation times of surrounding water molecules.
However, they are typically used as T2* agents, and their relaxation enhancement of bulk
water results in negative contrast observed on the image.17 Clinical iron (II) oxide
nanoparticle agents vary in size from 4 – 4000 nm in diameter. This size discrepancy allows
for agents to be used in different applications from MR angiography to digestive tract
enhancement.18 Due to the reactivity of a transition metal-based contrast agent, the
nanoparticles are coated in a biocompatible layer, typically comprised of a polymeric sugar
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derivative. These coatings vary in size and composition and all help to prevent aggregation
of the particles once injected into the bloodstream. Although multiple iron (II) oxide
nanoparticles have been approved clinically as contrast enhancing agents, they have fallen
out of favor due to anaphylactic side effects experienced by patients and a lack of contrast
specificity.19 Currently, all iron (II) oxide nanoparticle MRI contrast agents have been
discontinued.
1.3.1.2. Manganese Paramagnetic Agents
Both the II and III oxidation states of manganese have a paramagnetic 3d subshell
and have been shown to increase the T1 relaxation rate of water in vivo. However, inorganic
solution of Mn2+ were shown to be extremely toxic in initial studies and as a result only
one chelate of Mn2+ is approved clinically, a chelate of dipyridoxal diphosphate (DPDP)
(known as Mangafodipir and Teslascan™ clinically), Figure 1.6 Left.20 There has been
some research into encapsulating MnCl2 into liposomes, or chelating Mn2+ into a ligand
such as ethylenediaminetetraacetic acid (EDTA) and imbed the chelate into a lipid bilayer.
However, it was shown that free Mn2+ was released from both of these systems, thus
reducing their utility.20

Figure 1.6. Mn derived contrast agents, Mn(II)-DPDP (Left), and Mn(III)-TPPS4 (Right).
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1.3.2. Gadolinium Based Contrast Agents (GBCAs)
All clinically available contrast agents are complexes of the paramagnetic
lanthanide gadolinium (Gd). Due to its isotropic f-shell, Gd3+ has an extremely long
electronic relaxation time. This, combined with its ability to behave as a Lewis acid and
ligate water, makes it an excellent contrast agent. Although gadolinium-based contrast
agents (GBCAs) increase both T1 and T2 relaxation rates of water, the major difference in
signal intensity is observed in a T1-weighted image, as highlighted in Figure 1.5.
As a free ion, Gd3+ is toxic in vivo, displacing Ca2+ in bone and disrupting Ca2+
dependent biological processes.21 Therefore, Gd3+ is bound in an organic ligand to ensure
its safety as a contrast agent. Lanthanides have a preferred coordination number of 9, thus
all ligand systems are designed to be octadentate, leaving one available coordination spot
to ligate water and shorten its relaxation time constant. There are two main systems in
which a contrast agent ligand is defined: linear, in which a long organic chain wraps around
the metal to form a complex; and macrocyclic, a prearranged macrocycle that encapsulates
the metal to form a complex.
1.3.2.1. Linear Agents
All linear GBCAs are derivatives of the structure diethylenetriaminepentaacetic
acid (DTPA), shown in Table 1.1. The primary differences in these linear agents is the
charge of the complex. Most have a 2- charge while the two amide containing derivatives
are neutral. These have been developed to reduce osmotic pressure of the agents as aqueous
solutions.22
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Table 1.1. Clinically relevant linear derived GBCAs.

1.3.2.2. Macrocyclic Agents
The other variety of octadentate ligand structure used to bind gadolinium is the
macrocycle. All clinically available macrocyclic contrast agents are derived from dodecane
tetraacetic acid (DOTA). The three current clinically approved agents are shown in Table
1.2. Like their linear counterparts, the main difference between these agents is overall
complex charge. GdDOTA (Dotarem®) maintains a 1- charge while GdHP-DO3A
(ProHance®) and GdDO3A-Butrol (Gadavist®) are neutral. Slight modifications to the
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DOTA parent ligand result in the two derivatives, but all three have similar efficacies,
pharmacokinetics, and stabilities.
Table 1.2. Clinically relevant macrocyclic GBCAs.

1.3.2.3. Safety of GBCAs
Although linear agents are commonly used clinically, they are associated with a
major limitation. Namely, when evaluating GBCAs for their safety, thermodynamic
stability has traditionally been the standard metric. Linear GBCAs perform well
thermodynamically, thus it has been assumed that because the energy barrier of dechelation
in vivo was so high that these chelates remain intact for the duration of the scan and through
excretion. However, in 2006 this changed with a publication linking a new disease
occurring in renally compromised patients who had received GdDTPA.23 Coined
nephrogenic systemic fibrosis (NSF), it is characterized by the hardening of skin and tissue,
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eventually causing fibrosis in organs leading to death. Although GBCA administration is
observed in 95% of NSF patients, there has yet to be a defined method of
pathophysiology.24 Currently, prevention is the only measure, thus renally compromised
patients are dissuaded from contrast enhanced-MRI (CE-MRI).
The discovery of the correlation between NSF and GBCAs mobilized scientists into
researching the safety of GBCAs. Because thermodynamics were the key determination of
stability, other factors influencing safety were not considered. Both linear and macrocyclic
agents are small hydrophilic chelates which are cleared renally, typically in under 4 hours.25
However, if a patient is renally compromised, the chelate will enter hepatic clearance,
which can take much longer. Thus, the risk of dechelation is increased if the chelate is not
exceedingly kinetically inert. As a result, researchers began to collect data on kinetic
inertness as a marker of a superior safety profile, and these values are presented along with
their thermodynamic stabilities in Table 1.3.
The data presented in Table 1.3 show that although both the linear and macrocyclic
chelates perform similarly thermodynamically, their kinetic inertness constants are
significantly different. The high kinetic inertness constants observed in macrocyclic
chelates arises from their structure. The macrocyclic effect first described by Desreux,
states that the pre-organization of the ligand reduces the entropic penalty on its ligands
from coordinating with the metal.26 As a result, macrocyclic derived ligands from much
more kinetically inert complexes than their linear counterparts. Thus, macrocyclic agents
have a higher propensity to remain chelated for the duration of the scan through excretion,
even through alternative clearance modes. Appropriately, the increased kinetic inertness of
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macrocyclic derived GBCAs has made their study the primary focus of our group and many
MRI researchers around the world.
Table 1.3. Thermodynamic stabilities and metal – ligand dissociation constants for clinically
relevant GBCAs.27–31

1.4. SBM Theory and Relaxivity
Efficacy of a T1 contrast agent is termed relaxivity (r1), defined as how effective a
GBCA is at increasing the R1 relaxation rate constant of water as a function of
concentration. The higher the relaxivity, the more effective the agent. Relaxivity is
described by a series of equations developed by Solomon, Bloembergen, and Morgan,
known as SBM theory. Due to the complex nature of relaxivity, these equations attempt to
explain the physico-chemical properties of how a contrast agent behaves in solution. Each
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of these SBM parameters contribute to relaxivity in different capacities and are collectively
called relaxometry. Analyzing relaxometric data requires multiparametric data fitting, and
not all SBM parameters can be determined independently. Those parameters are generally
fixed to agreed upon values and the choice of those values can influence the values of other
obtained during the fitting process. As a result, many of the parameters within the SBM
equations are mutually compensatory; changing one value will impact another, and thus
complexity arises when determining optimal values for each. With these considerations in
mind, SBM theory allows for the extraction of physico-chemical properties of metal
chelates and facilitates the probing into their behavior as relaxivity agents. SBM equations
describe the dynamic interaction; binding of a water molecule to the lanthanide center, a
dipole-dipole interaction between the Gd3+ f-electrons and the protons on the bound water,
the subsequent water exchange with the surrounding bulk through a dissociative ligand
exchange process, depicted in Figure 1.7. The SBM equations are shown in Equations 1.3
through 1.10 and will be described in terms of longitudinal (T1) relaxation.29,32
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𝑐𝑞
1
(
)
=
𝑇1 55.5 𝑇1M + 𝜏M

Equation 1.3. T1 relaxation rate of bulk water is defined by the concentration (c), hydration
state (q), longitudinal proton relaxation time of water (T1M), and water exchange lifetime (M).

1
𝑇1,observed

=

1
+ 𝑟1 [Gd3+ ]
𝑇1,𝑑

Equation 1.4. Observed solvent relaxation rate (1/T1,

obs)

is a function of the sum of the

relaxation rate of the solvent nuclei without a paramagnetic agent (diamagnetic contribution,
1/T1,d) and the relaxivity of the paramagnetic agent (r1) times the concentration of Gd3+.

1
1
1
= 𝐷𝐷 + 𝑆𝐶
𝑇1M 𝑇1
𝑇1
Equation 1.5. Longitudinal proton relaxation time of water (T1M) is governed by the magnetic
field dependent dipole-dipole (DD) and scalar or contact (SC) mechanisms.
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𝑇1
𝑟GdH
(1 + τ2C2 ω2S ) (1 + τ2C1 ω2H )
Equation 1.6. DD contribution to T1 relaxation is modulated by electron spin (S), electron g
factor (g), nuclear gyromagnetic ratio (), Bohr magnetron (B), electron spin – proton
distance (rGdH), electron spin relaxation (C), electron Larmor frequency (S), and nuclear
Larmor frequency (H).

1
2𝑆(𝑆 + 1) 𝐴 2
𝜏𝑒2
(
)
=
(
2 )
3
ℏ
1 + 𝜔S2 𝜏𝑒2
𝑇1𝑆𝐶
Equation 1.7. SC contribution to T1 relaxation is modulated by electron spin (S), the hyperfine
or scalar coupling constant between the electron of the paramagnetic center and proton of
the bound water (A/ℏ), electron Larmor frequency (S), and SC correlation time (e).
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1
1
1
= +
+
𝜏C 𝜏R 𝑇1𝑒 𝜏M

Equation 1.8. Characteristic correlation time of the DD interaction (C), is the sum of
rotational correlation time (R), longitudinal electron spin relaxation time of the metal (T1e),
and water exchange lifetime (M).

1
1
1
=
+
𝜏e 𝑇1e 𝜏M
Equation 1.9. Characteristic correlation time of the SC interaction (e) is the sum of the
longitudinal electron spin relaxation time of the metal (T1e), and water exchange lifetime (M).

1 ZFS
Δ2
1
4
( )
= ( 𝜏V (4𝑆(𝑆 + 1) − 3)) (
+
)
2
2
𝑇1𝑒
50
1 + 𝜔𝑆 𝜏V 1 + (4𝜔𝑆2 𝜏V2 )
Equation 1.10. Field dependent paramagnetic electron spin relaxation time of zero field
splitting interactions (T1eZFS) is defined by the mean square ZFS energy (2), correlation time
for the modulation of the transient ZFS (V), and electron Larmor frequency (S). This
equation is only valid when V22<<1.

Figure 1.7. Relaxivity (r1) is defined by SBM parameters as described in Equations 1.3 – 1.10.
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1.4.1. Measurable Parameters of SBM Theory
The complicated and interdependent nature of the SBM equations can make it
difficult to determine which parameter influences relaxivity the most. However, certain
parameters are considered to have the greatest impact on relaxivity; those are described in
Table 1.4, along with their measurement technique. The most common method by which
SBM parameters are determined is by fitting the data generated from NMRD and 17O-NMR
profiles to SBM theory. Nuclear magnetic relaxation dispersion (NMRD) experiments
probe the longitudinal relaxation rate of the GBCA as a function of magnetic field strength.
17

O-NMR determines the reduced transverse relaxation rate of the quadrupolar 17OH2 as a

function of temperature. Both measurements are [Gd3+] dependent.
Table 1.4. SBM parameters that determine relaxivity (r1).29,32
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1.4.2. Interdependent Nature of SBM
Each of the SBM parameters directly influences relaxivity, therefore optimizing
one value would not directly improve the efficacy of the chelate. Instead, the contribution
of each parameter needs to be considered when building a high relaxivity agent. According
to SBM, a rapidly exchanging chelate (M ~30 ns) with slower rotation (R = inverse
Larmor frequency of the proton, ~20 ns, at low fields) would generate optimal relaxivity
values.33,34 This can be visualized when SBM parameters are fixed, and fitted to a three
dimensional plot, shown in Figure 1.8. This plot showcases the overwhelming influence
M and R have on relaxivity. At the bottom of the plot, M and R can be a wide range of
values to achieve the same relaxivity. However, as relaxivity increases, the values of M
and R become a very narrow range.
Thus, to design the most optimal GBCA, there are very defined values that M and
R must be to achieve the highest relaxivity possible. Currently, researchers are seeking to
tune the values of M and R to “climb up the mountain”; yet, no major leaps in improving
relaxivity have been realized. It is imperative to understand the influence and impact of
each SBM parameter on relaxivity to facilitate the most effective agent possible.
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Figure 1.8 When other SBM parameters are fixed, the influence of the water exchange
lifetime (M) and rotational correlation time (R) on relaxivity (r1) are realized. (B0 = 0.5 T,
and 298 K)

1.4.3. Rotational Correlation Time (R)
Also described as the tumbling rate, rotational correlation time (R) is specifically
defined as the time it takes the chelate to rotate one radian in solution. This value is
determined by fitting NMRD profiles to SBM theory. The Debye-Stokes equation is a
secondary measure not incorporated into SBM that allows for the mathematical
determination for R, Equation 1.11. Although combining SBM and Debye-Stokes provide
a semi-accurate description of tumbling, it makes several assumptions. First, the Debye-
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Stokes equation is only valid for a spherical molecule, which can be inaccurate for certain
chelate systems. Secondly, it is difficult to obtain an exact value for the effective radius,
and microviscosity is typically unknown, therefore assumed.

𝜏R =

3
4𝜋𝜂𝑟𝑒𝑓𝑓
3𝑘B 𝑇

Equation 1.11. Debye-Stokes equation for R is dependent on the microviscosity (), the
effective radius (reff), the Boltzmann constant (kB), and temperature (T).

A direct determination of R is available through Curie relaxation experiments. This
independent measurement technique determines the Curie spin contribution to the
transverse relaxation rate of the proton on the coordinated water. It is advantageous because
the Curie-contribution is lanthanide specific. However, this method does require certain
SBM parameters to be known, so it is primarily used in conjunction with NMRD as a
conformational technique to evaluate efficacy of fitting. Secondly, it has been used on nongadolinium containing lanthanide chelates, and although lanthanides have similar
properties, there is significant anisotropy in these chelates that contribute to the
measurement.35
When reviewing the SBM equations it is evident that R is the dominating factor
influencing relaxivity, illustrated by the mountain plot in Figure 1.8. Yet, there is a major
discrepancy between theory and practice for r1. Because all current clinically available
contrast agents are low molecular weight chelates, they tumble very quickly in solution.
Their tumbling rates are on the orders of 10s – 100s of picoseconds, when SBM has dictated
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ideal R values should be in the nanosecond range, depending on field. Ideally, the chelate
should tumble at the rate of the Larmor frequency of the protons on water. Thus, to improve
relaxivity, the barrier of R must be lifted.
The most obvious approach to slowing down molecular tumbling is increasing the
size of the chelate. Many efforts are underway to add bulky hydrophobic groups to the
ligand structure or bind the chelate in a macromolecule. It has been shown that
incorporating a GBCA into a small protein or biomarker can increase the relaxivity by an
order of magnitude due to the large reduction in molecular tumbling.36 However, it is
important to recognize that when a GBCA is conjugated into a larger system, the traditional
SBM approach to molecular tumbling does not apply; local as well as global tumbling must
be considered when determining R, because both tumbling rates contribute to r1. The
Lipari-Szabo approach approximates both contributions of molecular tumbling via the
addition of a spectral density function to R.37 With bioconjugation of GBCAs becoming
rapidly more popular, it is important to understand the impact local and global rotation
have on r1. Secondly, an accurate method of determining R is essential to fully understand
the interplay and dynamics a GBCA undergoes in solution.
1.4.4. Water Exchange Lifetime (M)
In a dissociative exchange mechanism, M has traditionally been defined as the
water residence lifetime and was thought to describe the amount of time a water molecule
remains bound to the lanthanide center. However, this is an inaccurate description of the
water exchange process and does not account for the contribution of the time water spends

CHAPTER 1. Introduction

35

unbound to the lanthanide. Instead, M is the inverse of the water exchange rate (1/kex),
denoted as the water exchange lifetime. The influence of M on relaxivity is twofold; it
determines the efficiency at which the relaxed water molecule exchanges with the bulk, as
well as contributes to C, which defines the dipole-dipole interaction between the felectrons of the lanthanide and the protons on the water molecule.
M is measured directly via variable temperature 17O-NMR spectroscopy. The data
generated from the 17O-NMR experiment form a bell curve in which there are two water
exchange regimes that determine M. The optimal value for M is field dependent, and this
value increases as magnetic field increases due to the spectral density function associated
with the M contribution to C. As the limiting effect of R is lifted at higher fields (>1
MHz), M begins to become an important factor in determining relaxivity.
Many low molecular weight hydrophilic chelates fall in the fast exchange regime,
with GdDOTA having a M of 244 ns.38 However, there is a point in which water exchange
is considered too fast, resulting in a negative impact on other SBM parameters. When water
exchange gets exceptionally rapid, the time in which a water molecule is not bound
becomes significant, resulting in a reduction of hydration state (q/r6). A chelate with a
reduced hydration state will negatively impact relaxivity. The effects of a reduced q/r6 is
explored in Chapter 2.
Another influencing factor on M is the lanthanide ion itself. The lanthanide ionic
radius contraction observed across the series, results in a longer metal-water distance.39
The longer bond distance in turn shortens M, resulting in faster exchange. Although we
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consider relaxometry in terms of GBCAs, it is important to appreciate the impact a
changing ionic radius has on water exchange. Experiments conducted on the same ligand
with different lanthanides, show a difference of two orders of magnitude comparing various
lanthanide chelates.29 These differences highlight the importance of precise determinations
of metal – water distance (rLnH), in order to generate accurate M values.
1.4.5. Activation Volume (V‡)
The description of M values does not fully define the entire water exchange event,
and thus the mechanism of exchange must be considered. Ligand exchange systems can be
either dissociative, interchange, or associative, however it is incorrect to view these
processes as discrete. Instead, the exchange process is a continuum, from associative at one
end, dissociative on the other with interchange in the center. Thus, various systems can
exchange water dissociatively, but have interchange character. The determination of
mechanism is via the analysis of the activation volume (V‡). V‡ is defined as the
difference between the partial molar volume of the transition state and the reactants.40 A
dissociative mechanism is the result of a large transition state thus a positive V‡, whereas
a small transition state is observed for an associative mechanism resulting in a
negative V‡.32 Thus, an interchange mechanism would have a V‡ of 0. Because water
exchange is on a continuum, chelates with slight positive or negative V‡ values can be
considered ID or IA, associated with interchange with a dissociative or associative character,
respectively. While variable temperature

17

O-NMR allows for the experimental

CHAPTER 1. Introduction

37

determination of M, variable pressure

17

O-NMR experiments gives rise to the

determination of V‡. The water exchange mechanism can be defined by Equation 1.12.
‡

∆𝑉
1
−
𝑃
= 𝑘ex = (𝑘ex )𝑇0 𝑅𝑇
τM

Equation 1.12. The water exchange mechanism. Where M is the water exchange lifetime, kex
is the water exchange rate, (𝒌𝐞𝐱 )𝑻𝟎 is the water exchange rate at zero pressure and
temperature T, and V‡ is the activation volume in cm3mol-1.

Nearly all small molecular weight poly amino carboxylate chelates exchange water
through a dissociative mechanism for two reasons. Firstly, all clinically relevant ligands
are octadentate; meaning there is only one available site to bind water, thus the relaxed
water molecule would need to leave prior to coordinating another. Secondly, the structure
of both linear and macrocyclic chelates are rigid; they would require energetically
unfavorable rearrangement to accommodate multiple water molecules.
Although all clinically relevant chelates exhibit dissociative exchange, their range
of activation volumes indicate that not all chelates exchange water in the same fashion. For
example, GdDTPA2- has an activation volume of 12.5 cm3mol-1, whereas GdDTPA-BMA
has a V0‡ of 7.3 cm3mol-1.41 Though both these chelates exhibit dissociative exchange,
GdDTPA2- has an activation volume nearly double that of GdDTPA-BMA. The
introduction of two neutral monoamides to the DTPA structure reduces the electron density
around the metal center enough to reduce the activation volume by nearly half. If we view
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mechanism as the continuum, GdDTPA-BMA would lie closer to the center of
“interchange” than GdDTPA2-, as illustrated in Figure 1.9.

Figure 1.9 Water exchange mechanism continuum with relevant gadolinium complexes based
on their activation volumes (V0‡). [Gd(H2O)8]3+ V0ǂ = -3.3 cm3mol-1. GdDOTA- V0‡ = 10.5
cm3mol-1, and GdDTPA2- V0‡ = 12.5 cm3mol-1.41

The lanthanide itself influences the activation volume as well. GdDOTA- has a
V0‡ of 10.4 cm3mol-1, however when the Gd is swapped for Eu, the V0‡ reduces to -0.5
cm3mol-1, thus the chelate changes from a dissociative to an associative mechanism.3
Further analysis shows that upon changing the europium from a 3+ oxidation state to a 2+,
the activation volume increases to 0.1 cm3mol-1.42,43 The combination of a low electronic
density around the Eu2+ center as well as long metal – water distance contributes to the
change from an associative to an interchange mechanism for EuDOTA. These data
demonstrate that the ligand structure directly impacts the water exchange mechanism, and
thus relaxivity.
1.4.6. Characteristic Correlation Time of Dipole-Dipole (C)
The relaxation rate of the protons of the bound water molecule is directly governed
by the fluctuation of the dipole-dipole interaction that occurs when the water molecule
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binds to the metal center. This characteristic correlation time of this interaction (C), is
dominated by the rotational correlation time (R). Like R, C is considered much too fast
according to SBM theory to obtain optimal relaxivity. It has been established that for the
highest relaxivity achievable, C must equal the inverse of the Larmor frequency of the
proton on the water.29 Thus, efforts are underway to slow tumbling in such a way that C
will also be slowed. However, because the Larmor frequency of a nucleus is field
dependent, optimizing this value is more complicated than simply slowing molecular
tumbling. From Equation 1.8, electron spin relaxation and water exchange lifetime also
influence C, and as a result will need to be simultaneously optimized to achieve high
relaxivity.
1.4.7. Mean Square ZFS Energy (2), Relaxation Rate Time Constant for the
Modulation of the Transient ZFS (V), and Electron Spin Relaxation Time (T1e)
Electronic relaxation can be defined by transient zero field splitting (ZFS) that
results from solvent collisions that cause distortions in the chelate.44 ZFS results from a
variety of mechanisms occurring in solution and in the chelate itself. Ligand field
interactions on the f-electrons of Gd3+, spin-orbit coupling, and electronic repulsion
intermolecularly, all cause the ZFS observed, resulting in electronic relaxation. The mean
square ZFS energy (2) is another parameter that contributes to relaxivity within the subset
of electronic relaxation. Its influence in Equation 1.10 is described by the distortions that
occur within a complex from a series of electronic interactions. The structure of the ligand
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directly defines 2; the more rigid the structure, the lesser impact these collisions and
interactions have on electronic relaxation and therefore the lower the 2 value.45
When water binds to the metal center through the interaction of the Lewis acid
metal with the electrons on the oxygen, a dipole-dipole interaction occurs between the
metal and the protons on the water molecule. This interaction is modulated via the
reorientation of the nuclear spin relaxation – electron spin vector of the lanthanide, V. V
values are magnetic field dependent and are defined through ZFS interactions.
V influences relaxivity of GBCAs via T1e. Electron spin relaxation time (T1e) is
defined as the reduction of electron spin magnetization of the lanthanide along B0. As a
result, this value is also magnetic field dependent. However, the electron spin
magnetization decay that occurs in the same direction of the magnetic field is too rapid to
be observed experimentally; the S = 7/2 spin state of Gd3+ results in a multiexponential
electronic relaxation.29 Thus, line shape analyses of electron paramagnetic resonance
spectra (EPR) allow for the determination of ZFS. Once these data are generated, they can
be fitted to Equation 1.10 to determine both V, and 2. The fitting of these values in turns
allows for the determination of T1e.
The impact of electronic spin relaxation and its components are dominating factors
on relaxivity at low fields. To optimize relaxivity, the molecular collisions and electronic
interactions that occur must be minimized to reduce the influence of electronic relaxivity.
This can be achieved through structural manipulation of the ligand by increasing rigidity
of the compound as well as increasing the symmetry of the overall complex. Both
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approaches help to minimize electronic interactions that cause electronic relaxivity, and
thus will increase relaxivity.
1.4.8. Hydration Number (q) and Lanthanide-Proton Distance (rGdH)
The hydration number (q) and the lanthanide – proton distance (rGdH) are typically
discussed as separate parameters, but because the exact location of the water molecule is
unknown, it is more constructive to discuss them in together, as established by Bertini et.
al.46 Equation 1.6 defines the longitudinal relaxation rate of bound water that is attributed
to the dipole-dipole interaction of the water molecule protons and the lanthanide center. In
this equation, it is shown that this observed relaxation rate has a sixth order dependence on
the lanthanide – proton distance (rGdH6); the spatial strength of the dipole disappears as a
cube root, thus the two dipoles are additive and result in a sixth order dependence. The
hydration number, or number of water molecules directly bound to the complex, is either
1 or 0 for all octadentate GBCAs. The combination of hydration number and distance
results in hydration state, q/r6. This value considers not only the number of bound water
molecules, but the distance of each molecule.
Hydration number is found through crystal structure analysis, though the utility of
this data is limited because solid state does not directly translate mechanisms in solution.
Luminescence lifetimes can also be utilized to determine q, however this does not work on
Gd3+ complexes due to the electronic nature of Gd3+.47 The metal – proton distance is an
even more difficult value to ascertain. The most common method of determining rGdH is
evaluation of the crystal structure of the chelate. However, protons do not appear in the
crystallographic data, so their actual location is implicit based on the location of the
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coordinated water oxygen. Again, solid state analysis is not a representation of solution
state. Horrock’s method allows for an accurate determination of hydration state, due to its
ability to measure the dipole-dipole interaction. However, difficulty arises when
distinguishing the influence of outer sphere water molecules.47
1.4.9. Conclusions
Researchers have used SBM theory to calculate that if each SBM parameter is
optimized, the highest possible relaxivity of a GBCA is ~100 mM-1s-1. However, there are
some important assumptions in this determination. First, electronic relaxation (T1e) is
assumed to be long, the magnetic field strength is fixed to 20 MHz, the temperature is fixed
to 298 K, and rGdH is fixed to a short value. Secondly, these assumptions do not account
for certain changes that occur when parameters such as water exchange rate become
increasingly rapid. Nonetheless, there is a stark difference between calculated SBM theory
and clinical practice; current clinically available GBCAs have relaxivities ~5 mM-1s-1.
In most cases, relaxivity is magnetic field strength and temperature dependent; it
decreases with increasing field strength and temperature. It is important to address the
current divergence within the field of MRI. Clinically, there has been a push to use MRI
instruments at higher and higher magnetic field strengths (1.5 T – 7 T, which equates to 65
MHz – 305 MHz). Although higher magnetic field strengths result in higher resolution
images, efficacy of GBCAs dramatically decrease due C of the GBCA modulating much
further away from the Larmor frequency of the proton. Thus, we are facing a dichotomy;
how do we incorporate the new push for higher magnetic field strengths while maintaining
the utility of GBCAs? Secondly, these high magnetic field strengths rely on the non-
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renewable resource liquid He to maintain the superconducting nature of the magnet. As a
result, although there is a push for higher magnetic field strengths diagnostically, it is
possible this He crisis could force clinicians to reduce to lower strength magnets that do
not require near absolute zero temperatures. Thus, it is imperative that the contribution of
each SBM parameter to relaxivity is recognized and considered to achieve effective
GBCAs. Only then can high relaxivity agents be achieved regardless of field strength.
1.5. Coordination Geometries and Regioisomerism in DOTA and DOTA-Derived
Chelates
1.5.1. Coordination Geometries of DOTA
The macrocyclic DOTA ligand has some interesting coordination features that need
to be discussed to appreciate the function of the resulting chelate. The tetraaza macrocycle
ring (cyclen) can adopt multiple conformations; however, studies have shown the
symmetrical [3, 3, 3, 3] configuration is the lowest energy conformation.48 As a result of
the multiple possible conformations, the ring helicity is assigned  or  depending
on the orientation of the nitrogen atoms in the [3, 3, 3, 3] ring, figure 1.10.

Figure 1.10. [3, 3, 3, 3] ring conformations of 1, 4, 7, 10-tetraazacyclododecane (cyclen).
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When acetate arms are introduced to the structure, they also impart their own
inherent helicity independent of the helicity of the ring. However, arms bind cooperatively,
thus all four pendant arms will adopt the same orientation, denoted  or . The combination
of ring and arm orientation results in two pairs of enantiomers, as shown in Figure 1.11.
These structures interconvert in solution, via arm rotation and ring inversion. Once
chelated, these structures also exist as two coordination geometries that can be described
by the combination of arm and ring helicity; () or () result in a square
antiprism (SAP) coordination geometry where () or () result in a twisted
square antiprism (TSAP) coordination geometry.

Figure 1.11. The four possible coordination isomers of GdDOTA. Interconversion between
SAP and TSAP is achieved through arm rotation and ring inversion.
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The impact of SAP and TSAP coordination geometry is more evident when these
structures are viewed from the side. The SAP coordination geometry is characterized by
its shorter cage height which results in a shorter distance between the nitrogen and oxygen
planes. In contrast, the TSAP coordination geometry is defined by its taller cage height,
resulting in a longer distance between the two planes, as shown in Figure 1.12. These
differences in cage heights result in a dramatic impact on M; the longer metal – water bond
distance sustained by the TSAP coordination geometry results in a kex that is two orders of
magnitude faster than the SAP coordination geometry.49 The exchange between SAP and
TSAP isomers is slow enough to be observed on the NMR time scale. Although there is
interconversion between the two coordination geometries, it has shown that GdDOTA
prefers to maintain 85% SAP.42

Figure 1.12. Side profiles of the two coordination geometries of DOTA chelates. Square
antiprism (SAP, left) and twisted square antiprism (TSAP, right).
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1.5.2. Substitution on the DOTA Scaffold
There has been much research into altering the parent DOTA structure to include
various moieties to maximize relaxometric properties. The main strategies of modifying
the base scaffold is via addition of groups on the macrocycle, on one to four -carbon
acetate arms, or replacing a pendant arm with a different coordinating ligand. Depending
on the type of moiety, this alters the possible ratio of coordination geometries as well as
the changes the interconversion, as shown in the flowchart in Figure 1.13.
The introduction of a benzylic substituent (NB-DOTA) results in two new
regioisomers to the structure, in which the moiety is on the corner or side carbon.50 A
benzylic moiety locks ring inversion, thus interconversion between these two distinct
regioisomers is not possible. However, the Corner and Side can interconvert between SAP
and TSAP via arm rotation. The impact of macrocycle substitution is explored thoroughly
in Chapter 2. Substitution on all four -carbon locks arm rotation, thus interconversion
between SAP and TSAP is only achievable through ring inversion. The tetra-methylated
DOTA derivative (DOTMA) has been well studied for its unique properties.51 Other types
of tetra-substituted chelates are investigated in Chapters 4 and 5. Combining both arm and
ring substitution results in four non-interconverting chelates in solution that can be
separated and analyzed independently. An example of this doubly substituted chelate, NBDOTMA is probed in Chapter 2.

CHAPTER 1. Introduction

Figure 1.13. Possible regio- and coordination isomers of substituted DOTA chelates.
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1.6. Bifunctional Chelators (BFCs)
Bifunctional chelators (BFCs) are ligands for medical applications with two
purposes; the first to safely and effectively bind a metal for therapeutic or diagnostic
imaging, the second to contain a reactive moiety to bind specifically and selectively to a
biological target of interest. One of the earliest known reports of a bifunctional chelator
was an 111indium complex used to label antibodies.52 Since then, BFCs have been primarily
used as ligands to sequester a metallic radionuclide that simultaneously bind to a small
protein, typically antibodies, for PET and SPECT imaging.53 BFCs have been proposed for
use as MRI contrast agents, specifically with the addition of a handle on the structure of a
DOTA-derived ligand system.54 The incorporation of a targeting vector into the ligand
scaffold of DOTA will afford direct target binding. This in turn could lower detection limits
due to increasing the specificity of the GBCA. Secondly, a Gd3+ based BFC would enable
MRI to be a direct diagnostic method, increasing its utility.
Although BFCs have yet to be translated to clinical practice, researchers envisage
a ligand system that contains a reactive moiety that can be easily modified for a variety of
applications. After modification, this ligand would be chelated, the complex would then be
conjugated via the targeting vector to a biological molecule of interest, such as a biological
ligand. The bioconjugate would be subsequently injected into the patient and the ligand
would bind to its relevant receptor, allowing for direct target imaging. This process is
depicted in Figure 1.14. There are some important considerations when designing this
system, such as the type of targeting vector added to the ligand system, as well as the
location of the reactive moiety on the ligand structure.
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Figure 1.14. The strategy for biological targeting of a BFC.

1.6.1. Attachment Strategies
The increased kinetic robustness of DOTA makes it an ideal scaffold to modify to
contain the targeting vector. However, the ideal location of this reactive moiety has yet to
be firmly established. The three most synthetically approachable attachment strategies of
the targeting vector are: off the macrocycle, through a pendant arm such as a monoamide,
or on the -carbon of a pendant arm. These three strategies are shown in Figure 1.15.
Examples of these three substituted chelates have been established in literature, however,
there has yet to be a thorough examination of their utility as potential BFCs for MRI.
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Figure 1.15. The three main attachment strategies for a targeting vector. Left: off the
macrocycle, center: via a monoamide pendant arm, right: on the -carbon of a pendant arm.

Once a group is substituted on the DOTA scaffold, relaxometric parameters are
impacted. It has been established that the introduction of a substituent on the macrocycle
or on the pendant arms, or, replacing one to four pendant arms to amides changes the
relative SAP/TSAP ratio in solution. As established, this dramatically impacts water
exchange. The introduction of various substituents on the DOTA scaffold also impacts
other SBM parameters which in turn affects relaxivity. To determine which strategy is the
most advantageous, there needs to be a systematic and thorough inquiry into the most
effective attachment strategy in terms of relaxivity and synthetic ease.
1.7. Scope of This Work
Multiple analogs of each BFC attachment strategy on DOTA have been synthesized
and explored for their efficacy within the context of water exchange kinetics and relaxivity.
Chapter 2 explores the impact of chelates of NB-DOTA and its derivatives have on
relaxivity, water exchange, and hydration state. Chapter 2 also includes an exploration of
chelates more rigid tetra-methylated NB-DOTMA chelates and a comparison to its parent
NB-DOTA. Chapter 3 compares the three main attachment strategies directly; three
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chelates were synthesized of similar molecular weights and hydrodynamic volumes each
representing an attachment strategy. These chelates were then converted to pseudo-BFCs
through the incorporation of a large biphenyl moiety, and their performances were
compared in terms of water exchange and molecular tumbling, and that impact on
relaxivity. Chapters 4 & 5 explore the impact of other types of moieties substituted on all
four -carbon pendant arms have on the water exchange mechanism and relaxivity. These
chelates were then crystallized to glean further information into their properties. Chapter 6
explores other types of mono-amide containing chelates as potential chemical exchange
saturation transfer agents (CEST).

52
CHAPTER 2
MACROCYCLE SUBSTITUTED CHELATES
2.1. Chelates Undergoing Extremely Fast Dissociative Water Exchange
SBM theory calculations have described a chelate that undergoes fast dissociative
water exchange (M ~ 20 ns), will yield the highest relaxivity.55 This in turn resulted in new
synthetic strategies to yield fast exchanging agents. Yet, the expectedly high relaxivites
were not achieved when the barrier of R was lifted, and tumbling was slowed. The reason
behind this discrepancy was not made clear until relaxometric data was generated for a new
chelate, GdNB-DOTMA, which exists as four discrete isomers in solution that can be
studied independently. The TSAP isomer of GdNB-DOTMA allowed for extremely rapid
water exchange to be determined and compared directly to its slower exchanging SAP
counterpart.
This was further confirmed when a biphenyl moiety was attached to the ligand
facilitating a longer R. Our group has demonstrated that the isolated TSAP and SAP
coordination isomers of GdBP-DO3MA Corner have vastly different M values.56 Although
they are both the Corner regioisomer, the SAP coordination geometry has a M value nearly
10 times that of TSAP. The only explanation for these differing M values for the same
regioisomer is one in which hydration state is reduced for the extremely rapidly exchanging
TSAP isomer.
While theory dictates that a chelate with a rapid dissociative water exchange rate
and slow molecular tumbling yields highest calculated relaxivity values, there is a point in
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which a chelate exchanges water too quickly, resulting in a detrimental impact on r1.56 The
reason behind this “Goldilocks zone” of dissociative water exchange lies in hydration state,
q/r6. It has been proposed that a chelate with a very fast dissociative water exchange rate
reduces q/r6, and is considered to have a reduced hydration state.2 Hydration state is a
measure of metal-proton distance (rGd-H) and the number of water molecules directly
coordinated to the metal center (q), an approach that more accurately describes the nature
of hydration, first implemented by Bertini et. al.46 Due to the octadentate structure of NBDOTA, the hydration number, q, of its Gd3+ chelate will always equal one. The sixth order
dependence of the metal-proton distance on relaxivity arises from the intrinsic nature of
the dipole-dipole interaction.

Figure 2.1. The dissociative water exchange mechanism described herein.

If dissociative water exchange is incredibly rapid, the amount of time a water
molecule spends coordinated to the metal center might be shorter than the time it spends
uncoordinated. Theory dictates that kex = 1/M when the time the water spends
uncoordinated with the metal, off, is negligible.32 In a dissociative mechanism, the water
must leave before a second coordinates, and q = 1 means we only need to consider two
water molecules, the one coordinated and leaving (H2Oa) and the one coming in to
coordinate (H2Ob), Figure 2.1. H2Oa must leave before H2Ob can coordinate, but we cannot
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determine this value experimentally. However, in the fast exchange regime when M < 30
ns, the amount of time H2Oa spends coordinated is very short. Thus, we can assume that
the exchange to H2Ob is also considerably rapid, yet still an influencing factor on relaxivity.
Thus, kex ≠ 1/M, instead off contributes to the overall dissociative exchange mechanism.
If off is now considered a non-negligible value, then we must consider its impact on
hydration state.
The process described in Figure 2.1 helps to illustrate the dissociative water
exchange mechanism, however it is important to distinguish the behavior of the binding
interaction to fully appreciate the relaxation process. The nature of the dipole-dipole
interaction does not require the water molecule to be ligated to the metal to feel the effect
of relaxation, thus, it is more constructive to think of this process as a matter of metal-water
distance rather than “bound” or “unbound”.57 Secondly, because q will always equal 1, the
more important parameter to consider is that of rGdH. The process described in Figure 2.1
depicts the importance of this distance, to differentiate between the “on” and “off” state.
Because water exchange is rapid, it is difficult to consider these two states
independently. Rather, it is more productive to think of hydration as a time averaged value.
In any dissociative water exchange process, the time the water is “bound” must be
significantly longer than it is “unbound”. However, once exchange becomes increasingly
rapid, the contribution of the “unbound” state becomes more significant, resulting in an
increase in the time averaged water exchange rate constant. As the time averaged water
exchange constant increases, there is an increase in the metal-water distance. Describing
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increasingly rapid water exchange as a change in rGdH elucidates the effect extremely rapid
water exchange has on chelate hydration.
It is also important to consider the dynamic component of rGdH. Because this value
is not a measurably accessible parameter, it is assumed based on solid state crystal structure
analysis of the Ln-OH2 bond. But not only does that not accurately describe the distance
from the metal to the proton, it neglects to address the dynamics involved in the water
exchange process. Viewing rGdH as a static component rather than a dynamic one is a pitfall
in properly understanding water exchange rate. Thus, if we describe the water exchange
process as a change in rGdH, we can begin to appreciate how hydration is impacted, and
thus better describe the effect seen in these rapidly exchanging chelates.
The resulting impact of these data is unanticipated; the hydration state of a chelate
can be reduced by an extremely rapidly exchanging chelate. This limits the highest
achievable relaxivity for an extremely rapidly exchanging chelate, because a reduction in
hydration state results in a decrease in relaxivity. Two chelates, GdNB-DOTA and GdNBDOTMA are two multi-isomeric systems that has been identified to undergo extremely
rapid dissociative water exchange. These chelates have been prepared by Drs. B. Webber
and K. Payne previously in our group, however further analyses of these systems had
remained unconducted.
2.2. The impact of rGdH on R
As described in Chapter 1, the distance between the lanthanide center and proton
of the coordinated water molecule is a difficult parameter to ascertain. It is typically
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assumed based on crystallographic data, but in fact is not known. As a result, the value
chosen for rGdH is a somewhat arbitrary value, yet its impact is profound on relaxivity and
rotation. Muller et. al. has demonstrated this interdependent nature of these two values by
fitting NMRD profiles to different rGdH values to generate different R values, as shown in
Table 2.1.58 The data in Table 2.1 highlight the importance of choosing the correct value
for rGdH; rotation can vary quite drastically depending on the value chosen. However, due
to the difficulty in determining the value for rGdH experimentally, it is more logical to
experimentally determine R, and allow for rGdH to be determined from fitted data. If R is
determined experimentally, the value for rGdH can be allowed to wander, and a more
accurate description of hydration state can be depicted. However, as described in Chapter
1, independent measurements of R can be difficult to ascertain and have some limitations.
Table 2.1. Values of R generated by fitting different values of rGdH to the NMRD profile of
MS-325 at 310 K.58

2.3. Regioisomerism in Macrocycle Substituted Chelates
Six years after the debut of NB-DOTA as a potential BFC for MRI, it was found
the introduction of the nitrobenzyl substituent on the macrocycle introduced two new
regioisomers upon chelation; in which the nitrobenzyl group is situated on the “Corner”
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carbon of the macrocycle, or “Side” carbon, as demonstrated by the Dale structures in
Figure 2.2.59 These two regioisomers are distinct; it is not possible to interconvert between
the Corner and Side regioisomers, due to the nitrobenzyl substituent preventing ring
inversion.60 Research by Payne and Webber has established that the Corner and Side
isomers of GdNB-DOTA have different properties.50,61 Their different hydrophobicities
allows them to be separated via RP-HPLC, with a ratio of 75% Corner and 25% Side, as
shown in the chromatogram in Figure 2.3, allowing them to be studied independently.62

Figure 2.2. Dale structures of the four coordination geometries of GdNB-DOTA.
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Figure 2.3. RP-HPLC chromatogram of the separation of the Corner and Side isomers of
GdNB-DOTA monitored at  = 270 nm.

The ratio of SAP and TSAP are also different in NB-DOTA chelates; the Corner is
95% SAP whereas the Side maintains 45% SAP coordination geometry. As a result, water
exchange kinetics in the Corner is expected to be much slower in comparison to the Side.
Chelates of NB-DOTMA also differentiate into Corner and Side isomers upon chelation.
The main difference is the addition of a methyl group substituted on all four -carbon
acetate arms results in four distinct chelates, as shown by their Dale structures, Figure 2.4.
This selective substitution affords for the impact coordination geometry as well as
regioisomerism has on relaxivity and its corresponding parameters. It is expected that the
two TSAP isomers are expected to have extremely rapid water exchange kinetics in
comparison with their SAP counterparts.
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Figure 2.4. Dale structures of the four coordination geometries of GdNB-DOTMA

2.4. Relaxometric Analysis of the Corner and Side Isomers of GdNB-DOTA
GdNB-DOTA was prepared by Dr. K. Payne and relaxometric analysis was
conducted by our collaborator, Professor M. Botta at the University of Eastern Piedmont
Amedeo Avogadro in Torino, Italy. The transverse relaxation rate constant, R2, of 17O was
measured for both the Corner and Side of GdNB-DOTA at various temperatures. These
data were fitted to SBM theory, and the water exchange lifetimes for both chelates were
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determined, Figure 2.5 Top. The relaxivity, r1, was measured as a function of magnetic
field strength to construct NMRD profiles, Figure 2.5 Bottom.

Figure 2.5. Top: Temperature dependence of 17O transverse relaxation rate constants of the
Corner (◆) and Side (◼) isomers of GdNB-DOTA. Bottom: NMRD profiles of the Corner
(◆) and Side (◼) isomers of GdNB-DOTA recorded at three temperatures.
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O-NMR data collected to SBM equations allows

various physico-chemical parameters associated with the chelate to be determined, these
data are shown in Table 2.2.63
Table 2.2. Calculated relaxometric values from the fitted 17O-NMR R2p and NMRD profiles
of GdNB-DOTA, at 298 K and 20 MHz from Rust et. al.63

The most obvious difference when comparing the Corner and Side is their very
different relaxivities. The Side isomer has a higher relaxivity than the Corner.
Regioisomers would be expected to exhibit the similar properties, thus the Corner and Side
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should have identical relaxivities. This difference could be explained by the fact that the
Side isomer has a much higher percentage of TSAP in solution. It has been demonstrated
that a high ratio of TSAP can result in extremely rapid dissociative water exchange and
produce lower relaxivity.56 Reviewing the M values for the Corner and Side, it is confirmed
that the Side isomer undergoes rapid dissociative water exchange; its weighted M value is
over 10 times shorter than the Corner. The M value of 12.4 ns observed in the Side means
that it is undergoing such a rapid dissociative exchange mechanism, that it must experience
a reduced hydration state, q/r6. However, we do not observe the expected detrimental
impact this would have on relaxivity. In fact, it has a higher relaxivity value than that of
the Corner. So, we must posit the question, what is facilitating the high relaxivity observed
in the Side while simultaneously allowing it to suffer a reduction in q/r6? This explanation
must fall in terms of rotational correlation time, R.
The data presented in Table 2.2 show that the Corner isomer tumbles at a faster rate
(R = 90 ps) than the Side isomer (R = 120 ps). The Corner and Side are regioisomers; they
have identical molecular masses and structures and should therefore have similar
hydrodynamic volumes; they should tumble at the same rate in solution. However, the data
presented in Table 2.2 suggest otherwise, so either these data were fitted incorrectly or,
these two isomers have different properties. In a low-molecular weight chelate exclusively
undergoing dissociative water exchange, the predominating influences on relaxivity are R
and q/r6,64. Thus, in order for the Side to have a higher relaxivity than the Corner, it must
be tumbling at a slower rate. Otherwise we would observe the impact of a reduction in q/r6
causing the relaxivity of the Side to be lower than the Corner. This is a result of the
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interplay of R and rGdH. TSAP isomers that are in rapid water exchange have demonstrated
to have a longer rGdH value.51 However, the increase in rGdH will result in an increase in
R.58 A value of 3.1 Å is a justifiable rGdH for a pure TSAP isomer; however this value
results in the expected longer R shown in the Side isomer with its higher proportion of
TSAP in solution.51 However, the increase in R experienced by the Side isomer when rGdH
is increased is not justified without further exploration into tumbling between the two
regioismers.
2.5. Relaxometric Analysis of the Corner and Side Isomers of GdNB-DOTMA
The four isomers of GdNB-DOTMA were prepared by Drs. B. Webber and K.
Payne and analyzed relaxometrically by Professor M. Botta. The relaxometric values
determined after fitting the 17O-NMR and NMRD profiles for the four isomers are shown
in Table 2.3. As expected, the M values for the TSAP isomers of both the Corner and Side
were much shorter than their SAP counterparts. The reduction of hydration state for these
extremely rapidly exchanging chelate results in a reduced relaxivity for both TSAP
isomers.
What is most interesting about these data, is the R values for the SAP Corner
isomer and both TSAP isomers are nearly identical. However, the longer R value of the
SAP Corner isomer results in a longer relaxivity in comparison to the two TSAP isomers,
because of the decrease in q/r6 for both TSAP isomers. One anomaly in these data is the
TSAP Side isomer: it has the lowest R values of the four chelates and is shorter than the
other TSAP isomer. There are two possible explanations for the short R of the TSAP Side.
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Either the interdependent nature of the fitting parameters impacts a change of R, or, the
Side isomers behave differently in solution. The most effective means to probe this
anomaly is through independent analyses of molecular tumbling.
Table 2.3. Selected fitted relaxometric values for the four isomers of GdNB-DOTMA at 298
K and 20 MHz. Values from Webber et. al.65

2.6. Exploration into Self-Association of the Side Isomer of GdNB-DOTA
A series of experiments were undertaken to develop a thorough understanding of
how molecular tumbling impacts hydration and relaxivity in NB-substituted chelates. We
hypothesized that for the Side isomer to tumble at a slower rate than the Corner, it must be
either forming an aggregate, or self-associating in solution. This would account for the fact
that the Side has faster than optimal dissociative water exchange kinetics than the Corner,
yet higher relaxivity. We first sought to explore this phenomenon on the two regioisomer
chelates of NB-DOTA.
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2.6.1. T1-Relaxation Studies on GdNB-DOTA
Our first approach in testing this hypothesis to collect variable temperature
longitudinal relaxation measurements on the Corner and Side isomers at 20 MHz. T1
relaxation measurements were taken in triplicate at five different concentrations to generate
a curve of r1 versus temperature. Theoretically, as the concentration of the chelate
increases, the likelihood of self-association in the Side would increase, and thus tumbling
would be slowed, and we would observe the Side isomer to have a higher relaxivity than
the Corner. Our results were inconclusive; there was not a discernable differences in the
relaxivities of the Side versus Corner as the concentration was increased, as shown in
Figure 2.6. We hypothesize that collecting data at one field strength limited the results.

Figure 2.6. Relaxivities (r1) of GdNB-DOTA Corner (◆) and Side (◼) isomers at different
concentrations and temperatures.

2.6.2. Attempt of an Amino-Substituted Chelate (GdAB-DOTA)
We hypothesized that reduction of the nitro-substituent to an amino group –
converting GdNB-DOTA to GdAB-DOTA, would increase the hydrophilicity of the
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benzylic substituent. This would reduce the effect of self-association. Several attempts of
isolating pure chelates of GdNB-DOTA Corner and Side were undertaken, however due to
the increased hydrophilicity of the amino group, the crude chelate was difficult to separate
into regioisomers on the RP-HPLC. Nevertheless, the RP-HPLC method was eventually
optimized and samples were sent to our collaborator for analysis, but the NMRD profiles
proved inconclusive; the multiparameter influence on relaxivity prevented a definitive
determination if tumbling was different between the two.
2.6.3. 1H-NMR Experiments on EuNB-DOTA
The next set of experiments involved collecting 1H-NMR spectra of both the Corner
and Side isomers of EuNB-DOTA at seven different concentrations of chelate, against a
tert-butanol internal standard. By collecting spectra at increasing concentrations of chelate,
we hypothesized that we would observe a change in shift of the SAP axial proton
resonances of the macrocycle. We postulated that the change in shift would be different for
the Corner and Side, because if the Side self-associated, the “dimer” would shield these
protons and shift them upfield. However, the change in chemical shift of these protons was
incredibly minimal (<0.1 ppm in most cases), that we could not confidently draw
conclusions from this experiment.
2.6.4. Luminescence Studies on NB-DOTA Chelates
2.6.4.1. Stern-Volmer Experiments: Self-Quenching Study
Previous studies have demonstrated the presence of dimers in solution using SternVolmer experiments.66,67 These experiments used a Nd3+ chelate as a quencher for a Eu3+
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chelate. Titrating the Nd3+ chelate into a solution of the Eu3+ chelate affords Stern-Volmer
quenching constants for the luminescent lifetime (KSV) and the emission intensity (KSV).
KSV is largely determined by collisional quenching and therefore should be unaffected by
self-association. In contrast, KSV is affected by both collisional and static quenching and
is sensitive to self-association. Comparing these two quenching constants can afford an
assessment of the extent of self-association.
A sample of NdNB-DOTA Corner was titrated it into a solution of EuNB-DOTA
Corner, then the emission intensity and luminescence lifetime of Eu3+ was measured. This
experiment was then repeated with the Side isomer. These experiments should be
conducted at low concentrations to avoid the effects of self-quenching; thus, the first
experiment was conducted at [EuNB-DOTA] = 10 M and [NdNB-DOTA] = 0 – 37 M.
The determined quenching constants showed there is little to no meaningful difference
between them, Table 2.4. However, it is likely that self-association does not occur at the
low concentrations at which these experiments were conducted; these experiments were
conducted at two orders of magnitude lower than the 1H-NMR relaxometric experiments
and three orders of magnitude lower than the 17O-NMR relaxometric experiments. If selfassociation is weak, it is reasonable to assume than an effect observable at higher
concentrations would be undetected at much lower ones. The Stern-Volmer plot can be
seen in the Chapter 2 Appendix. Attempts to run Stern-Volmer experiments at higher
concentrations, such as those used in relaxometric studies were frustrated by significant
non-linearity in the data, attributed to self-quenching.
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Table 2.4. Stern-Volmer quenching constants for the luminescence lifetime and emission
lifetime for NB-DOTA Corner and Side.

2.6.4.2. Fluorescence and Absorbance Studies
We hypothesized that if the Side self-associates, it will be observable via
fluorescence or absorbance spectroscopy. This may result in shifts to the emission or
absorbance peaks or change their intensity. In order to test this possibility, solutions of
GdNB-DOTA Corner and Side were prepared over the following concentrations: 0.2 mM,
0.25 mM, 0.32 mM, 0.4 mM, 0.5 mM, 0.64 mM, 0.8 mM, 1 mM, 1.25 mM, 1.6 mM, and
2 mM. Emission spectra of each solution were collected at ex = 270 nm, 297 nm, and 340
nm. The intensity values from the emission data of the peaks at 597 nm (ex = 297 nm),
and 543 nm (ex = 270 nm), were plotted as a function of chelate concentration. Excitation
spectra of each solution were collected at em = 400 nm, 535 nm, and 590 nm.
The data from these experiments showed a decrease in intensity as a function of
increasing concentration for both Corner and Side isomers. This general trend is an
indication of self-quenching of the chelate due to increased molecular collisions. The Side
isomer however, decreased in intensity much more rapidly than the Corner with increasing
concentration. These results were promising; the Corner and Side behaved differently in
both sets of data, but definitive conclusions remained difficult to draw. These spectra can
be seen in the Appendix.
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2.6.5. Curie Relaxation Study on TbNB-DOTA

Scheme 2.1. Chelation of NB-DOTA with terbium chloride.

The final study into self-association of the Side isomer was a multi-field Curie
relaxation experiment. Utilizing this methodology, R can be determined independently,
allowing us to confirm that the Corner and Side isomers do indeed tumble at different rates.
Chelation of NB-DOTA with terbium chloride was achieved in water at pH 5.5, Scheme
2.1. The Corner and Side regioisomers were separated via RP-HPLC, then 1H-NMR spectra
of each were collected at three magnetic field strengths, 9.4 T, 11.5 T, and 14.1 T at 298
K. The Curie-spin mechanism is specific for each lanthanide and contributes to the
transverse relaxation rate of a proton. It is dependent on the magnetic field strength (B0),
the metal-proton distance (rLn-H) and the rotational correlation time. Curie-spin can be
defined by equation 2.1.68 Assuming the metal-proton distance from crystallographic data,
the Curie-spin mechanism allows for the mathematical determination of R of the metal –
axial proton vector independently from

17

O-NMR and NMRD at a given temperature.

Although this value is not identical to the R determined for the metal – OH2 vector, it is
similar and allows us to compare the values generated from both experiments.
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Equation 2.1. The Curie-spin mechanism contribution to transverse relaxation rate. Where
0 is the vacuum permeability, I is the gyromagnetic ratio, B is the Bohr magneton, eff is
the effective magnetic moment of the lanthanide ion, kB is the Boltzmann constant, T is the
temperature, r is the metal-proton distance, and R is the rotational correlation time.

Evaluation of NMR spectra of the two TbNB-DOTA complexes were completed
through an analysis of their most shifted axial proton (axS) of the macrocycle ring, as shown
in Figure 2.7. Using the metal-proton distance from the crystal structures of TbTCE-DOTA
(SAP) and TbDOTMA (TSAP), these data were fit into Equation 2.1 for the determination
of R, Table 2.5.51,69 The values for rLnH were chosen as a better representation of the Corner
and Side chelates. Crystal structures for the terbium complexes for TCE-DOTA and
DOTMA exist in primarily the SAP and TSAP coordination geometry, respectively, and
allow for a more accurate description of the Corner and Side terbium chelates of NBDOTA synthesized. Data for TbNB-DOTA Corner SAP was not collected due to the low
abundance of this species in solution (5%).
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Figure 2.7. The most shifted axial proton (axS) dependence on the transverse relaxation rate
of TbNB-DOTA Corner SAP (⚫), Side SAP (), and Side TSAP () at three magnetic field
strengths, 9.4 T, 11.5 T, and 14.1 T at 298 K. G = 10-4 T.

Table 2.5. Terbium – proton distances (rTbH) and rotational correlation times (R) for TbNBDOTA Corner and Side using the Curie-spin mechanism.

It is clearly shown that these two chelates, Corner and Side, tumble differently in
solution. The values of R obtained with the rotational correlation times generated via
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fitting the NMRD profiles (Table 2.3), suggesting the values selected for the metal-proton
distance to be accurate. The slower tumbling rate of the Side isomer in comparison to the
Corner confirms our hypothesis that the Side self-associates in solution. This slowed
rotation would account for its higher relaxivity despite its faster than ideal dissociative
water exchange rate and reduced hydration state.
As predicted, these results confirm that the Side isomer suffers from a reduction in
hydration state due to its faster than optimal dissociative water exchange kinetics.
However, this does not cause the expected negative impact on relaxivity owing to its slower
tumbling; in fact, it has one of the highest relaxivities of any low molecular weight
macrocyclic chelates. This is in contradiction to established theory that a chelate with a
reduced hydration state will have lower than optimal relaxivity. Thus, it seems as if its
slower tumbling rate resulting from self-association, compensates for its extremely rapid
dissociative water exchange. The interdependent nature of the SBM equations prevents
independent probing of each value to determine its impact on relaxivity; a change in one
relaxometric value results in an expected change in another. Thus, it is impossible to
determine the true impact hydration state has on overall relaxivity without further
experimentation.
2.6.6. Curie Relaxation Approach on TbNB-DOTMA
Methyl (R)-2-(((trifluoromethyl)sulfonyl)oxy)propanoate (2-1) was synthesized
from methyl-D-lactate under air- and water-free conditions, with 2,6-lutidine in
dichloromethane (-78 °C to ~20 °C). 2-1 was then alkylated on NB-cyclen (purchased from
Macrocyclics®) with potassium carbonate and dichloromethane (-78 °C to ~20 °C, 18 hrs;
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40 °C, 48 hrs), resulting in an enantiopure ligand (Me4-NB-DOTMA S-SSSS). The ligand
was then chelated with TbCl3 and purified via preparatory RP-HPLC to yield two TbNBDOTMA complexes: Corner S-SSSS (TSAP), and Side S-SSSS (TSAP), Scheme 2.2.

Scheme 2.2. Synthesis of TbNB-DOTMA S-SSSS.

1

H-NMR spectra were collected of TbNB-DOTMA Corner and Side at 2.1 T, 9.4

T, and 14.1 T and 302 K. Analysis of their most shifted axial protons was completed as
demonstrated in Aime et. al. via line-width analysis.35 Because Tb3+ chelates of NBDOTMA are not isochemical to their Gd counterparts, and due to the lack of temperature
control on the 90 MHz spectrometer, we cannot allow this analysis to be an exact
measurement or comparison to the R values determined via NMRD analysis. Therefore,
the data presented in Table 2.6 are given without errors and should be treated as general
trends and not exact values. However, we can examine the differences observed between
the two analyses. Because Tb3+ does not have an isotropic f-shell, it will exhibit anisotropy
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in an external magnetic field, this can give rise to differences in the observed NMR signal,
as shown in the line-width analysis in Figure 2.8 Top.

Figure 2.8. Analysis of the most shifted axial (axS) protons of TbNB-DOTMA (S-SSSS)
Corner and Side isomers. Top: 1H-NMR spectra of the most shifted axS protons of the two
regioisomers. Bottom: Field dependence of the transverse relaxation rate constant of the most
shifted axS protons of the Corner (blue) and Side (red) regioisomers.65
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The line-width analysis of the two Tb3+ complexes showed that the axS protons with
the widest lines tumble the most slowly, Table 2.6. As expected, the slower molecular
tumbling observed corresponds to the higher transverse relaxation rate determined for these
protons, Figure 2.8 Bottom. Conversely, the narrowest lines of both Tb3+ complexes show
that they tumble the fastest, Table 2.6, resulting in a much lower R2, Figure 2.8 Bottom.
This large difference in anisotropy observed within the line-width analysis coincides with
disparate estimated R values in Table 2.6, yet, the general trend when we observe the
analysis of the widest versus shortest line R values both depict the Side tumbling more
slowly. Furthermore, when the average is taken of all the lines, to reduce the observed
anisotropy, the Side isomer still tumbles slower than the Corner. These data, supported by
our previous Curie relaxation analysis of NB-DOTA chelates, demonstrate that although
the Corner and Side are isomers, they tumble at different rates.63 We were able to publish
these findings in 2020.65 This independent observation of different molecular tumbling
rates of regioisomers is remarkable; their different in solution behavior requires further
experimentation.
Table 2.6. Estimated R values for TbNB-DOTMA S-SSSS Corner TSAP and Side TSAP
from the Curie relaxation analysis of the 1H-NMR spectra presented in Figure 2.8.65
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2.6.7. The Difference in Exchange Between Corner and Side Isomers
All the systems studied herein demonstrate the Side isomer exhibiting faster water
exchange kinetics. Density functional theory (DFT) can be used to calculate the effect
substitution has on the macrocycle ring. DFT calculations collected by our collaborator Dr.
T. McCormick show the macrocycle having to distort to accommodate the bulky
nitrobenzyl substituent, Figure 2.9. The distortion in the antiprism NCCN torsion angle ()
influences the location of the metal within the cage; the Corner isomer with an  of 68.4°
and 66.9° for the Side. Crystallographic data of LnDOTMA chelates demonstrate that
dissociative exchange most likely arises from flattening of the macrocycle ring.70 The
lower  of the Side correlates with the flattening of the macrocycle, and implies the Side
isomer distorts in a conformation that is closer to the transition state of exchange. This
distortion would reduce the energy barrier to dissociative water exchange, causing the
mechanism of exchange to be increasingly rapid.

Figure 2.9. DFT modeling calculations of the distortion of the macrocyclic cage in GdNBDOTA Corner (Blue), and Side (Pink).
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2.7. Conjugation with a Biphenyl Moiety – Implications as a Bioconjugate
Although we were able to demonstrate that the Corner and Side isomer have
different water exchange kinetics, the impact of this on relaxivity has not been thoroughly
explored. Because the Side isomer self-associates in solution if that action is lifted it will
still maintain a high relaxivity. By adding a biphenyl moiety via a thiourea off the
macrocycle, the chelate will participate in hydrophobic interactions which in turn will
induce it to tumble more slowly; the barrier of R can be lifted and the effects of water
exchange on relaxivity becomes evident.
The commercially available IB-DOTA (purchased from Macrocyclics®) was
reacted in a biphasic solution of 4-phenylbenzylamine in water and dioxane (~20 °C, pH
9) to yield the target ligand, BP-DOTA. This was then subsequently chelated with
GdCl3‧6H2O in water at (pH 5.5 60 °C), then the Corner and Side regioisomers were
separated via RP-HPLC to yield the two pure target chelates, Scheme 2.3.

Scheme 2.3. Synthesis of target chelate, GdBP-DOTA from IB-DOTA.
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An addition of a biphenyl moiety has been shown to induce a chelate to form
micelles in solution above a certain concentration, known as the critical micelle
concentration (CMC).71 Through dynamic light scattering (DLS) it was determined that the
Side forms a much larger micelle in comparison to the Corner; 18 nm compared with 10
nm, Figure 2.10. A micelle that is nearly twice the size of its regioisomer indicates the Side
is self-associating prior to micellular formation.

Figure 2.10. Dynamic light scattering (DLS) distribution of the micelles formed by the Corner
(●) and Side (●) isomers of GdBP-DOTA.

NMRD profiles were generated for both Corner and Side isomers of GdBP-DOTA,
Figure 2.11. The fitted NMRD profiles generated relaxometric values, Table 2.7.
Reviewing the data generated for both chelates below their respective CMCs, illustrated as
circles in Figure 2.11, the introduction of a bulky biphenyl moiety slowed down R in
comparison with the NB derivatives, and resulted in an expected increase in relaxivity. In
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consistence with the relaxometric data from the NB-DOTA chelates, the Side tumbles
much slower in solution in comparison with the Corner, 190 ps compared to 120 ps,
respectively.

Figure 2.11. NMRD Profiles at 298 K of GdBP-DOTA Corner below the CMC (), and above
the CMC (▲); Side below the CMC (), and above the CMC (▲). [Corner]below = 0.15 mM,
[Corner]above = 1.51 mM; [Side]below = 0.2 mM, and [Side]above = 1.48 mM.

Although these data support the premise that the Side tumbles slower than the
Corner due to self-association, this system cannot be fully appreciated while these chelates
are behaving as discrete molecules in solution. Thus, increasing the concentration to the
point of micellular formation, the effects of self-association observed in the Side can be
highlighted.
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Table 2.7. Relaxometric values from the fitted NMRD profiles of the Corner and Side isomers
of GdBP-DOTA at 298 K below the CMC.

The linear dependence of T1 on concentration of gadolinium can allow for the
determination of the concentration in which a molecule forms a micelle. The CMC was
determined by collecting T1 at 298 K and 20 MHz as a function of chelate concentration,
and the concentration in which the relaxation rate deviates from the linear dependence is
the CMC. The resulting fitted data from the NMRD profiles as well as CMC determination
are shown in Table 2.8, with the NMRD profiles above their respective CMC values are
illustrated as the triangles in Figure 2.11.
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Table 2.8. Critical micelle concentrations, micelle diameters, and relaxivities from the NMRD
profiles of GdBP-DOTA Corner and Side above the CMC at 298 K and 20 MHz.

As shown in the data in Table 2.8, the GdBP-DOTA Side has a higher CMC when
compared with the Corner. These findings are surprising because the chelates are
regioisomers of each other and thus have identical molecular weights and should have
identical hydrodynamic volumes. The Side forming micelles at a higher concentration than
the Corner further supports these chelates behaving differently in solution.
Analysis of the fitted relaxometric data from the NMRD profiles of GdBP-DOTA
Corner and Side above their CMCs provides insight into the impact of two relaxometric
properties on relaxivity. Incorporation of these hydrophobic chelates into micelles fully
lifts the impact R has on relaxivity. Thus, the true impact q/r6 can be probed. As seen by
the NMRD profiles of GdBP-DOTA Corner and Side above the CMC, they have very
different relaxivities, Table 2.8. At 298 K and 20 MHz, the Side was found to have a
relaxivity nearly double that of the Corner. Yet, while reviewing their M values, the Side
is exchanging water so rapidly, it is considered higher than optimal; the compensatory
factor of its slow molecular tumbling, from its self-association, allows for the Side to have
a much higher relaxivity value.
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Thus, slow rotation has a greater impact on relaxivity than hydration state,
especially at high fields. This is highlighted by the “hump” seen in the NMRD profile ~20
MHz. When the rotation of a chelate is substantially slowed, relaxivity is optimized, due
to R modulating close to the Larmor frequency of the protons on water. The incorporation
of a large bulky group and subsequent micelle formation allows for this slowed rotation
and therefore optimal relaxometric kinetics. Although the “hump” is observed in the Corner
isomer, it is less pronounced due to its shorter R.
The relaxometric results of the Side isomer are promising in terms of designing a
bifunctional chelator with optimal relaxivity. However, it is important to recognize that the
Side isomer constitutes only 25% of the overall sample of chelate and is incredibly
expensive and difficult to synthesize. Furthermore, if we remove the impact of selfassociation of the Side, which most likely would not occur when a macrocycle substituted
bifunctional chelator is incorporated into a bioconjugate, the detrimental impact of having
a reduced hydration state would result in limited relaxivity.
2.8. Conclusions
Our independent experimental determination of R for both regioisomers of GdNBDOTA and TbNB-DOTMA via Curie relaxation studies allowed us to glean insight into
the impact rotation has on relaxivity. These experimental data revealed that the Corner and
Side tumble at different rates. We were able to demonstrate that the Side isomer selfassociates in solution while the Corner does not, thus causing a longer R and higher
relaxivity. Yet the rotation was still too rapid to determine the impact on relaxometry.
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Through the addition of a biphenyl moiety on the macrocycle, we lifted to barrier of rapid
rotation of a small molecular weight chelate, to determine which has a greater influence on
relaxivity: rotation or dissociative water exchange. We demonstrated that due to the
extremely rapid dissociative exchange mechanism of the Side isomer, the amount of time
water spends unbound is non-negligible. As a result, the rapid dissociative exchange
mechanism of the Side isomer results in a reduced hydration state.
Although the Side has slower rotation than the Corner due to self-association in
solution, this impact on optimal relaxivity is limited. When designing a scaffold for a
bifunctional chelator, the final incorporation into the bioconjugate must be considered. The
self-association seen in the Side isomer of both the nitrobenzyl and biphenyl derivative
would likely not occur in a macromolecular bifunctional chelator. As a result, the faster
than optimal dissociative water exchange kinetics of the Side would have a detrimental
effect on relaxivity, due its reduced hydration state. The Corner isomer does not exhibit
ideal rotational correlation or dissociative water exchange kinetics to be considered as a
scaffold for a bifunctional chelator.
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CHAPTER 3
COMPARISON OF THREE FUNCTIONALIZATION STRATEGIES
3.1. Building a Better Bifunctional Chelator
The growing prevalence of bifunctional chelators (BFCs) in laboratory settings has
generated a myriad of data regarding ideal structure and function. Furthermore, the
commercial availability for many macrocyclic and linear precursors allow researchers to
easy alter the active moiety for a variety of functionalization applications. However, there
are some considerations when designing this scaffold. Their ubiquity in the laboratory
setting is not matched in clinical practice, and as a result, their long-term stability in vivo
has not been addressed. Additionally, there has not been a thorough study into the impact
on relaxometric properties based on the point and method of functionalization. Three
commonly implemented strategies for attachment of the targeting vector are: off the
macrocycle, through a monoamide pendant arm, or on the -carbon of one of the pendant
arms, as illustrated in Figure 3.1.
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Figure 3.1. Point of attachment of a targeting vector on a DOTA-based BFC; off the
macrocycle (Left), through a monoamide pendant arm (Center), or on the -carbon of a
pendant arm (Right).

In Chapter 2, the effects of substituting a nitrobenzyl moiety on the macrocycle ring
of a DOTA chelate were explored. NB-DOTA is a well-established macrocyclic BFC
precursor, and as a result, we sought to design ligand systems that can be compared directly
to this structure in terms of efficacy and synthetic ease. This will allow for the direct
comparison of the results in Chapter 2 with two new structures that were designed to be of
a similar size.
The first structure we designed to directly compare to NB-DOTA is DO3A-NBAM.
This monoamide substituted ligand has an identical molecular weight to NB-DOTA, which
allows for direct comparison. The advantage of the NBAM pendant arm is two-fold; no
stereocenters are generated on the chelate, and the synthesis is shorter and cheaper. A major
advantage of this synthetic strategy is that the relatively mild conditions and inexpensive
starting materials means it could be easily translated into a large-scale industrial setting. In
contrast, the starting material for NB-DOTA, NB-cyclen, is synthetically difficult and low-
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yielding, thus very expensive, secondly, once chelated, NB-DOTA adopts two distinct
regioisomers that require costly separation via RP-HPLC.
However, one drawback of the NBAM system is in the effect of replacing a
negatively charged acetate with a neutral amide has been shown to cause much slower
water exchange.72 This is due to a reduction of electron density around the metal center,
causing it to hold onto the water molecule for a longer time, even if it has been sufficiently
relaxed. Therefore, the overall impact on relaxometry needs to be explored.
The second attachment strategy we explored for comparison to NB-DOTA is
attaching a moiety on an -carbon of one pendant arm. DOTA-NF differs from NB-DOTA
and DO3A-NBAM by one methylene group due to the mechanism of synthesis; if the
moiety were a benzyl rather than a phenyl substituent, the elimination product rather than
the SN2 would predominate. However, this slight difference is the closest possible synthetic
structure that will allow for comparison. A benefit of this strategy is that it allows for the
complex to maintain the electron dense tetra-acetate pendant arms unlike GdDO3ANBAM, while also not chelating into distinct regioisomers like GdNB-DOTA. DOTA-NF
chelates have been studied previously as a potential scaffold for a BFC, but thorough
analysis of this structure as a bioconjugate have yet to be established.73
These three structures have similar molecular weights and hydrodynamic volumes.
This allows for the comparison of these three strategies in terms of their synthesis and
properties. This direct comparison will allow for the determination of how attachment
strategy influences relaxometry, as shown in Figure 3.2.
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Figure 3.2. The three nitro-substituted macrocyclic chelates analyzed in Section 3.4.1.

Further exploration of these three chelates was taken by the addition of a biphenyl
moiety. This group is added to the macrocyclic structure by first converting the nitro group
to an isothiocyanate, thus transforming the ligand into a BFC. The addition of the bulky
hydrophobic biphenyl group via a thiourea linkage allows for the differences of the location
of the moiety to be probed while examining their behaviors as pseudo-BFCs. The three
biphenyl-containing chelates are shown in Figure 3.3.

Figure 3.3. The three biphenyl-substituted macrocyclic chelates analyzed in Section 3.4.2.
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3.2. Synthesis of Monoamide Attachment Strategy Chelates
3.2.1. Synthesis of Nitro-Substituted Monoamide Chelates (LnDO3A-NBAM)
The total synthesis of LnDO3A-NBAM chelates is shown in Scheme 3.1. The
DO3A-tert-butyl ester was prepared using the methods of Raghunand et. al.74 A facile
nucleophilic acyl substitution with 4-nitrobenzylamine generated the 2-bromo-N-(4nitrobenzyl) acetamide (3-1, 77% yield).62,75 DO3A-tert-butyl ester was alkylated with
potassium carbonate and acetonitrile at 60 ℃ using 3-1 to generate the protected ligand (32, 87% yield). The esters were cleaved using 4M HCl in water to generate the ligand
(DO3A-NBAM, 21% yield). The ligand was chelated lanthanide chlorides (EuCl3, GdCl3,
YbCl3) in water and acetonitrile at pH 5.5 to yield the complex, then each was purified via
RP-HPLC (LnDO3A-NBAM).
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Scheme 3.1. Total synthesis of LnDO3A-NBAM Chelates. (Ln = Eu, Gd, Yb).

3.2.2. Synthesis of Biphenyl-Substituted Monoamide Chelates (LnDO3A-BPAM)
The introduction of the biphenyl moiety is shown in Scheme 3.2. This was achieved
by first reducing the nitro group by hydrogenation with Pd/C as a catalyst in water to result
in the amine derivative (DO3A-ABAM, 88% yield). The resulting amine ligand was
converted to an isothiocyanate group with thiophosgene in a biphasic reaction with water
and chloroform (DO3A-IBAM, 86% yield). A biphenyl group was introduced by coupling
the isothiocyanate to the primary amine on 4-phenylbenzylamine in dioxane (DO3ABPAM, 48% yield).
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Scheme 3.2. Synthesis of LnDO3A-BPAM Chelates. (Ln = Eu, Gd, Yb).

Although chelation of DOTA-type ligands is usually facile, the chelation of DO3ABPAM was not. The typical chelation reaction occurs by mixing the deprotected ligand
with excess metal chlorides in a solution of water at pH 5.5; to ensure solubility of both
ligand and metal, and this solution is then gently heated at 60 ℃ for 18 – 24 hours.
Chelation is confirmed when the pH of the solution drops due to release of protons on the
ligand. However, chelation of DO3A-BPAM did not occur under these conditions. The
initial attempts of chelating DO3A-BPAM under standard conditions resulted in the
expected drop in pH, and these solutions were purified via RP-HPLC. The chromatogram
resulted in a single peak, which was confirmed to be pure ligand by 1H-NMR. We
hypothesize the hydrophobic biphenyl moiety prevented the ligand from effectively going
into solution to properly coordinate the free metal. One issue with the initial chelation
reaction was solubility; the hydrophobicity of DO3A-BPAM prevented it from being
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soluble in water, so the reaction mixture was stirred vigorously to ensure interaction of the
metal and ligand. Hence, various solvents were attempted to get both the metal and ligand
in solution, including: acetonitrile, dimethylformamide, dioxane, ethanol, and methanol. It
was found that a mixture of a 1:1:1 acetonitrile, dioxane, and water at pH 8 afforded a
chelate. The isolation of pure chelate via RP-HPLC was also slightly more difficult; free
ligand, clean LnDO3A-BPAM chelate, as well as DOTA and LnDOTA due to hydrolysis
of the amide, were found present in the individual fractions. The new chelation conditions
were altered further to a solution of DO3A-BPAM and relevant metal chlorides (EuCl3,
GdCl3, YbCl3) in a mixture of acetonitrile and water at pH 7, high enough to be above the
pKa of the carboxylates but low enough to not hydrolyze the amide, and this allowed for a
cleaner RP-HPLC chromatogram and pure product (LnDO3A-BPAM).
3.3. Synthesis of -Carbon Pendant Arm Attachment Strategy Chelates
3.3.1. Synthesis of Nitro-Substituted -Carbon Pendant Arm Chelates (LnDOTA-NF)
Although some relaxometric data was collected for GdDOTA-NF, not enough
complex was generated to collect all necessary data, thus more chelate was needed to
complete the analysis. A synthetic route to GdDOTA-NF has been developed by Aime et.
al.73 However, with a large quantity of DO3A-tert-butyl esters and it seemed that DOTANF could be synthesized following a similar route as DO3A-NBAM chelates. The
comparison of these two synthetic strategies are shown in Scheme 3.3.
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Scheme 3.3. Proposed synthetic strategy compared to the literature synthesis of DOTA-NF

Synthesis of a suitable alkylating agent was achieved by an adapted procedure from
Lim et. al., in which a bromide leaving group was installed on ethyl 2-(4nitrophenyl)acetate via an allylic bromination using N-bromosuccinimide and irradiation.76
This reaction results in a racemic ethyl 2-bromo-2-(4-nitrophenyl)acetate product as shown
in Scheme 3.4 (3-3, 86% yield). The preparation of 3-3 used much milder conditions than
a traditional bromination like that proposed by Harpp et. al.; N-bromosuccinimide with
light in acetonitrile, resulting in a longer reaction time (15 days).77
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Scheme 3.4. Synthesis of ethyl 2-bromo-2-(4-nitrophenyl)acetate (3-3)

Although the new proposed preparation of the DOTA-NF ligand appears facile, the
synthesis of the protected ligand proved to be unexpectedly challenging. Alkylation of
DO3A-tert-butyl esters with 3-3 was a slow and low-yielding reaction. It was difficult to
isolate appreciable quantities of the protected ligand 3-4. Therefore, the reaction conditions
were examined. Ligand alkylation optimization was pursued with a multivariable
approach, with the rationale describe below.
In alkylation reactions, the base serves as a “proton sponge”; it coordinates free
protons after the nucleophilic amine on the macrocycle attacks the electrophilic carbon on
the arm. Cesium carbonate is typically used as the base in alkylations due to its high
polarizability and when coupled with a polar aprotic solvent such as acetonitrile, its
increased basicity facilitates C – N bond formation, thus it is common practice to use
Cs2CO3 as the base for these reactions.78 However, due to its large ionic radius, cesium has
the lowest solvation in organic solvents. After multiple attempts in generating sufficient
quantities of 3-4 using Cs2CO3 as the base, other bases were considered in order to improve
their utility. Potassium carbonate is another common base that is used in alkylation
reactions, and with its smaller ionic radius, has slightly higher solubility in organic
solvents. Triethylamine is an organic base that effectively abstracts free protons and is
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completely soluble in organic solvents. In the multivariable approach described in Table
3.1, both potassium carbonate and triethylamine were explored as bases.
Acetonitrile is a common SN2 solvent for alkylations. However, many alkylations
involving -substituted alkylating agents report using chloroform as the solvent system.
After multiple iterations utilizing acetonitrile as the solvent in the alkylation of DO3A-tertbutyl esters with 3-3, changing the solvent to chloroform was done in the multivariable
approach described in Table 3.1.
With preliminary alkylation attempts following the traditional reaction conditions
of Cs2CO3 and acetonitrile, product formation was monitored by ESI-MS. We originally
hypothesized this reaction was slower than previous alkylations; the sterics of a phenyl on
an -carbon are increased in comparison to the benzyl group observed with DO3A-NBAM
synthesis. Thus, the reaction was tested at intervals of 24 hours by ESI-MS. However, we
observed product degradation after reactions left for longer than 48 hours. As a result, for
the multivariable approach, we stopped reactions at the 48-hour mark.
The variable reaction conditions are described in Table 3.1. Product formation was
monitored by ESI-MS where the percent formation is compared to the percent of starting
ligand DO3A-tert-butyl esters.
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Table 3.1. Multi-variable approach to synthesis of the protected ligand (3-4) percent product
formation after 24- and 48-hour reaction times.

The results of this multivariable experiment were unexpected. The presence and
type of base made a large impact; with the reactions containing no base having 1% product
formation at both time points. Although triethylamine is more soluble in chloroform than
potassium carbonate, the inorganic base had a higher product formation at both time points.
The most surprising result is the reaction temperature. Under typical alkylation conditions,
the reactions are heated between 40 ℃ and 70 ℃, common practice is a reaction
temperature of 60 ℃. However, both base-containing reactions had higher product
formation at both time points at the ambient reaction temperature (~20 ℃). We are unsure
as to why the lower temperature yielded more product, yet this experiment demonstrates
that temperature had the greatest impact on product formation.
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As a result of this multivariable approach, for optimal yield the final reaction
conditions for alkylation of DO3A-tert-butyl esters with 3-3 utilized chloroform as the
solvent, potassium carbonate as the base, at room temperature. After alkylation, to yield
the protected ligand 3-4, the tert-butyl esters and ethyl ester were hydrolyzed with
potassium hydroxide, and the ligand was purified via RP-HPLC to generate the ligand
DOTA-NF. The purified ligand was then chelated with lanthanide chlorides (Eu and Gd)
with acetonitrile and water at 60 ℃ and pH 5.5, then purified via RP-HPLC to yield a clean
chelate (LnDOTA-NF). The new total synthesis of LnDOTA-NF chelates is shown in
Scheme 3.5.

Scheme 3.5. Total synthesis of LnDOTA-NF chelates. (Ln = Eu, Gd).
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3.3.2. Synthesis of Biphenyl-Substituted -Carbon Pendant Arm Chelates (LnDOTABP)
The biphenyl ligand, DOTA-BP, was synthesized using the same sequence of
reactions as DO3A-BPAM, Scheme 3.6. DOTA-BP was chelated under the traditional
conditions of chelation; a mixture of acetonitrile and water heated at 60 ℃ and pH 5.5, the
crude chelation mixture was then purified via RP-HPLC to yield a pure product, LnDOTABP.

Scheme 3.6. Synthesis of LnDOTA-BP chelates. (Ln = Eu, Gd).

3.4. Analysis of the Three Nitro-Substituted Chelates
Analysis of the 1H-NMR spectra of the europium complexes of each nitrosubstituted chelate via line fitting in NUTS of the axial protons of the macrocycle affords
the determination of the coordination geometry ratios. The percent square antiprism (SAP)

CHAPTER 3. Comparison of Three Functionalization Strategies

98

coordination geometry is shown in Table 3.2. As described previously, the SAP
coordination geometry results in a shorter bond distance between the metal and the water
molecule, and thus slower water exchange (kex).79 Based on this, we would expect GdNBDOTA Side with 45% SAP to have the fastest exchange, and the Corner isomer to have
the slowest water exchange of the four isomers. However, another influencing factor is the
coordinating ligands. GdDO3A-NBAM containing one neutral amide ligand will donate
less electron density than its acetate counterparts, and as described earlier, will result in
slower exchange. This coupled with its high SAP ratio would most likely result in the
slowest water exchange of the four chelates.
Table 3.2. Structures of the parent complex EuDOTA and the three substitution strategies:
Macrocycle (EuNB-DOTA), Monoamide Pendant Arm (EuDO3A-NBAM), and -Carbon
Pendant Arm (EuDOTA-NF), with their percent of SAP coordination geometry.

After synthesis of the gadolinium complex of DO3A-NBAM, it was sent to our
collaborator Professor Mauro Botta at the University of Eastern Piedmont Amedeo
Avogadro in Torino, Italy where 17O-NMR and NMRD profiles were generated. The fitted
Nuclear Magnetic Relaxation Dispersion (NMRD) profile and variable temperature
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NMR transverse relaxation rate (R2p) profile for this complex are shown in Figure 3.4. The
NMRD profiles and 17O-NMR R2p profiles for GdNB-DOTA Corner and Side are shown
in Chapter 2. The fitted data were then entered into SBM theory to generate relaxometric
data, shown in Table 3.3. The fitted relaxometric data for GdDOTA, GdNB-DOTA Corner
and Side, and GdDOTA-NF are included in Table 3.3 to allow for comparison.
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Table 3.3. Calculated relaxometric values from the fitted 17O-NMR R2p and NMRD profiles
of GdDOTA, GdNB-DOTA, GdDO3A-NBAM, and GdDOTA-NF, at 298 K and 20 MHz.
ǂ

Values from Aime et. al.51

At high fields, the major influence on relaxivity is the rotational correlation time,
R. If chelates tumble too quickly in solution they are unable to effectively interact with
and relax water molecules. All five of the chelates presented in Table 3.3 are considered
low-molecular weight chelates, and as a result, their relaxivities will be limited by their
rapid tumbling. The parent structure, GdDOTA has the lowest relaxivity of all five
chelates. This is due primarily to size; the nitrobenzyl substituted chelates have higher
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molecular weights and hydrodynamic volumes, and will tumble slower in solution than
GdDOTA, resulting in their higher relaxivities. However, if we review the four
nitrobenzyl-substituted chelates, they have vastly different tumbling rates, and thus
relaxivities as illustrated in Figure 3.5. Yet, these chelates were designed to be as identical
as possible; their structures differ by a methylene, and their molecular weights are within
14 units of each other. Thus, we would expect them to behave similarly in solution, and
tumble at close to the same rate. Yet, even the Corner and Side isomers tumble differently,
with the Side tumbling much slower than the Corner.
As described in detail in Chapter 2, it is evident the Side isomer self-associates in
solution, resulting in a slower tumbling rate in comparison with the Corner. The R value
of GdDOTA-NF is the same as that of the Corner isomer of GdNB-DOTA. This leads us
to hypothesize that it does not self-associate in solution and is in line with other small
molecular weight chelates. GdDO3A-NBAM has shown no evidence of self-association
and as a result, its R is much shorter in comparison with NB-DOTA chelates. The
differences in tumbling rates must arise from the location of the substituent on the DOTA
scaffold. This in turn could cause the chelates to differ in terms of hydrodynamic the extent
of self-association.
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Figure 3.5. Relaxivities (■ r1) and rotational correlation times (■ R) of the four chelates
examined herein, compared to the parent structure, GdDOTA, at 20 MHz and 298 K.

A secondary influence on relaxivity is the preferred coordination geometry of the
chelate. With no moiety, GdDOTA has a preferred coordination of approximately 85%
SAP.80 The introduction of a nitrobenzyl group on the macrocycle, which generates two
new regioisomers in which the substituent is on the Corner or Side carbon of the cycle,
causes the coordination geometry to diverge. The Corner isomer increases to adopt a 95%
preferred SAP geometry whereas the Side decreases to a 45% SAP conformation. 81 This
division of coordination geometry arises from a steric effect when substituting on the
macrocycle; the equatorial position on the Side carbon is more sterically hindered, and
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requires the chelate to adopt the taller cage of the TSAP geometry.50 As stated previously,
GdDO3A-NBAM has a high SAP conformation, this coincides with what is observed for
amide-containing DOTA-based ligands, with chelates of DOTAM employing exclusively
SAP conformation.82 GdDOTA-NF has been shown to have a slightly lower SAP
conformation than its parent GdDOTA; although the major species, it exists only
approximately 65% in the SAP geometry. This is in line with other -substituted chelates;
GdDOTMA adopts a 25% SAP coordination geometry.51 The increased sterics imparted
by substituting on the -carbon of each pendant arm results in the unusually high TSAP
conformation of rigid tetra-methylated chelates. This effect is lessened in GdDOTA-NF
due to only one arm being substituted. However, the bulkiness of a nitrophenyl group still
imparts sterics on the ligand structure, thus increasing the preference to the TSAP
geometry.73
Because coordination geometry directly impacts the access of water molecules to
the lanthanide center, it is no surprise that these chelates have drastically different M
values. The TSAP coordination geometry causes the water to be pushed away from the
lanthanide center, resulting in faster exchange. The higher TSAP geometry of the Side
awards it the shortest M which results in a reduced hydration state (q/r6) and directly
impacts relaxometry (see Chapter 2). The Corner has a slower M, considered slightly
longer than optimal, and as a result has a relaxivity slightly lower than the Side.
As predicted, GdDO3A-NBAM has the longest water exchange lifetime (M) of the
five chelates, and therefore slowest water exchange rate (kex). The rate limiting step of a
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dissociative exchange mechanism is breaking of the metal-ligand bond, with the reduced
electron density of a monoamide coupled with high its high SAP ratio, results in a longer
than optimal M value, which therefore results in an expected low relaxivity. Yet, the
relaxivity measured for GdDO3A-NBAM is comparable to GdDOTA; this is expected for
chelates in the fast water exchange regime that are limited by R.29
Conversely, GdDOTA-NF has the second shortest M of the chelates surveyed. Its
faster water exchange is not so fast that it would suffer from a reduction in hydration state
(q/r6) like observed in GdNB-DOTA Side. From the perspective of water exchange,
GdDOTA-NF has the highest potential of optimal relaxometry. However, the true impact
of water exchange kinetics is not fully appreciated while these chelates are dominated by
the effects of rotation (R).
It is impossible to truly probe the impact water exchange kinetics has on efficacy
whilst these chelates are small, due to the overwhelming influence of R. At higher
magnetic field strengths, theory dictates optimal rotational correlation time to be in the
nanosecond range, while all four of these chelates have R values in the picosecond range.34
Therefore, to fully appreciate the impact of M on relaxivity, the rate of tumbling must be
reduced by ligand modification. The addition of a bulky biphenyl group to the ligand
structure allows us to lift the barrier of R, and fully probe how the point of moiety
attachment impacts M and ultimately relaxivity.
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3.5. Analysis of the Three Biphenyl-Substituted Chelates
To allow for molecular tumbling to be slowed, a bulky biphenyl moiety was
attached to each of the three studied structures. This allowed for a thorough analysis on
how attachment strategy influences relaxometry.
3.5.1. Critical Micelle Concentration Studies
After synthesis of the gadolinium complexes of DO3A-NBAM and BP-DOTA
Corner and Side, they were sent to our collaborator Professor Mauro Botta at the University
of Eastern Piedmont Amedeo Avogadro in Torino, Italy where
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profiles were generated. The fitted Nuclear Magnetic Relaxation Dispersion (NMRD)
profiles for GdDO3A-NBAM below the critical micelle concentration (CMC) and above
the CMC are shown in Figure 3.6. The fitted NMRD profiles for GdBP-DOTA Corner and
Side are shown in Chapter 2. The gadolinium complex of DOTA-BP has been sent to
Professor Mauro Botta, however due to the COVID-19 outbreak,
profiles are still in the process of collection.
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Figure 3.6. NMRD Profiles of GdDO3A-BPAM below its CMC (Top), and above its CMC
(Bottom).
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The CMC is the concentration at which a chelate forms a micelle in solution.
Amphiphilic chelates will spontaneously form micelles in solution at a specific
concentration, where their hydrophobic moieties will pre-assemble due to repulsive
interactions with their hydrophilic counterparts.83
The CMC is determined by measuring the relaxation rate (R1) of the solution while
titrating in the chelate, the inflection point is the CMC. The measured R1 for each chelate,
GdBP-DOTA Corner, Side, and GdDO3A-BPAM were fitted to Equation 3.1 after
collection, shown in Figure 3.7 and Table 3.4. Forming a micelle in solution slows down
molecular tumbling and allows for the barrier of R to be lifted, and the true impact of M
on relaxivity can be explored.
As shown in Table 3.4, GdDO3A-BPAM forms micelles at a lower concentration
than the Corner or Side isomer of GdBP-DOTA. A difference in CMC typically arises due
to size of the discrete chelate; CMC decreases with increasing size.84 Yet, these three
chelates have nearly identical molecular weights and hydrodynamic volumes. These data
suggest that the orientation of the monoamide pendant arm is such that the structure of
GdDO3A-BPAM is larger than both isomers of GdBP-DOTA, resulting in a lower CMC.
Secondly, GdDO3A-BPAM forms smaller micelles compared to both isomers of GdBPDOTA. This coupled with an already known longer than optimal M, would result in
GdDO3A-BPAM to have lower than optimal relaxivity.
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Figure 3.7. Determination of the critical micelle concentration (CMC) of GdBP-DOTA
Corner (◼ Top), Side (◆ Center), and GdDO3A-BPAM ( Bottom).
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𝑅1obs − 𝑅1d = 𝑅1p = (𝑟1n.a. − 𝑟1a ) × CMC + 𝑟1a × 𝐶
Equation 3.1. Equation to determine critical micelle concentration, 𝑹𝐨𝐛𝐬
= measured
𝟏
longitudinal relaxation rate constant in the presence of the chelate, 𝑹𝐝𝟏 = measured relaxation
rate constant in the absence of the of chelate, 𝒓𝐧.𝐚.
𝟏 = relaxivity of the non-aggreated chelate,
𝒓𝐚𝟏 = relaxivity of the aggregated chelate, C = concentration of the chelate.

Table 3.4. Critical micelle concentrations (CMC), micelle diameters, and relaxivities above
their respective CMCs for GdBP-DOTA Corner and Side isomers, and GdDO3A-BPAM, at
298 K and 20 MHz.

The fitted relaxometric data for GdDO3A-BPAM were entered into SBM theory to
generate relaxometric data, shown in Table 3.4. To determine relaxivity above the CMC,
the traditional SBM theory is not sufficient due to the impact of local and global rotation.
The Lipari–Szabo approach is used to determine the influence of each of these rotational
motions on relaxivity, shown in Table 3.4. A combined NMRD profile for all three chelates
above their respective CMC values is shown in Figure 3.8. The fitted relaxometric data
generated for GdBP-DOTA Corner and Side, and GdDO3A-BPAM below their respective
CMCs is shown in Table 3.5.
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Table 3.5. Calculated relaxometric values from the fitted 17O-NMR R2p and NMRD profiles
of GdBP-DOTA Corner and Side isomers, and GdDO3A-BPAM, below their respective
CMCs, at 298 K and 20 MHz.

Figure 3.8. NMRD profiles of GdBP-DOTA Corner (), GdBP-DOTA Side (), and
GdDO3A-BPAM (◆) above their respective CMC values, at 298 K.
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Above the CMC, the water molecules organize into a hydration shell, therefore the
water exchange that is measured is not the typical mechanism observed for a small
molecular weight chelate. Instead, the water molecule bound to the chelate exchanges with
one in the pre-organized layer, rather than the bulk water outside the micelle. Thus, we see
a much longer M above the CMC for all three of these chelates. The impact of micellular
formation is seen most strikingly on rotation. Above the CMC, rotation slows to the
nanosecond range; according to SBM theory, this drastically slowed tumbling rate will give
rise to higher relaxivity values. Additionally, by lifting the barrier of R, we see the impact
water exchange has on relaxivity. The fitted relaxometric values of GdDO3A-BPAM
above its CMC are shown in Table 3.6.
Table 3.6. Relaxometric data from the fitted
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BPAM above its CMC value, at 298 K and 20 MHz.
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Both below and above the CMC GdDO3A-BPAM has a much longer M when
compared to the Corner and Side isomers of GdBP-DOTA. This results in the chelate
falling out of the fast water exchange regime. Although its relaxivity value above the CMC
is similar to the Corner isomer of GdBP-DOTA, they cannot be compared directly due to
the different sizes of their micelles. Though GdDO3A-BPAM forms the smallest micelles,
its global rotation (R) decreased significantly. This slowed tumbling results in the
increased relaxivity of GdDO3A-BPAM, however the benefits of slowed tumbling
resulting in higher relaxivities cannot be fully achieved while this chelate exchanges water
so slowly.
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Figure 3.9. Temperature dependence of relaxivity for GdDO3A-BPAM below the CMC
(Blue) and above the CMC (Red).

This is highlighted when observing the relaxivity as a function of temperature,
Figure 3.9. As temperature increases, GdDO3A-BPAM has a reduction in relaxivity below
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the CMC, however, above the CMC relaxivity increases. This opposition of observed
relaxivity arises from differing water exchange regimes for this chelate. When chelates
increase in size, their molecular tumbling slows. The reduction in R causes the chelate to
fall out of the fast water exchange regime, as observed above the CMC. R gets shorter with
increasing temperature resulting in a decrease in relaxivity if the chelate is in the slow
exchange regime. However, if the relaxivity increases with increasing temperature,
exchange is fast enough that an increase in R can maintain the chelate in the fast exchange
regime. Referring to the SBM Mountain Plot described in Chapter 1, M and R can be a
wide range of values without influencing a major change in relaxivity. However, as
relaxivity is increased, the values of M and R have a much narrower range for optimal
relaxivity. Thus, when water exchange is slowed like in GdDO3A-BPAM, it falls out of
the range to have the highest relaxivity. This limits the functionality of GdDO3A-BPAM
as an effective contrast agent.
Comparing these three chelates above their CMC values demonstrates the influence
M has on relaxivity. GdDO3A-BPAM has much too slow water exchange to be considered
optimal. In contrast, the Side isomer of GdBP-DOTA has much too fast water exchange,
resulting in a reduced hydration state of the chelate, which in turn limits its efficacy. GdBPDOTA Corner has a water exchange rate that is slightly slower than optimal, and we
hypothesize the GdDOTA-BP will have a kex slightly closer to optimal. We can mimic the
effects of kex on bioconjugate efficacy by incorporating these chelates into a large
macromolecule, poly--cyclodextrin. Then, we can truly compare the impact of too slow
water exchange (GdDO3A-BPAM), versus a reduced hydration state (GdBP-DOTA Side).
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3.5.2. Incorporation into Poly--Cyclodextrin
Dilute solutions of GdDO3A-BPAM, GdBP-DOTA Corner, and GdBP-DOTA
Side were prepared and poly--cyclodextrin, a macrocyclic oligosaccharide, was titrated
in. The longitudinal relaxation rate was collected at 20 MHz and 298 K, Figure 3.10. The
biphenyl moieties on these chelates has been shown to bind with the polysaccharide and
can provide information on the binding affinity. Next, NMRD profiles for these three
chelates incorporated into poly--cyclodextrin were collected, Figure 3.11. The fitted
profiles were used to generate relaxometric data, Table 3.7.

Figure 3.10. Longitudinal relaxation rates for the three chelates GdBP-DOTA Corner (),
GdBP-DOTA Side (), and GdDO3A-BPAM (◆), as a function of concentration of poly-cyclodextrin, at 298 K and 20 MHz.
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Figure 3.11. Fitted NMRD profiles of GdBP-DOTA Corner (), GdBP-DOTA Side (), and
GdDO3A-BPAM (◆) conjugated with poly--cyclodextrin, at 298 K.

Table 3.7. Calculated relaxometric values from the fitted 17O-NMR R2p and NMRD profiles
of GdBP-DOTA Corner, GdBP-DOTA Side, and GdDO3A-BPAM incorporated with poly-cyclodextrin at 298 K and 20 MHz.
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The NMRD data were fitted using the SBM equations as well as the Lipari–Szabo
approach to generate their relaxivities as bound bioconjugates at 20 MHz and 298 K, Table
3.7. The binding affinities of the chelates to poly--cyclodextrin were determined using a
1:1 binding model. These data show that the binding affinity to poly--cyclodextrin is
much higher for GdDO3A-BPAM in comparison with the Corner and Side isomers.
Because all three of these chelates have the same biphenyl hydrophobic moiety that will
interact with poly--cyclodextrin, the differentiation between binding constants must arise
from another characteristic of the chelate.
As described in Chapter 2, the Side isomer of GdBP-DOTA has a preferred TSAP
coordination geometry, this would most likely cause it to interact with poly--cyclodextrin
in a different fashion than its Corner counterpart.75 It has been observed that the neutral
carbonyl of a monoamide has shown to bring the poly--cyclodextrin moiety closer to the
lanthanide, resulting in a higher binding affinity.85 This could account for the higher
binding affinity seen in GdDO3A-BPAM. Tightness of binding correlates to longer R
values due to the contributions of both local rotation of the chelate within the bioconjugate
and global rotation of the entire system.
Although GdDO3A-BPAM has lower relaxivity in comparison to both isomers of
GdBP-DOTA, this value does not take into consideration the impact a higher binding
affinity has on the change in the observed relaxation rate constant (R1). To probe how this
would impact the contrast seen on an image clinically, we can calculate the change in R1
using Equation 3.2. If the total concentration of gadolinium is fixed to a typical clinical

CHAPTER 3. Comparison of Three Functionalization Strategies

117

dose (0.1 mM), and it is assumed that any unbound bioconjugate is cleared and does not
contribute to relaxation, it is evident that GdDO3A-BPAM with its lower relaxivity imparts
a large change on the observed R1, as shown in Table 3.8. Although the greatest change is
observed in the Side isomer of GdBP-DOTA, this only constitutes 25% of the total mixture,
and the lower contribution of the Corner would play into the overall observed change.
Thus, the higher binding affinity of GdDO3A-BPAM would increase the signal intensity
and thus overall generated image contrast.
∆𝑅1 = 𝑟1 × [Gd]
Equation 3.2. The measured difference in relaxation rate to determine contrast in an image,
where r1 is the relaxivity of the contrast agent in mM-1s-1 and [Gd] is the concentration of
gadolinium in mM.

Table 3.8. Mathematical determination of the binding affinity on the change in relaxation
rate constant (R1), where Ka is the binding affinity, GdT is the concentration of the target
dose of GBCA.

3.6. Conclusions and Future Directions
When designing a bifunctional chelator, it is important to recognize the impact the
mechanism of substitution as well as position of the targeting vector has on relaxivity. The
three main functionalization strategies, off a macrocycle, through a monoamide pendant
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arm, and on an -carbon on a pendant arm, represented by GdNB-DOTA, GdDO3ANBAM, and GdDOTA-NF, respectively, highlight the relaxometric influence of
substitution on the DOTA scaffold. We have demonstrated that substitution alters
coordination geometry, and as a result, water exchange kinetics. For optimal relaxivity, the
ideal water exchange rate is a finite range. These values can be tuned by altering the
chemical structure of the ligand, and therefore care must be taken when selecting a
substitution position on the macrocycle.
Our results comparing these three strategies highlight the impact the point of
attachment dramatically influences relaxometric properties. The two monoamide derived
chelates both exhibited slow water exchange due to the nature of a coordinating amide
pendant arm. This slowed exchange will be a limiting factor on relaxivity once the barrier
of R is lifted and the chelate is incorporated into a bioconjugate. Both the Corner and Side
isomers of the macrocycle substituted chelates had some advantageous properties; the
slowed molecular tumbling of the Side isomer results in an increased relaxivity, but this is
limited by the fact it also suffers from a reduced q/r6, and comprises only 25% of the
solution mixture. We therefore conclude that neither the macrocycle substitution strategy
nor the monoamide substitution strategy will result in the ideal scaffold for a BFC. The carbon pendant arm strategy resulted in a high relaxivity, slowed molecular tumbling, as
well as a water exchange rate that is fast but does not cause a reduction in q/r6. More
information will be available for a full comparison, but we hypothesize the data generated
for the biphenyl derivative of this strategy will result in the highest relaxivity.
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CHAPTER 4
TETRA -CARBON SUBSTITUTION:
SYNTHESIS & RELAXOMETRY
4.1. Substitution on the -Carbon Pendant Arm of DOTA
With the increasing utility of DOTA chelates, researchers began altering the
structure by substitution of moieties and examining their effects. DOTMA, in which a
methyl group is installed on each -carbon of the pendant arm, was first described by
Brittain and Desreux in 1984.86 Further substitution patterns were synthesized, with the
most common -substituted chelates being the various mono, tri and tetra-substituted
ligands shown in Figure 4.1.73,87–89
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H4-DOTA-BOM3

H4-TCE-DOTA
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Figure 4.1. Common pendant arm -substituted ligands. The introduction of a substituent on
the -carbon of a pendant arm imparts a stereogenic center, some of which are selected for
in stereospecific reactions, others result in a mixture of diastereoisomers or racemates.

4.2. Properties of -Carbon Pendant Arm Substituted Chelates
The addition of a substituent on one or multiple -carbon pendant arm has an
impact on multiple functions of the chelate. The original investigations into DOTMA
proved an opportunity to explore the impact the introduction of four chiral centers have on
photophysical properties.86 Whereas many researchers found the introduction of moieties
on the -carbon to impart a handle for functionalization or further optimization of
relaxometric properties.87 Although -carbon substitution was not expected to change the

CHAPTER 4. Tetra -carbon Substitution: Synthesis & Relaxometry

121

binding of a lanthanide to the ligand system, it was anticipated it would alter certain
relaxometric properties. The effect tetra-substitution has on these properties is explored in
the context of DOTMA chelates.
4.2.1. Stereochemistry of -Carbon Pendant Arm Substituted DOTA Derivatives
Tetra-substitution of the pendant arms of DOTA introduces four new stereocenters.
The lowest energy conformation for pendant arm -carbon substitution is when all four
arms maintain the same stereochemistry.90 The notations for the helicity of the system are
denoted as  or  for the pendant arms, and  or  for the conformation of the
macrocycle. The helicity determines the coordination geometry of the ligand, with ()
or () producing the SAP isomer, and () or () producing the TSAP
geometry. The introduction of a methyl group to each -carbon pendant arm increases the
preferential coordination geometry of DOTMA chelates to be predominately TSAP.
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The DOTMA structure first introduced by Brittain and Desreux produced the most
studied ligand today, the RRRR-enantiomer (). The most facile synthesis involves an
enantiospecific reaction of the amino acid alanine to synthesize the S-propionate arms, and
subsequent SN2 to alkylate onto 1,4,7,10-tetraazacyclododecane (cyclen), resulting in the
arms retaining the same RRRR stereochemistry. Although four enantiomers of DOTMA
are possible, two are inaccessible through arm rotation seen with DOTA; substitution on
each pendant arm locks out the interconversion, Figure 4.2. This is due to the torsional
strain introduced with -carbon substitution. As a result, the ligand will preferentially
substitute the methyl group anti to the lanthanide.

Figure 4.2. The four possible stereoisomers of GdDOTMA. The two structures with  arm
helicity (left) are inaccessible from the  conformation (right) due to the -substituted methyl
groups freezing out arm rotation.

The  arm conformation is possible if starting from R-propionate arm starting
materials, however, is much less common due to the expense associated with R-amino
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acids. Beginning with racemic starting materials for the arms does not afford an
enantiopure product. A study in which each pendant arm was equipped with a carboxyethyl
arm showed the varying properties the four stereoisomeric products.89 Interestingly, some
of these structures were able to interconvert via arm rotation.
Although chelates of TCE-DOTA allowed researchers to glean insight into the
various properties of diastereoisomers of a tetra -carbon substituted structure, it is not the
ideal model for a GBCA. These various structures will have differing chemical properties
including kinetic inertness and relaxivity. Therefore, it is important to use a synthetic
strategy that is stereospecific to result exclusively in the homochiral conformation. This
affords the most kinetically robust structure.
4.2.2. Water Exchange Kinetics
As described by Webber and Woods, the impact of the exchange event on the
structure of the ligand had not been fully appreciated.64 The ligand undergoes a structural
change when the water is bound versus unbound. When a water molecule is coordinated to
the chelate, the ligand cage is open to accommodate the water. When the water leaves, the
lanthanide sinks down in the cage simultaneously to its ionic radius decreasing. The cage
collapses slightly around the metal center, causing a slightly closed conformation. This
process repeats when a new water molecule coordinates to the metal. This dynamic process
influences the mechanism of exchange observed for macrocyclic chelates and needs to be
explored further.
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As described with NB-DOTA chelates in Chapters 2 and 3, a higher ratio of TSAP
in solution results in a very short water exchange lifetime, M.63 GdNB-DOTA Side exists
55% in the TSAP coordination geometry, and exchanges water very quickly, with a M of
12.4 ns. GdDOTMA in contrast, exists 81% in the TSAP geometry and yet has M of 85
ns.91
4.2.3. Relaxivity of -Substituted Chelates
The introduction of a substituent on each -carbon pendant arm has shown to have
a drastic impact on coordination geometry as well as water exchange kinetics. However,
the change in relaxivity is minimal. This is due to the overwhelming influence of chelate
rotation, R. As seen with previously explored small molecular weight chelates, the impact
of ligand modification is only observed when the barrier of R is lifted.
4.3. Synthetic Strategy of Tetra -Carbon Substituted Chelates
We wanted to expand the library of -carbon substitution to determine if
relaxometric properties could be tuned based on functional group. With the promising
preliminary results of a more kinetically robust chelate with -carbon pendant arm tetrasubstitution, we wanted to explore the impact of changing this moiety. Furthermore, we
wanted to create a structure that would eventually allow a handle for functionalization for
use as a BFC. Once the target compound is identified, the R-group can be modified to
include a reactive moiety such as an azide (like seen in DOTAZA), a monoamide (as
explored in Chapter 3), or a carboxylate (TCE-DOTA).
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Figure 4.3. Retrosynthetic pathway to various -carbon substituted pendant arm chelates
with potential chiral amino acid starting materials.

With the ubiquity of chiral amino acids, we saw the potential for the synthesis of a
variety of pendant arms that could be synthesized in the same fashion to alkylate onto
cyclen, Figure 4.3. These stereospecific reactions result in the homochiral ligand, allowing
for the most kinetically robust chelate. The three structures proposed herein have increasing
sterics, with all four -carbon pendant arms containing either isopropyl (DOTiPrA),
isobutyl (DOTiBuA), or phenyl (DOTFA) moieties, Figure 4.4.
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Figure 4.4. The three tetra-substituted ligand systems studied, tetra-isopropyl (H4-DOTiPrA,
Left), tetra-isobutyl (H4-DOTiBuA, Center), and tetra-phenyl (H4-DOTFA, Right)

4.3.1. Attempted Synthesis of DOTiPrA
The synthetic strategy for the protected tetra-isopropyl ligand, Me4-DOTiPrA was
proposed by installing a leaving group (LG) on the methyl ester of the amino acid L-valine,
then alkylating this arm onto cyclen. This stereospecific reaction where all four arms
alkylate sequentially results in a homochiral protected ligand with all isopropyl groups
maintaining R configuration, Scheme 4.1. Monitoring of alkylation progress was
performed via ESI-MS where the percent of each alkylation species was determined by
comparing their relative intensities in the mass spectrum.

Scheme 4.1. Proposed synthetic strategy for the tetra-isopropyl protected ligand, Me4DOTiPrA, where LG denotes the leaving group.
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The first leaving group investigated was a bromide. A double SN2 diazotization
rection of the amino acid L-valine results in an enantiospecific retention of stereochemistry
to convert the amine to a bromide.92 A methyl ester protection group was installed on (S)2-bromo-3-methylbutanoic acid via a Fisher esterification to produce methyl (S)-2-bromo3-methylbutanoate (iPr-1), Scheme 4.2 Top. However, when iPr-1 was used to alkylate
cyclen, the predominate species was di- and tri-alkylated. The reaction conditions were
tuned to optimize tetra-alkylation, such as: base (K2CO3, and Cs2CO3), temperature (60℃,
70℃, and 80℃), and reaction time (24 hrs, 48 hrs, up to four weeks). None of these
conditions yielded tetra-alkylated in appreciable quantities, therefore we sought to find a
better leaving group that would pull electron density away from the -carbon.
The second leaving group attempted was a mesylate. This leaving group can be
installed under similar mild conditions like the bromide. A similar double SN2 reaction was
performed on L-valine, in this instance the amine was converted to a hydroxyl group.
Methyl ester protection groups were installed on (S)-2-hydroxy-3-methylbutanoic acid via
a Fisher esterification to produce methyl (S)-2-hydroxy-3-methylbutanoate. The hydroxyl
group was converted to a mesylate via a substitution reaction to yield methyl (S)-3-methyl2-((methylsulfonyl)oxy) butanoate (iPr-2), Scheme 4.2 Middle. Cyclen was alkylated with
iPr-2

with cesium carbonate in dry dichloromethane under air free conditions. Although

this reaction progressed faster than the corresponding bromide, the predominate reaction
products remained di- and tri-alkylated cyclens.
The final attempt to tetra-alkylate cyclen was to use install a triflate at the -carbon.
Triflates are excellent leaving groups due to the stability of their conjugate base and pull
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the greatest electron density away from the -carbon due to the trifluoro group. A triflate
of methyl L-alaninate can be used to synthesize Me4-DOTMA, so we sought to utilize this
established procedure.91 However, they are extremely reactive when exposed to water, and
thus must be installed under air- and water-free conditions. The hydroxyl group was
converted to a triflate via a substitution reaction in dry dichloromethane with lutidine under
air-

and

water-free

conditions

to

yield

methyl

(S)-3-methyl-2-

(((trifluoromethyl)sulfonyl)oxy) butanoate (iPr-3), Scheme 4.2 Bottom. The reaction of
iPr-3

with cyclen was performed under air- and water-free conditions. This reaction

yielded the highest ratio of tetra-alkylated ligand, however di- and tri-alkylated was still
present in appreciable quantities. Secondly, the installation of a triflate is notoriously low
yielding due to its susceptibility to hydrolyze when exposed to moisture, thus we sought to
seek a different route for synthesizing a tetra-substituted bulky ligand. The results of all
three of these synthetic attempts are shown in Table 4.1.
Table 4.1. Comparison of the three leaving group strategies for alkylating cyclen with an iPr
methyl ester after four days of reacting.

CHAPTER 4. Tetra -carbon Substitution: Synthesis & Relaxometry

129

Scheme 4.2. Synthesis of iPr Methyl Ester Arms. The brominated arm iPr-1 (Top), the
mesylate arm iPr-2 (Middle), and the triflate arm iPr-3 (Bottom)

4.3.2. Attempted Synthesis of DOTiBuA Chelates
The lack of successful tetra-alkylation with the isopropyl-substituted prompted us
to seek a different substituent on the -carbon. We hypothesized that replacing the
isopropyl moiety with an isobutyl would reduce the steric hindrance on the -carbon and
allow for it to be more susceptible to nucleophilic attack. This reaction sequence followed
the same proposed for Me4-DOTiPrA where a double SN2 diazotization rection of the
amino acid L-leucine results in an enantiospecific retention of stereochemistry to convert
the amine to a bromide.92 A methyl ester protection group was installed on (S)-2-bromo-4methylpentanoic acid via a Fisher esterification to produce methyl (S)-2-bromo-4methylpentanoate (iBu-1). Subsequent alkylation onto cyclen results in the protected
ligand, Me4-DOTiBuA, Scheme 4.3.
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Scheme 4.3. Proposed synthetic pathway for LnDOTiBuA chelates.

Surprisingly, the alkylation of cyclen with iBu-1 proceeded quicker than the
isopropyl derivative. However, di- and tri-alkylated species were still present in the
reaction mixture in appreciable quantities. This reaction appeared to go towards dialkylated quickly, with no mono-alkylated species present after three days. After additional
equivalents of iBu-1 were added to the reaction mixture, and a continued reaction time of
~18 weeks, the reaction mixture consisted of exclusively tri- and tetra-alkylated, Table 4.2.
The reaction mixture was then column purified to isolate the tetra-alkylated Me4-DOTiBuA
at 36% yield. The isolated protected ligand underwent ester hydrolysis and chelation with
europium chloride. Unfortunately, the remaining ligand was in such low quantities that
chelation with gadolinium was not productive.
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Table 4.2. ESI-MS reaction monitoring of tetra Me4-DOTiBuA formation compared with diand tri-alkylated species (Me2-DO(2iBuA) and Me3-DO(3iBuA), respectively).

A triflate leaving group was attempted for the tetra-isobutyl ligand, as shown in
Scheme 4.4. The reaction was very low yielding, and workable quantities of protected
ligand was not synthesized. Due to the difficulty of producing enough tetra-alkylated
ligand, this project was discontinued. The comparison of the two attempted leaving group
strategies is illustrated in Table 4.3.
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Scheme 4.4. Synthesis of Me4-DOTiBuA via alkylation of cyclen with the triflate derivative of
the isobutyl arm (iBu-2).

Table 4.3. Comparison of the two leaving group strategies for alkylating cyclen with an iBu
methyl ester after four days of reacting.

4.3.3. Comparing the Isopropyl and Isobutyl Substitution Strategies
Both an isopropyl and an isobutyl derivative were synthesized to produce a tetraalkylated cyclen. Various leaving groups were surveyed for their ability to rapidly result in
exclusively tetra-alkylated product. It is evident upon the comparison of these two
substituents that the reduced sterics on the -carbon associated with an isobutyl group
results in a higher ratio of tetra-alkylated cyclen in solution when compared with its
isopropyl counterpart, Table 4.4. However, both iPr-1 and iBu-1 demonstrate that a
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bromide leaving group yields predominately di- and tri-alkylated cyclens, and appreciable
ratios of tetra-alkylated only occur after reacting for 130 days.
To reduce the reaction time by increasing the electrophilicity of the -carbon, we
sought to replicate the previously published synthesis for DOTMA via installation of a
triflate leaving group for both the isopropyl and isobutyl strategies.91 However, like the
bromide reactions the alkylation reactions of cyclen were unable to generate a high ratio of
tetra-substituted cyclens in solution, Table 4.4. Both the iPr and iBu substitution strategies
proved to be unsuccessful in generating exclusively tetra-substituted protected ligands,
regardless of leaving group type. We hypothesize the electrophilicity at the -carbons of
the methyl ester of L-valine and L-leucine were not sufficient to be prone to nucleophilic
attack from the amine on cyclen. Secondly, the increased sterics imparted on both
compounds by the introduction of larger aliphatic groups prevented an effective opening
for nucleophilic attack of the macrocyclic cyclen. More optimization experiments in which
different reaction conditions are surveyed might increase the proportion of tetra-alkylated
in solution, however the amount of effort required to isolate appreciable quantities of ligand
does not yield either strategy as advantageous.
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Table 4.4. Comparing two leaving group strategies for the alkylation of cyclen with an iPr or
i

Bu methyl ester with their highest percentage of tetra-alkylated after the reaction was

stopped.

4.3.4. Synthesis of DOTFA Chelates
The double SN2 diazotization of D--phenylglycine results in an enantiospecific
retention of stereochemistry resulting in (R)-2-bromo-2-phenylacetic acid. A methyl ester
protection group was installed via a Fischer esterification to produce methyl (R)-2-bromo2-phenylacetate (4-1). Cyclen is alkylated with 4-1 via an SN2 which results in an inversion
of stereochemistry, resulting in the protected ligand Me4-DOTFA. Unlike the attempted
tetra-isopropyl and tetra-isobutyl derivatives explored previously, Me4-DOTFA alkylated
within 24 hours. Given the increased steric demand of this alkylating agent, this is a
surprising result. The increased electrophilicity of the -carbon imparted by the
corresponding phenyl group presumably made this alkylation facile. The esters were then
hydrolyzed with 4 eq of 1M KOH to produce the ligand H4-DOTFA. H4-DOTFA was
chelated with appropriate lanthanide (III) chlorides or oxides, then purified via RP-HPLC
to yield colorless solids. The reaction sequence is illustrated in Scheme 4.5.
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Scheme 4.5. Total synthesis of LnDOTFA chelates.

4.4. Analysis of LnDOTFA Chelates
4.4.1. Structural Analysis of DOTFA Chelates
After gadolinium in the lanthanide series, chelates of DOTA have shown to exist
primarily in the SAP coordination geometry. However, when a methyl group is substituted
on the -carbon of all four pendant arms, this preference shifts to TSAP. Previous studies
have shown that the ratio of coordination geometry in DOTA chelates is lanthanide ion
dependent. The early lanthanides preferentially adopt the more-open TSAP geometry to
accommodate their larger ionic radii, whereas the later lanthanides, with their smaller ionic
radii, maintain a higher proportion of SAP.80 While this trend is observed slightly for
DOTMA chelates, they maintain a predominance of TSAP across the entire lanthanide
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series, with a maximum ratio of SAP being approximately 30% for dysprosium, as shown
in Figure 4.5.91
Analysis of the 1H-NMR spectra of LnDOTFA allowed for determination of their
coordination geometry ratios. Due to the C4 symmetry of these chelates, the spectra
produced by all the LnDOTFA chelates exhibit one peak representing the TSAP
coordination geometry and one representing the SAP coordination geometry. As shown in
Figure 4.6, chelates of DOTA preferentially maintain the SAP coordination geometry with
the exception for the early lanthanides, whereas tetra -carbon substituted chelates have a
preferred TSAP coordination geometry universally across the series. 91 Lanthanide
contraction is observed across the lanthanide series, in which the ionic radius decreases as
atomic number increases.
As a result, SAP predominates in the later lanthanides for chelates of DOTA. In
contrast, the addition of a moiety on the -carbon pendant arm alters the ligand structure
so the SAP coordination geometry is less accessible. Although DOTMA and DOTFA
chelates exhibit similar preferential TSAP coordination geometry, their ratios are different.
DOTMA reaches its maximum SAP ratio at terbium with a mole fraction of 0.3, whereas
DOTFA reaches its maximum SAP at erbium with a mole fraction of 0.43. These values
give insight into the water exchange mechanism occurring in -carbon substituted chelates.
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Figure 4.5. Coordination geometry mole fractions for LnDOTA (), LnDOTMA (), and
LnDOTFA ().

4.4.2. Relaxometric Analysis of GdDOTFA
4.4.2.1. Results and Discussion on the Discrete Chelate
The purified GdDOTFA chelate was sent to our collaborator, Professor Mauro
Botta at the University of Eastern Piedmont Amedeo Avogadro in Torino, Italy for

17

NMR and NMRD experiments. The simultaneously fitted NMRD profiles and VT

17

O-

O-

NMR data for GdDOTFA are shown in Figure 4.6, and fitting parameters are in Table 4.5.
The fitted relaxometric data for GdDOTA and GdDOTMA are included in for comparison.
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Table 4.5. Calculated relaxometric values from the fitted 17O-NMR R2p and NMRD profiles
of GdDOTA, GdDOTMA, and GdDOTFA, at 298 K and 20 MHz. ‡Values from Aime et. al.91
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Figure 4.6. 1H-NMRD profiles of GdDOTFA at 283 K, 298 K, and 310 K and pH 6.6 (Top);
temperature dependence of the transverse 17O water relaxation rate (R2p) at 67.8 MHz and
pH 6.6 (Bottom).
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The relaxometric data shown in Table 4.5 show some striking differences between
GdDOTFA and the two established chelates GdDOTA and GdDOTMA. GdDOTFA has a
much longer rotational correlation time (R) than either GdDOTA or GdDOTMA. This is
not surprising due to the bulky phenyl rings contributing to the slowed tumbling. The R of
GdDOTFA is more comparable to that of the Side isomer of GdNB-DOTA (R = 120 ps).63
As described in Chapter 2, the Side isomer self-associates in solution, giving rise to its slow
molecular tumbling. Although these two chelates tumble at a similar rate, their relaxivities
are quite different. GdDOTFA has a much higher r1 (7.7 mM-1s-1) than the Side (6.1 mM1 -1 63

s ). The discrepancy in relaxivity arises from their differences in water exchange. As

explored in Chapter 2, GdNB-DOTA Side undergoes an extremely rapid dissociative water
exchange process results in a reduction in q/r6, which in turn results in a reduction in
relaxivity.63 Although the Side isomer is able to compensate for its extremely rapid water
exchange by slowed molecular tumbling, its sub-optimal water exchange kinetics cannot
outmatch those of GdDOTFA.
A similar comparison in molecular tumbling can be made with GdDOTMA. The
lower molecular weight of GdDOTMA results in its shorter R in relation to GdDOTFA.
As the dominating influence of relaxivity in smaller molecular weight chelates, this in turn
gives GdDOTMA a much lower r1 than GdDOTFA. As a result of its higher percentage of
SAP in solution, M for GdDOTMA is much longer than that of GdDOTFA. As lowmolecular weight chelates that tumble quickly in solution, M does not have as great of an
influence over relaxivity for either of these chelates. Yet, we can glean insight into water
exchange by reviewing their R2 plots and M values. The

17

O plot for each coordination
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isomer of GdDOTFA shows the transverse relaxation rate as a function of temperature,
Figure 4.6 Bottom. The curve generated for the SAP isomer shows the expected bell curve
with its maximum at approximately 305 K. This indicates that the chelate exchanges water
in the fast exchange regime. In contrast, curve of the TSAP isomer does not reach its
maximum in the experimental range. As seen with the Side isomer of GdNB-DOTA, the
maximum of this curve is reached at a much lower temperature. This is indicative of the
extremely rapid water exchange regime, resulting in a reduction of q/r6. Although the
TSAP coordination isomer of GdDOTFA does peak at a low temperature, there is no
evidence of a reduction in hydration state; its relaxivity is the highest of the chelates
surveyed.
Electronic spin relaxation (T1e) is defined by V and 2 and influence the dipoledipole interaction of the paramagnetic lanthanide and the ligating water. The influence of
electronic relaxation predominates at low fields and optimization is through structural
manipulation of the ligand. The larger the molecule, the greater the influence of electron
spin relaxation, so due to the larger molecular weight of GdDOTFA, we would expect V
to have a large influence on relaxivity.44 Secondly, because V is a measure of electron spin
relaxation as a result of intra- and inter-molecular collisions between different electronic
dipoles, there is a potential that the large phenyl groups reduce these types of interactions
by shielding the lanthanide center, resulting in a much longer V than the other two chelates.
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4.4.3. Lifting the Barrier of R
4.4.3.1. -Cyclodextrin Binding Studies
With the promising preliminary data of GdDOTFA we probed its relaxometric
potential more thoroughly through macromolecular binding studies. -cyclodextrin was
titrated into of a solution of GdDOTFA at 0.18mM, and the longitudinal relaxation rate
was collected at 20 MHz and 298 K. This experiment was then repeated with poly-cyclodextrin, a large macromolecular version of -cyclodextrin. These collected binding
curves are shown in Figure 4.7. and their fitted data in Table 4.6. The slowed molecular
tumbling with the chelate incorporated into the macromolecular sugar results in the
expected increased relaxivity. This is comparable to the Side isomer of GdBP-DOTA
incorporated with poly--cyclodextrin. However, GdDOTFA has a much lower binding
affinity for cyclodextrin in comparison with either regioisomer of GdBP-DOTA; both of
which have Ka values three orders of magnitude higher than that of GdDOTFA. This is
most likely the result of the structure of the chelate; its slightly smaller molecular weight
indicates a lower hydrodynamic volume, which would prevent it from effectively
interacting within the binding pocket of -cyclodextrin.
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Figure 4.7. The observed longitudinal relaxation rate of water (R1) as a function of
concentration of -cyclodextrin (Left) or poly--cyclodextrin (Right) in a solution of
GdDOTFA [0.18 mM] at 20 MHz and 298 K.
Table 4.6. Selected data for GdDOTFA bound with -cyclodextrin and poly--cyclodextrin
at 20 MHz, and 298 K. [GdDOTFA] = 0.18 mM.

4.4.3.2. Human Serum Albumin Studies
Another macromolecule of interest is human serum albumin (HSA). Using HSA as
a biologically relevant bioconjugate has allowed researchers to deem feasibility for chelate
behavior in vivo. For the purposes of GdDOTFA, it provides information on efficacy by
slowing down the barrier of molecular tumbling, to probe if water exchange kinetics are
optimal. The relaxivities for both -cyclodextrin bioconjugates were promising and
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prompted investigation on how GdDOTFA would behave if it were incorporated into a
larger protein as a pseudo-BFC.
Because GdDOTFA does not contain a targeting vector, the binding to HSA will
be through non-specific hydrophobic interactions potentially with one of its drug binding
sites. One method to probe the interaction of a molecule with blood-based proteins is
differential scanning calorimetry (DSC), which generates a curve of molar heat capacity as
a function of temperature. This allows for the thermodynamics of conformational changes
in proteins during different binding events. Through this, we can determine how
GdDOTFA binds to HSA and other proteins in blood, as well as its binding capacity. These
experiments were carried out by our collaborators Matthew Eskew and Dr. A. Benight.
DSC melting experiments involved temperature scans at 1 °C/minute and were carried out
on HSA (2 mg/mL) alone, and GdDOTFA (200 M) in HSA (2 mg/mL). The thermogram
generated shows the partial molar heat capacity (Cp) of the plasma as a function of
temperature and shows the interaction of the binding event of the chelate to the four major
proteins in blood, Figure 4.8. If a ligand binds to the native state of a plasma protein, it will
stabilize it, thus increasing its melting temperature, which would correlate to a peak shift
to a higher temperature on the thermogram. If GdDOTFA binds preferentially to the native
state of HSA, the temperature at which the bound protein-ligand complex denatures will
be higher than the temperature at which free HSA unfolds.
The thermograph generated shows the four major proteins present in serum and
their corresponding unfolding events, with the small peak at ~50 ℃ corresponding to
fibrinogen, the large peak at ~65 ℃ corresponding to HSA, the shoulder peak at ~75 ℃
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corresponding to immunoglobulins A and G (IgA, IgG), and the small peak at ~ 85 ℃
corresponding to transferrin. The upshift in temperature of the HSA peak when GdDOTFA
is present indicates a weak binding event occurring, and as a result, overlaps with the
IgG/IgA peak. These preliminary data suggest that although GdDOTFA interacts with the
components of plasma, these interactions are weak, therefore despite the inclusion of four
hydrophobic groups, the pharmacokinetics are unlikely to be substantially impacted. This
means that GdDOTFA has potential for use in vivo because it would not bind too strongly
with plasma preventing it from being effectively cleared. The interactions between those
chelates and HSA did not seem as strong as GdDOTFA. Secondary studies into binding
sites remain unfinished due to the outbreak of COVID-19.

Figure 4.8. The change in partial heat capacity (Cp) as a function of temperature for the
binding of GdDOTFA with plasma (●), and the change in partial heat capacity as a function
of temperature of pure plasma (▬)
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According to the SBM theory, if R and M are optimized, the maximum relaxivity
that is achievable for a GBCA is 100 mM-1s-1 at 20 MHz. This is illustrated in the mountain
plot in Figure 4.9. Although there have been many attempts to use SBM theory to design a
chelate with optimal R and M values, it is difficult to predict the behavior of the chelate
in solution. As described in Chapter 1, the higher the relaxivity, the tighter the bounds R
and M can be, thus it becomes increasingly difficult to achieve extremely high r1 values.

Figure 4.9. When other SBM parameters are optimized, the influence of the water exchange
lifetime (M) and rotational correlation time (R) on relaxivity (r1) are realized. (B0 = 0.5 T)

The proton relaxation rate (R1) of water was measured as a function of
concentration of HSA, with GdDOTFA at 0.09 mM, Figure 4.10. and Table 4.5. This
allowed for the determination of the binding capacity of GdDOTFA to HSA as well as a
relaxivity. The experimentally determined binding capacity of GdDOTFA and HSA is
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much higher than previously studied chelates. We hypothesize that its four hydrophobic
phenyl groups fit well into one or multiple the drug binding sites, restricting molecular
motion even more than a single interaction (R local), but this needs to be explored with
further experiments.93 Furthermore, the multiple drug binding sites of HSA bind
allosterically; binding of one molecule alters the behavior of subsequent binding.
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Figure 4.10. The observed longitudinal relaxation rate of water (R1) as a function of
concentration of human serum albumin in a solution of GdDOTFA [0.09 mM] at 20 MHz and
298 K.
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Table 4.7. The binding affinity (KA) of GdDOTFA to human serum albumin (HSA) and the
relaxivity of the bound chelate to HSA at 20 MHz and 298 K.

The relaxivity for GdDOTFA bound to HSA was found to be 110.3 mM -1s-1; the
highest possible relaxivity according to the SBM model! Although these results are in the
context of incorporation into a large protein (MWHSA = 66.5 KDait must also be considered
that the binding constant is weak, therefore at any time only a small fraction of GdDOTFA
is in the bound form. GdDOTFA has better M and R than previously discussed chelates,
but both values are not considered optimal according to SBM. Because HSA has multiple
drug binding sites, it can bind more than one GdDOTFA chelate, causing a high relaxivity.
However, when other phenyl-containing macrocyclic chelates were tested with HSA, their
relaxivities were half of GdDOTFA.75 The extremely high relaxivity observed when
GdDOTFA is bound to HSA could be in part its high binding affinity. When a chelate is
bound to a macromolecule, there is local rotation of the chelate within the bioconjugate, as
well as rotation of the global structure. Because GdDOTFA binds so effectively to HSA, it
is possible its local rotation is limited, and global rotation is the major or sole contributor
to R. At this magnetic field strength, relaxivity is defined by R and a large slowly tumbling
structure would facilitate high relaxivity. The slow rotation and high binding affinity of
GdDOTFA coupled with a M value that is considered fast, but not so fast that the chelate
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experiences a reduced hydration state, would result in the extremely high relaxivity
observed in this experiment.
The only explanation for this extremely high relaxivity must lie within M. Theory
dictates the only way to reach the top of the SBM mountain is either a large influence of
second sphere water, which is not observed in the crystallographic data presented in
Chapter 5, or more likely, a change in water exchange mechanism. The barrier of R is
lifted when GdDOTFA is conjugated into HSA, therefore the predominating influence of
relaxivity is water exchange. The only means in which GdDOTFA can maintain such a
high relaxivity without contradicting SBM theory is if the mechanism of exchange is not
dissociative. Thus, an investigation into the water exchange mechanism needs to be
addressed.
According to variable pressure NMR experiments conducted by Merbach et. al.,
nearly all small molecular weight chelates of gadolinium exchange water in a pure
dissociative fashion.41 If we view water exchange as a continuum, with associative on one
end of the spectrum and dissociative on the other, interchange will lie in the center. The
water exchange mechanism of a chelate is determined via its calculated activation volume
(Vǂ); a negative Vǂ correlates to associative, positive Vǂ with dissociative. Where the
magnitude of Vǂ describes the location of the exchange mechanism on the continuum.
The most definitive determination of water exchange mechanism is via variable pressure
1

H-NMR. Unfortunately, the only researcher performing these experiments in our field has

retired and his instrument is currently non-functioning. Therefore, we were unable to
collect these data to conclusively prove a change in water exchange mechanism in the
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solution state. Further studies into the mechanistic impact of water exchange were
conducted in the solid state and are provided in Chapter 5.
4.5. Conclusions and Future Directions
The initial goal of the structures studied herein was to determine how the nature of
an -carbon substituent affected the structural and relaxometric behavior of the chelate.
Although tetra-isopropyl or tetra-isobutyl chelates were not successfully isolated, the
exercise into determining various synthetic strategies gleaned insight into mechanism of
tetra substitution, as well as provide evidence into which moieties are unsuccessful.
The surprising synthetic ease of a tetra-phenyl substituted chelate, LnDOTFA,
provided potential for an ideal scaffold for use as an MRI contrast agent. The relaxometric
results of GdDOTFA were surprising; it has one of the highest relaxivity as a discrete
chelate of all the small molecular weight chelates studied in our group thus far. GdDOTFA
has a water exchange rate that is considered very fast, yet this does not have a negative
influence on hydration state nor relaxivity. This is the result of the means in which it
exchanges water. Preliminary evidence suggest that GdDOTFA does not undergo a pure
dissociative water exchange mechanism. This is quite unique; nearly all octadentate
macrocyclic chelates exchange water in an exclusive dissociative fashion. Although further
studies are required in order to confirm a change in water exchange mechanism, this
preliminary evidence require a change in thinking of the way GBCAs behave
relaxometrically.
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The most promising results of the relaxometric experiments of GdDOTFA have
been its incorporation into macromolecules. Binding to the polysaccharides -cyclodextrin
and poly--cyclodextrin resulted in the expected increase in relaxivity due to slowed
molecular tumbling. However, the high relaxivities were not drastically higher than
observed in other chelates. It was not until GdDOTFA was introduced into a solution of
HSA that its relaxometric potential was fully observed. Although GdDOTFA had a low
binding affinity for HSA, the relaxivity recorded of this experiment is higher than what had
been established as possible by SBM theory. This was very surprising and unexpected.
Larger biphenyl-containing chelates have shown a drastic increase in relaxivity when
bound to HSA, however they were not of this magnitude, and not from weak hydrophobic
interactions.75 We hypothesize that the binding of GdDOTFA to the various drug binding
sites of HSA is different than observed with other macrocyclic chelates, and this interaction
will need to be probed further.
The high relaxivity observed when GdDOTFA is bound to HSA changes the way
we view SBM theory as determination of optimal relaxometry. As illustrated by the SBM
mountain plot in Figure 4.7, at increasingly longer values of R, the value of M to achieve
high relaxivity narrows to a very tight range. The M value for GdDOTFA as a discrete
chelate does not fit into this range, and according to SBM, should result in a much lower
relaxivity. Therefore, we propose a different mechanism of water exchange exhibited by
GdDOTFA; one that is not considered purely dissociative but closer to interchange on the
water exchange continuum. Further studies will need to be conducted to fully explore the
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mechanism by which GdDOTFA exchanges water; but at present we may hypothesize that
some interchange character could account for its extremely high relaxivity.
Although GdDOTFA is not considered a BFC due to the lack of handle for
bioconjugation, its high relaxometric potential makes it an incredibly useful chelate.
Incorporating -substituted phenyl groups onto a macrocyclic BFC scaffold could provide
higher relaxivity than a non-substituted chelate, as has been demonstrated with DOTMA
derived BFCs.36 Furthermore, with evidence that a rigid tetra-substituted chelate imparts
higher kinetic inertness, a DOTFA-derived BFC might prevent dechelation in vivo. Further
kinetic and thermodynamic studies will need to be completed to confirm this. Nonetheless,
the DOTFA scaffold is synthetic versatile and advantageous, its gadolinium complex ideal
relaxometrically, and has a high potential for being modified as a BFC system.
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CHAPTER 5
TETRA -CARBON SUBSTITUTION:
CRYSTAL STRUCTURES OF DOTFA CHELATES
5.1. Introduction
After analyzing GdDOTFA relaxometrically, detailed in Chapter 4, we wanted to
explore the crystallographic nature of various DOTFA chelates. Previously published Xray crystal data from chelates of DOTMA was the first incidence of gleaning solution state
behavior from the solid state.70 By crystallizing DOTFA across the lanthanide (Ln3+) series,
we can utilize this established precedence to greater understand how DOTFA behaves
when it exchanges water, providing supporting evidence into its behavior relaxometrically.
Crystal structure analysis allows for the determination of the number of water molecules
bound to the lanthanide center, denoted as hydration number, q. Water molecule distances
greater than a certain value, typically >3 Å, are considered uncoordinated, whereas <3 Å
are considered coordinated. In DOTA-based chelates, q is defined by the coordination
number (CN) of the lanthanide of interest; chelates with a water molecule bound have a
CN = 9 and chelates without a water molecule bound have a CN = 8. Thus, it is typically
described that a chelate that is hydrated is q = 1, and dehydrated is q = 0.
Defining hydration by only analyzing q is an incomplete description of hydration
and does not account for important structural changes that occur within the system. For
chelates of DOTMA, their high TSAP ratios result in a longer metal-water distance. This
coupled with the lanthanide contraction across the series can cause the measured bond
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distance to be longer than what is typically considered hydrated. An analysis must also
account for the change in ionic radius that occurs as the coordination number changes. This
impacts how we view hydration; for example, GdDOTMA has an rLnH = 2.5 Å and is
considered hydrated. In contrast, HoDOTMA has an rLnH = 2.66 Å and is considered
dehydrated. Thus, it must be addressed how we should describe the hydrated ion of these
intermediate cases.70 Secondly, the conformational changes that occur to both the ligand
structure as well as the ionic radius when the water exchange process occurs are not
accounted for in these measurements. Thus, it is imperative to include other analyses to
fully describe hydration, as well as define this concept. There is an important distinction
between hydration and q; they are not interchangeable concepts or values. q is a quantified
description of the number of water molecules bound, whereas hydration incorporates this
number, but also includes the position of the bound water molecule. Thus, we can view
hydration as a non-binary construct. Combining these concepts accounts for other factors
that influence what defines a hydrated chelate.
Our group has demonstrated that chelates of DOTMA show a continuum of
hydration, in which hydration is not a binary value of one (hydrated) or zero (dehydrated),
rather it exists as a spectrum in which some chelates of DOTMA exist as partially
hydrated.70 This evidence is quite groundbreaking; up until this seminal publication, some
researchers would intepret that fractional hydration numbers to mean that some chelates
crystallizing with one water molecule coordinated at <3 Å, and some crystallizing with one
water molecule >3 Å, resulting in a net q value of <1.29 This justification for observed
partial hydration states in various octadentate lanthanide chelates implies that individual
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complexes crystallize differently, but this is not observed in crystal structure analysis.
Thus, the best explanation is that chelates of DOTMA with q values that are less than one
but greater than zero are partially hydrated; meaning that they cannot be described as CN
= 9 or CN = 8 and their water-lanthanide distances are between values that is what is
typically considered hydrated or dehydrated. The results of this publication indicated that
further study into the crystal structures tetra-substituted chelates was warranted, thus we
grew crystals of DOTFA chelates.
One method to determine whether a chelate is hydrated is analysis of its d/c ratio.94
This measurement is a ratio of the distance from the nitrogen plane to the lanthanide center
(d) over the distance from the nitrogen plane to the oxygen plane (c), as shown in Figure
5.1. The d/c ratio decreases linearly with decreasing ionic radius. This allows for a more
direct determination of hydration, due to the increased accuracy in measuring the location
of the lanthanide within the cage.95 As the lanthanide contraction occurs across the series,
the metal drops within the cage, resulting in a decrease of the d/c ratio. This corresponds
with a loss of a coordinated water molecule, rendering the complex q = 0, and describing
hydration without the requirement of determination of water molecule location.
There are other structural parameters that can be measured to glean insight into
chelate hydration. Three angles, the O-Ln-O angle, the antiprism torsion angle , and the
NCCN angle, along with the area of the oxygen plane, all influence chelate hydration, as
shown in Figure 5.1. The O-Ln-O angle and the oxygen plane area, O4, both correlate to a
linear decrease with decreasing ionic radius. Lukeš et. al. have proposed that an O-Ln-O
angle of less than 136° results in an O4 area that is too small to coordinate water, thus this
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measurement can distinguish between hydration states.96  shows the torsion angle
between the nitrogen and oxygen planes, and a smaller angle indicates a longer distance
between these two planes.91 An interesting conformational change occurs to the N-C-C-N
angle during the dissociative water exchange process. When the water molecule leaves, the
lanthanide drops into the macrocycle cage, because of its decreasing ionic radius. This in
turn causes the N-C-C-N torsion angle to decrease, resulting in increasing distortion.70 This
piece of evidence demonstrates the impact dissociative water exchange has on both the
metal and the ligand structure.

Figure 5.1. Left: Side view depiction of the d/c ratio and the O-Ln-O torsion angle. Center:
Top view depiction of the O4 and N4 areas, and the torsion angle of the antiprism, . Right:
The NCCN angle, carboxylates and substituents removed for clarity.

5.2. Crystallization and Structural Analysis of LnDOTFA Chelates
5.2.1. Crystallization
Synthesis of the ligand DOTFA, its chelation with appropriate lanthanide triflates,
chlorides, and oxides, and their RP-HPLC purification is described in Chapter 4. X-ray
quality crystals were grown by dissolving the lyophilized and filtered chelates in a minimal
volume of water. The solution was gently heated until complete dissolution was achieved.
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The heat was then turned off and they were partially covered to facilitate crystal growth.
The X-ray quality crystals were solved by our collaborator, Dr. Ed Valente at the
University of Portland.
5.2.2. Crystal Structure Hydration
The chelates of DOTFA all formed similar crystal structures upon analysis. Four
selected crystal structures of the later lanthanides are shown in Figure 5.2. The
crystallographic data are shown in Table 5.1.

Figure 5.2. Later lanthanide crystal structures of DOTFA chelates: DyDOTFA (●),
ErDOTFA (●), TmDOTFA (●), YbDOTFA (●). YbDOTFA is the only structure that
crystallized without an apical water coordinated.

Analysis of all chelates of DOTFA demonstrated a preferential coordination
geometry of TSAP, like that observed with chelates of DOTMA.70 Upon observation of
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the crystal structures of the later lanthanides, it is evident that YbDOTFA (●) did not
crystallize with a water molecule bound and is considered completely dehydrated. In the
crystal structure of TmDOTFA (●) the Mercury software shows a water molecule “bound”.
However, the Ln-OH2 distance is 2.661 Å, too long to be considered a formal bond. In
Figure 5.3, the Ln-OH2 distance is plotted against the ionic radius. The ionic radius is
calculated using the same Pauling hard-sphere approached used in the analysis of DOTMA
chelates.70 The linear dependence of the coordination number on ionic radius is important
due to the difficulty in accurately determining coordination number independently. Instead,
the ionic radius is calculated and then mathematically applied to coordination number
values determined by Shannon.97 The ionic radius is calculated by averaging both the four
Ln-O distances and four Ln-N distances and subtracting the corresponding ionic radii of
oxygen and nitrogen, respectively, as shown in Equation 5.1.

Figure 5.3. Metal-water distances versus lanthanide ionic radius for DOTFA chelates.
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[(Ln − N) − I. R.N ] + [(Ln − O) − I. R.O ]
2

Equation 5.1. Calculation to determine the ionic radius (I.R.) for a lanthanide is dependent
on the average ionic radii of the four coordinating oxygens (O) and four coordinating
nitrogens (N).

The data presented in Figure 5.3 show the Ln-OH2 distance decreasing linearly with
decreasing ionic radius until Er3+. Thus, a clear break in this trend is observe at Er3+. An
“erbium break” would be a new concept in lanthanide chemistry, however, would be
analogous to the commonly referenced gadolinium break. The behavior observed in
DOTFA chelates is quite different from DOTMA, which exhibits a linear decrease in the
Ln-OH2 distance across the lanthanide series.70 The gadolinium break, which is well
documented in many chelates derived from DOTA, is the point in which chelates shift in
their properties after gadolinium.98 This erbium break is surprising as chelates of DOTMA
follow the typical trend of the gadolinium break; where hydration properties shift.
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Table 5.1. Calculated values from crystallographic data for chelates of DOTFA.

The ionic radii of each Ln3+ ion in DOTFA were plotted across the lanthanide
series, then the ionic radius dependence on coordination number is plotted as dashed lined
boundaries for both CN = 8 and CN = 9 adopted from Shannon, Figure 5.4.97 These CN
bounds highlight that chelates of DOTFA maintain a CN close to 9 through ErDOTFA,
and then TmDOTFA and YbDOTFA both reduce to a CN = 8. This is in stark contrast to
DOTMA, which exhibits a gradual change from 9 to 8 over the later lanthanide series.
However, as stated previously, hydration should not be considered a discrete differentiation
between q = 1 and q = 0, but a continuum from hydrated through partially hydrated, to
dehydrated. This is well described by the gradual change observed in DOTMA chelates,
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where the change in CN begins to occur at Gd and the IR begins to decrease steadily. In
contrast, DOTFA chelates show an abrupt change from q = 1 to 1= 0 at a later point in the
series. This approach to chelate hydration is highlighted in Figure 5.5. As the only
“dehydrated” chelate in the curve in Figure 5.5, TmDOTFA remains the outlier with its
small ionic radius and reduced coordination number.

Figure 5.4. Ionic radii calculated for each chelate of DOTFA. The gray and blue lines are
calculated CNs of the lanthanide, taken from Shannon.97
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Figure 5.5. Calculated coordination numbers for each chelate of DOTFA based on waterlanthanide distance.

The longer metal-water distances observed in the later lanthanides are indicative of
partial hydration. This is reflected in their reduced calculated coordination numbers. This
had been established by our group previously; DOTMA chelates exhibiting fractional
hydration occurs across the lanthanide series.70 Although the chelates of DOTFA follow a
similar trend as chelates of DOTMA, there are some noticeable differences that potentially
provide insights into water exchange. We originally hypothesized that the bulkier phenyl
pendant arms would weigh down the pendant arms, causing water exchange to slow.
However, the relaxometric results in Chapter 4 demonstrate that exchange is faster in
GdDOTFA than in GdDOTMA. Upon crystal structure analysis, it appears the phenyl
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groups pull the acetate arms down in such a manner to allow better access for water to bind
in comparison with chelates of DOTMA. This is supported by examining the O-Ln-O
angle, Figure 5.6. In chelates of DOTMA, the O-Ln-O angle was shown to contract linearly
across the series. This linear contraction is observed from Ce3+ to Er3+ in DOTFA chelates,
but this contraction is more gradual. This supports the hypothesis that the phenyl groups
hold the chelate in a more “open” conformation. After Er3+, the O-Ln-O angle begins to
decrease sharply, resulting in an O-Ln-O angle of YbDOTFA is comparable to that of
YbDOTMA.

Figure 5.6. Lanthanide ionic radius as a function of O-Ln-O angle for LnDOTFA.

This difference can be seen in their corresponding d/c ratios, Figure 5.7, which
effectively affords the position of the metal within the ligand cage. The d/c ratios across
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LnDOTFA follow a similar trend to the O-Ln-O angle and again are quite different from
the linear behavior observed for LnDOTMA. In the middle of the lanthanide series, the d/c
ratio is larger for DOTFA than observed for DOTMA. This indicates that until Er3+, the
metal ion lies closer to the O4 plane in DOTFA than it does in DOTMA. corresponding to
an increased hydration in comparison. This renders the metal ion more accessible to water
and correspondingly increase hydration in comparison.

Figure 5.7. Ionic radius as a function of d/c ratio for LnDOTFA.

5.2.3. Water Exchange Mechanism via Crystal Structure Analysis
It has been demonstrated that there is a linear correlation between the coordination
number calculated from ionic radius and the metal-water distance.70 This correlation allows
for the change in metal-water distance to be indicative of fractional coordination, which in
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turn elucidates hydration. If we consider the series to all be GdDOTFA, the first chelate
(CeDOTFA) would represent GdDOTFA as a CN = 10. Whereas the last chelate in the
series (YbDOTFA) would embody GdDOTFA as CN = 7. This approach places the center
of the series, actual GdDOTFA, as CN = 8.5. We can then contemplate what this means
for the water exchange mechanism. A CN of 8.5 implies that gadolinium is partially
hydrated; but this does not reflect its performance relaxometrically. Thus, the more likely
explanation is that the partial CN = 8.5 does not reflect a semi-hydrated chelate, instead it
is a chelate with a long Ln-OH2 distance that exchanges water via a different mechanism.
This is further supported via analysis of the ionic radius of GdDOTFA. As described
previously, when the water uncoordinates, the ionic radius of the lanthanide decreases, thus
if GdDOTFA is exchanging water dissociatively, we would observe a small ionic radius in
the transition state.
The crystallographic data show that DOTFA does not lose a coordinated molecule
until the ionic radius of the lanthanide is less than 1.003 Å, which occurs at Tm3+. In
contrast, DOTMA begins to lose coordinated water molecules at 1.032 Å, which occurs at
Dy3+. This may be significant in terms of understanding the mechanism of exchange
occurring in GdDOTFA. Convention states that GdDOTMA undergoes dissociative water
exchange, thus in the transition state Gd3+ is CN = 8. The ionic radius of an eight coordinate
Gd3+ is 1.053 Å. This value is larger than the 1.033 Å at which DyDOTMA has a stable q
= 0 complex in the crystal structure. However, this difference does not render these
complexes dissimilar. In a high energy transition state, it is likely that GdDOTMA could
lose a coordinated water molecule to become CN = 8. In contrast, the crystallographic data
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suggest that this is not the case for GdDOTFA; the chelate does not lose a coordinated
water molecule because its open conformation promotes hydration. As described in
Chapter 1, water exchange is considered a continuum of associative-interchangedissociative mechanisms. The more open structure of DOTFA most likely allows greater
access to the incoming water molecule while the existing water molecule remains bound
or close. This in turn leads to more interchange character in the mechanism. The high
relaxivity experienced by GdDOTFA while maintaining a short M also suggest such a
change in mechanism, as explored in Chapter 4. Although future experiments are required
to confirm, this is the first time that crystallographic data imply a change in water exchange
mechanism.
5.3. Racemization in DOTFA Chelates
Upon receiving solved crystal structures of DOTFA chelates it was immediately
clear that all 15 chelates existed as a racemic mixture of RRRR and SSSS according to their
space groups. Yet, the synthesis of DOTFA chelates is stereospecific; each reaction step
apart from chelation is an SN2 reaction from an enantiopure amino acid starting material
and should result in an exclusive SSSS conformation at each -carbon pendant arm. The
space group revealing a racemic mixture of the two homochiral species, mean that a
mechanism is occurring facilitating this conversion.
However, with four chiral centers, the number of possible isomers is much higher
than the found homochiral racemate. If racemization were occurring at each chiral center
separately, we would observe two enantiomeric pairs of four diastereoisomers, and the 1H-
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NMR spectra of LnDOTFA chelates would reflect a mixture of diastereoisomers, like that
in the simulated spectrum in Figure 5.8.

Figure 5.8. Simulated 1H-NMR spectrum of racemic EuTCE-DOTA.

Because we only observe the two coordination geometries of SAP and TSAP in the
1

H-NMR spectra of all DOTFA chelates, the other possible diastereoisomers must be

inaccessible. Substitution on the -carbon prevents arm rotation, and it has been shown
that arms bind and rotate cooperatively.99 The enantiopure D--phenylglycine should
facilitate the homochiral SSSS ligand upon alkylation, thus it is unlikely that the other
possible diastereoisomers would arise due to the higher energy conformation required with
racemization.100 Because we were unsure if DOTFA chelates were existing as a mixture of
diastereoisomers at some point in the enantiospecific synthesis and then resolving to the
homochiral racemate, or if they were simply racemizing during chelation, two experiments
were conducted to determine the point of racemization.
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5.3.1. Chiral Shift Reagent Study on the Bromoacetate Alkylating Agent
We first decided to check the enantiopurity of the bromo-alkylating agent, 4-1. A
small

amount

(5

mg)

of

the

chiral

shift

reagent,

europium

tris[3-

(trifluoromethylhydroxymethylene)-(+)-camphorate] was added to 4-1 and an 1H-NMR
spectrum was collected. If both enantiomers were present, the shift reagent would in effect
act as a chiral derivatizing agent wherein the topicity of the chiral protons (S) and (R) would
no longer be isochronis and would be distinguishable by NMR. The 1H-NMR spectra
before and after the addition of the chiral shift reagent are shown in Figure 5.9. As shown
by the spectrum in Figure 5.9 Bottom, the chiral proton at ~5.4 ppm did not split into two
peaks, therefore the alkylating agent 4-1 is enantiopure.

Figure 5.9. 1H-NMR spectra of 4-1 (Top) and 4-1 with the chiral shift reagent (Bottom).
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5.3.2. D Measurements in DOTFA
Next, D measurements were collected via polarimetry on Me4-DOTFA, H4DOTFA, and two enantiopure chelates of DOTFA. These data are presented in Table 5.2.
In no cases were rotation of plane polarized light observed.
Table 5.2. D values for products in each synthetic step of synthesizing DOTFA chelates.

5.3.3. Synthesis and Analysis of Racemic EuDOTFA
The inconclusive data generated from the D experiment led us to explore the
impact of racemization by synthesizing EuDOTFA from a racemic starting material. There
are three potential results of this experiment depending on how this reaction sequence
racemizes. First, the racemic starting material could give rise to six potential
diastereoisomers in solution: RRRR (SSSS), RSSS (SRRR), RSRS, and RRSS.99 A second
option is that if racemization occurs in order to achieve the lowest energy conformation the
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product would be a mixture of 50% RRRR and 50% SSSS. Finally, it is possible that only
the D-isomer of the starting amino acid racemizes, which would result in a product mixture
of 25% SSSS and 75% RRRR. DL-methyl mandelate was reacted with phosphorus
tribromide in chloroform at ~ 20 °C for 96 hours to yield the bromide starting material (51) and the crude product was used without further isolation, shown in Scheme 5.2. A
mixture of 5-1 and cylcen was heated in acetonitrile for 48 hours to yield a crude protected
ligand (Racemic Me4-DOTFA). Upon analysis via ESI-MS, it was shown that the reaction
solution was a mixture of di-, tri-, and tetra-alkylated ligand, and was subsequently purified
via column chromatography to isolate the tetra-alkylated Me4-DOTFA product. The
methyl esters were hydrolyzed with 1M KOH in THF at reflux to yield a crude ligand
(Racemic H4-DOTFA). The ligand was chelated with europium chloride in water at pH
5.5 to yield a crude complex (Racemic EuDOTFA).

CHAPTER 5. Crystal Structures of DOTFA Chelates

171

Scheme 5.1. Synthesis of racemic EuDOTFA.

Analysis of the 1H-NMR spectrum of the racemic H4-DOTFA ligand shows a
mixture of diastereoisomers, with no diastereoisomers predominant (data not shown).
Upon chelation, the 1H-NMR spectrum of the racemic EuDOTFA also revealed a mixture
of diastereoisomers, however, the homochiral RRRR and SSSS conformations were the
majority species. These data suggest that the chelation of H4-DOTFA promotes the
homochiral configuration as the lowest energy conformation, and this most likely occurs
during chelation, Figure 5.10. Further studies are needed in order to confirm that
racemization occurs during chelation, and the mechanism of action, but these preliminary
data suggest that reaction conditions facilitate the homochiral as the predominate species,
as well as reduce the presence of other diastereoisomers.
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Figure 5.10. Zoomed in section of the 1H-NMR spectrum of Racemic EuDOTFA. The axial
protons in this region show the predominance of the homochiral (RRRR/SSSS) conformation
in the large TSAP peak at ~18 ppm, and the smaller SAP peak at ~50 ppm.

5.4. Conclusions
With the relaxometric success of GdDOTFA, it was important to glean more
information on how chelates of this ligand behave in the solid state. Analysis of the crystal
structures of DOTFA chelates revealed some surprising information. The calculated values
from the crystal structures are strongly indicative that there is a change in water exchange
mechanism for GdDOTFA. Because DOTFA does not become dehydrated until the ionic
radius of the lanthanide is below 1.003 Å and the ionic radius of GdDOTFA with a CN =
8 is greater than that, these data suggest that GdDOTFA does not exchange water under a
pure dissociative mechanism; rather has some influence of interchange. These data are
supported by the relaxometric data found in Chapter 4, GdDOTFA having an extremely
high relaxivity, while maintaining a short M, mean that it must exchange water differently.
These data give rise to the implication of DOTFA-derived chelates as BFCs.
Although DOTFA does not contain a handle to attach a targeting vector, these preliminary
studies were essential to probe the utility of functionalizing off the -carbon pendant arm.

CHAPTER 5. Crystal Structures of DOTFA Chelates

173

Due to the extremely high relaxivity of the parent GdDOTFA, modification studies are
currently being undertaken in our group to alter DOTFA into a BFC. Modification of this
structure provides the ideal scaffold for a high relaxivity agent, and although further study
is required to explore stability, precedence indicates that modified DOTFA chelates will
maintain a superior safety profile than their traditional DOTA counterparts.91
A secondary surprising result of the crystallographic study of DOTFA chelates was
the discovery that DOTFA forms a racemate upon chelation. Although the reaction
sequence of DOTFA chelates is enantiospecific, we hypothesize the  system of the
aromatic ring on the -carbon pendant arm stabilizes the system upon chelation, causing
enolization. Although this was unexpected and unintended, these results are not negative.
Because this reaction preferentially racemizes DOTFA chelates to the lowest energy
conformation, this implies that a non-enantiopure starting material can force the reaction
towards the homochiral RRRR/SSSS. Further optimization studies would be required to
facilitate this reaction, but the implication is that costly enantiopure synthetic strategies
would not be required when synthesizing DOTFA derived BFCs.
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CHAPTER 6
OTHER CHELATES OF INTEREST: DO3A-MONOAMIDES
6.1. Monoamides in Medicine and Research
6.1.1. Background
Monoamides have been a facile route of conjugation in the biomedical industry for
some time.101,102 The ability to couple a variety of active amines, such as lysine residues in
proteins, to N-hydroxysuccinimide esters (NHS) has allowed for a variety of biomolecules
to be synthesized quickly and effectively, Figure 6.1.103 These amine coupling reactions
can take place at physiological pH as well as under relatively mild conditions, which make
them an advantageous approach for synthesis of biologically robust linkages. The most
common use of the NHS coupling reaction is tagging relevant biomolecules such as
proteins and antibodies with fluorescent probes in order to glean important biological
information.104

Figure 6.1. Active coupling of N-hydroxysuccinimide ester with a terminal amine to form an
amide and N-hydroxysuccinimide.

Monoamide containing gadolinium-based MRI contrast agents (GBCAs) are
relatively commonplace in clinically settings. Two clinically available linear agents,
Omniscan™ and OptiMARK® both contain two amides in which the carbonyl coordinates
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the metal, Figure 6.2. The resulting chelates have a neutral charge, resulting in a reduced
osmolality. 32

Figure 6.2. The structures of two clinically available MRI contrast agents containing amides.
Omniscan™ (gadodiamide) (left), and OptiMARK® (gadoversetamide) (right).

6.1.2. Properties of Amides as GBCAs
The implication of replacing two coordinating ligands with a neutral amide is a
resulting net charge of 0. This change of coordinating ligand directly impacts the
relaxometric properties of the chelate. This phenomenon is highlighted in Table 6.1.
GdDTPA2-, the scaffold by which many linear chelates are derived from, has a water
exchange lifetime, M, of 303 ns. However, when two acetate coordinating pendant arms
are replaced with acetamide arms (GdDTPA-BMA) or methoxyethyl acetamide arms
(GdDTPA-BMEA), M increases by an order of magnitude. Macrocyclic agents, derived
from the ligand DOTA, also show the impact of replacing carboxylates with amides.
GdDOTAM3+ and GdDTMA3+ both contain tetraamide coordinating pendant arm,
changing the charge of both complexes to 3+. The impact on water exchange is dramatic;
M is on the order of thousands of nanoseconds versus hundreds for GdDOTA-. This drastic
change in water exchange impacts the efficacy of a chelate as an MRI contrast agent. In
order to have maximum efficacy as a contrast agent, defined as relaxivity (r1), requires the
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water exchange rate to be rapid. Due to the nature of amide containing chelates, relaxivity
is not optimized; r1 for GdDOTAM3+ is half of its tetracarboxylate counterpart, GdDOTA(2.5 mM-1s-1 and 4.5 mM-1s-1, respectively).
One interesting finding in comparing the chelates in Table 6.1, is their difference
in activation volumes, V‡. This value defines the mechanism of water exchange. Ligand
exchange mechanisms for chelates can either be associative, interchange, and
dissociative.40 As described in detail in Chapter 1, these mechanisms are not discrete, but
in fact lie on a continuum from associative at one end to dissociative at the other, with
interchange in the middle. Although all GBCAs exchange water through a dissociative
mechanism, they can lie on different parts of the continuum. By replacing carboxylate
pendant arms with neutral amides, the dissociative character is decreased; GdDOTA- has
an activation volume of 10.5 cm3mol-1 and EuDOTAM3+ has a V‡ of 4.9 cm3mol-1.105
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Table 6.1. Selected relaxometric properties of linear and macrocyclic chelates, comparison of
amide containing and non-amide containing complexes.29,32,106
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6.1.3. Chemical Exchange Saturation Transfer
Although amide containing ligand systems do not have optimal relaxometric
properties to be optimal GBCAs, their slow water exchange kinetics allow them to have
utility in a different modality of medical imaging. Chemical exchange saturation transfer
(CEST) is a methodology that provides information about biological processes via ligand
exchange systems, as described in detail in Chapter 1. First described by Balaban et al.,
CEST can illuminate metabolic processes, temperature, pH and other physiological
information.107 Through low power saturation pulses, CEST differentiates between two
pools of exchangeable protons.
For biological processes such as metabolism, many exchangeable labile protons on
metabolic molecules of interest are in such low concentrations in comparison to the bulk
water of the system, their peaks are completely buried under the water signal. Thus, in
order to probe these systems, their labile protons of interest, need to be separated from the
bulk water system. Using a para-CEST agent, allows for the protons to be shifted away
from the bulk water signal. Paramagnetic anisotropic lanthanide (III) chelates have shown
to be effective shift reagents, shifting the exchangeable water molecule protons to hundreds
of PPM away from the bulk water solvent signal. Commonly lanthanide (III) ions used for
para-CEST agents are europium, dysprosium, holmium, erbium, thulium, and ytterbium.
For a para-CEST agent to be effective when coupled with the low power saturation
CEST pulse sequence, the exchange rate between the two pools of water needs to be slow.
Thus, the slow water exchange kinetics of an amide-containing ligand system is ideal for
maximum CEST effect. Altering the structure of H4-DOTA by integrating amide
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coordinating pendant arms, allows for the amide proton to exhibit simple exchange with
the bulk water.108 The CEST shift reagent can shift this exchangeable proton away from
the bulk water peak, and altering the type of coordinating amide can impact the rate of this
exchange process. This slow exchange process probed by a para-CEST system allows
researchers to glean information about metabolic rates due to water playing an integral role
in the metabolism of various biologically relevant molecules.
6.1.4. Bimodal Agents and Bifunctional Chelators
With the growing prevalence of bifunctional chelators (BFCs) in laboratory
settings, the ideal structure to attach a targeting vector to a macrocyclic scaffold has yet to
be established. As described in Chapter 3, functionalizing through a monoamide pendant
arm provides a facile handle for subsequent bioconjugation. As shown with GdDO3ANBAM in Chapter 3, the substitution of one carboxylate pendant arm with a monoamide
slows water exchange substantially. Although not ideal for a GBCA, this slowed water
exchange could be implemented into a BFC for use as a para-CEST agent. This would
allow for a bimodal agent in which metabolic processes of interest could be monitored via
selective conjugation with a biologically relevant molecule.
Furthermore, by exploring different amide pendant arms the ligand structure can be
tuned in order to find a GBCA with optimized water exchange kinetics. Ratnakar et al. has
described the impact on water exchange based on the type of functional group in the paraposition of a phenyl-derived monoamide.109 The electronic impact of the type of group
highlights the impact a withdrawing or donating group has on kex, with donating groups
increasing the exchange rate substantially. The increased electron density being donating
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towards the lanthanide center will reduce the electronic deficiency, thus increasing the rate
of water exchange. If these effects could be increased, a monoamide pendant arm
containing a functionalizable moiety might provide to be a facile approach to a BFC
structure.
6.2. Synthesis of Monoamide Chelates
Three monoamide pendant arm containing chelates were synthesized with
assistance from Alexis Newberry. They were chosen due to their differing sterics as well
electronic properties. Two primary amines and one secondary amine were selected for
conversion to a monoamide, aniline, benzylamine and dibenzylamine, as shown in Figure
6.3. The synthesis of the three monoamides was completed via a facile nucleophilic acyl
substitution, adapted from Woods et al.8 Syntheses for the DO3A-phenylamide and DO3ABenzylamide ligands have been reported previously with slightly different conditions and
lower yields.110 The synthesis proposed herein utilized mild conditions and robust yields,
and did not require silica-column purification of the ligands like in the literature.

Figure 6.3. The three monoamide containing chelates explored herein. (Ln = Eu, Gd, Yb).
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All three monoamide chelates were synthesized using the same procedure, Scheme
6.1. The DO3A-tert-butyl ester was prepared using the methods of Raghunand et. al.74 A
facile nucleophilic acyl substitution with aniline and potassium carbonate in
dichloromethane at 60 °C generated the bromo-amide alkylating agent (6-1, 96% yield; 63, 90% yield; 6-5, 95% yield). DO3A-tert-butyl ester was alkylated with potassium
carbonate and acetonitrile at 60 ℃ using the bromo-amide alkylating agent to generate the
protected ligand (6-2, 90% yield; 6-4, 99% yield; 6-6, 75% yield). The esters were cleaved
using 4M HCl in water to generate the ligand (DO3A-Phenylamide, crude; DO3ABenzylamide, crude; DO3A-Dibenzylamide, 65% yield). The dibenzylamide protected
ligand (6-6) was subject to column purification to yield a pure product. The ligand was
chelated lanthanide chlorides (EuCl3, GdCl3, YbCl3) in water and acetonitrile at pH 5.5 to
yield the complex, each was then purified via RP-HPLC (LnDO3A-Phenylamide,
LnDO3A-Benzylamide, and LnDO3A-Dibenzylamide).
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Scheme 6.1. Total synthesis of LnDO3A-Monoamide chelates (Ln = Eu, Gd, Yb).

6.3. Analysis of the Monoamide Chelates
After RP-HPLC purification, 1H-NMR spectra were collected for both the
europium and ytterbium complexes of the three ligands produced. Analysis of the 1H-NMR
spectra of the ytterbium complexes of each chelate via line fitting in NUTS of the axial
protons of the macrocycle affords the determination of the coordination geometry ratios,
Figure 6.4. The percent square antiprism (SAP) coordination geometry is shown in Table
6.2. These data show the expected high ratio of SAP for all three monoamides synthesized.
The ratio of SAP was higher in all three YbDO3A-monoamide chelates than the tetraamide YbDOTAM. However, this is not entirely surprising, it has previously been
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demonstrated that increasing the number of coordinating amide pendant arms from one to
two, results in an increase in the percentage of TSAP in solution.111,112 The high ratio of
SAP for all three chelates would increase the shift difference of the protons on an 1H-NMR
spectrum. As a result, both YbDO3A-Phenylamide and YbDO3A-Benzylamide would
make good candidates for CEST analysis. Because YbDO3A-Dibenzylamide does not
contain an exchangeable proton, it would not be able to undergo CEST. CEST experiments
were started on both chelates, however due to the outbreak of COVID-19 were not
completed.

Figure 6.4. Axial proton regions of the macrocycle in the 1H-NMR spectra of Yb complexes
of DO3A-Dibenzylamide (Top), DO3A-Phenylamide (Center), and DO3A-Benzylamide
(Bottom).
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Table 6.2. Coordination geometry ratios for amide-containing chelates.
*Values from Aime et. al.51 †Values from Aime et. al 106

One unexpected piece of data arose upon analysis of the 1H-NMR spectra of the Yb
complexes. Analyzing the shifts of the axial protons on the macrocycle and the aromatic
protons on the monoamide pendant arm revealed strong evidence that these complexes
maintain different orientations. This is evident when the shifts of these protons of the three
chelates are compared. The differences in axial proton shifts observed in the 1H-NMR
spectra of the three YbDO3A-Mononamides are subtle, however, are in slightly different
locations, with YbDO3A-Phenlyamide having the furthest downfield shifted peak, Figure
6.4. Analyzing the aromatic region of the 1H-NMR spectra for the three chelates, it is more
apparent that their aromatic protons of have very different shifts, Figure 6.5.
The aromatic protons of YbDO3A-Phenylamide are shifted slightly downfield,
whereas YbDO3A-Benzylamide and YbDO3A-Dibenzylamide both have upfield shifted
aromatic protons. This difference can be attributed to the position of the aromatic group
within the magnetic field induced by the f-electrons of the Yb3+ ion. The protons on
aromatic substituted chelates typically shift in the region that is seen in their ligand
structures, in the range of ~7 – 10 ppm. However, if the orientation of the aromatic group
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is positioned in a way that it is influenced by the paramagnetic lanthanide, an upfield shift
can occur. What is interesting about these three monoamides is that the addition of a
methylene group results in a shift of the aromatic protons. Furthermore, the induced shift
experienced by YbDO3A-Benzylamide and YbDO3A-Dibenzylamide are different; the
aromatic protons of YbDO3A-Benzylamide are shifted upfield, while YbDO3ADibenzylamide has aromatic protons in the same upfield region as YbDO3A-Benzylamide
but also some that are slightly downfield of those.

Figure 6.5. Aromatic proton regions in the 1H-NMR spectra of Yb complexes of DO3ADibenzylamide (Top), DO3A-Phenylamide (Center), and DO3A-Benzylamide (Bottom).

Although these differences in observed proton shifts in these chelates appear to be
structural in origin, crystal structures of analogs of tetra-phenylamide and tetrabenzylamide chelates have been published and may provide greater insight into these
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structural changes. The crystal structure of the Tm3+ complex of the tetra-para-methoxyphenylamide from Milne et. al. shows the phenyl groups of the amide pendant arms to be
oriented up towards the oxygen plane, as shown in Figure 6.6 Left.113 The addition of a
methylene group as seen in the Gd3+ complex of the tetra-para-methyl-benzylamide
derivative from Basal et. al. orients the benzylic groups of the amide pendant arms down
towards the nitrogen plane, as shown in Figure 6.6 Right.114

Figure 6.6. The superposition of the crystal structures of the p-OMe derivative of TmTetraphenylamide (Left) and the p-Me derivative of GdTetra-benzylamide (Right) on a heat map
of the magnetic field induced by the paramagnetic Ln3+ ion. In each case two pendant arms
of the chelate and any aromatic substituents are not shown for clarity. The magnetic field is
assumed to be perfectly axial with the principal magnetic axis aligned along the Ln-OH2 bond
(if present). Red regions correspond to a downfield shift for Ln3+ and blue regions correspond
to upfield shifts in the 1H-NMR. Crystal structures obtained from Milne et. al. and Basal et.
al.113,114

When these crystal structures are superimposed onto a “heat map”, where the blue
region indicates upfield shifts and red indicates downfield shifts, it is evident why the
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change in shift is observed for the DO3A-Monoamides. The phenyl groups of the
tetraphenylamide chelate (Figure 6.7 Left) are in the orange-yellow region of the
superimposed heat map; this corresponds to downfield shifts in the observed 1H-NMR
spectrum. In contrast, the benzyl substituents on the tetrabenzylamide chelate (Figure 6.7
Right) are completely in the blue region of the heat map which reflects upfield shifts in the
1

H-NMR spectrum.
These data suggest that the type of amide substituent influences structure and would

therefore impact how the three DO3A-Monoamide chelates behave in solution. We would
expect that DO3A-Phenylamides would have slower water exchange due to the greater
influence of the paramagnetic lanthanide; this would likely correspond to a shorter metalwater bond distance. Both DO3A-Benzylamide and DO3A-Dibenzylamide chelates would
likely have faster water exchange than the phenylamide derivative. Their structures are less
influenced by the paramagnetic lanthanide as demonstrated by their upfield shifts, which
would result in a longer metal-water distance and thus faster exchange.
6.4. Conclusions and Future Directions
We presented a facile and inexpensive synthesis for three different DO3Amonoamides. This synthetic strategy facilitates alteration of the monoamide pendant arm
by using different primary or secondary starting amines. The three ligands synthesized,
DO3A-Phenylamide, DO3A-Benzylamide, and DO3A-Dibenzylamide represent attractive
scaffolds to study slower exchanging systems. YbDO3A-Phenylamide and YbDO3ABenzylamide provide two novel structures to study the CEST effect in a monoamidesubstituted chelate. Unfortunately, CEST collection was interrupted due to the COVID-19
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pandemic and data is still being processed. We hypothesize that both YbDO3APhenylamide and YbDO3A-Benzylamide will have long M values due to their near 100%
SAP coordination geometry ratios, resulting in a high CEST effect. This should also reduce
relaxivity as gadolinium chelates, as seen with GdDO3A-NBAM in Chapter 3.
The shift differences in the aromatic protons on the phenyl and benzyl substituents
on the Yb complexes of these three chelates elucidated interesting information about
structure. These unexpected shift differences can be explained when reviewing crystal
structures of tetraamide analogs. The orientation of the aromatic ring on these chelates is
up in the phenylamide derivative, and down in the benzylamide derivative. Thus, the
addition of a methylene group alters the structure drastically enough to result in differences
in 1H-NMR spectra. These preliminary data suggest that these differences could influence
the rate in which these monoamide chelates exchange water, with DO3A-Phenylamide
most likely having a slower water exchange rate than DO3A-Benzylamide and DO3ADibenzylamide due to its closer proximity to the lanthanide center.
The increased hydrophobicity of LnDO3A-Dibenzylamide chelates should allow it
to have a slower rotational correlation time in solution. This makes this scaffold an
intriguing option necessitating further exploration into a dibenzyl-substituted chelate and
comparing them to non-aromatic substituted monoamide chelates. The data presented in
Chapter 3 explores the impact of a monoamide substituted chelate as a potential BFC
scaffold. Although the chelates presented herein do not contain an active moiety for
functionalization, their structures represent the impact slightly tuning the monoamidesubstituted scaffold has on water exchange and relaxivity. The higher ratio of TSAP for
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chelates of DO3A-Dibenzylamide might provide a slightly shorter M than other
monoamide substituted chelates, rendering it a better tuned structure as a GBCA.
Relaxometric data is currently being collected on the gadolinium chelates of all three
structures, and these data will give further insight into the effect structure has on function.
These data could help facilitate tuning the scaffold of DO3A-NBAM explored in Chapter
3, to develop a more robust and effective BFC.
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CHAPTER 7
EXPERIMENTAL
7.1. General Procedural Remarks
All reagents and solvents were obtained from commercial sources and used as
received. 18.2 M·cm water was used in all reactions, workups, purification, and analysis.
All dry solvents were obtained from a solvent still with adsorption columns for oxygen and
water.
HPLC purified compounds utilized a Waters 2545 Quaternary Gradient Module
affixed with a Phenomenex Luna C18(2) 50  250 mm column. All methods applied a 50
mL/min flow rate, continuous He sparge, a polar phase of aqueous 0.037% HCl (w/w), and
an organic phase of 100% acetonitrile. The gradient used in each purification is described
below. Absorption was monitored using a Waters 2489 UV-Vis detector at wavelengths
described below.
All NMR analyses were conducted on a Bruker Avance II+ spectrometer operating
at 400.13 MHz with a 5 mm BBFO probe, or a Bruker Avance III+ spectrometer operating
at 600.14 MHz with a 5 mm TXI probe, when denoted. Temperature controlled
experiments utilized the installed variable temperature controller model 2416 with a BCU05 chiller. All NMR spectra were obtained by preparing synthesized compounds in 99.9%
enriched D2O, CD3CN, or CDCl3.
Mass spectra were acquired on a ThermoElectron LTQ-Orbitrap Discovery high
resolution mass spectrometer.
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7.2. Synthesis, purification, and characterization of Chapter 2 Complexes
7.2.1. Synthesis of TbNB-DOTMA S-SSSS Corner and Side Isomers
7.2.1.1. Methyl (R)-2-(((trifluoromethyl)sulfonyl)oxy)propanoate (2-1)

Scheme 7.1. Synthesis of methyl (R)-2-(((trifluoromethyl)sulfonyl)oxy)propanoate (2-1).

On a Schlenk line under inert conditions (N2 gas), methyl-D-lactate (0.91 mL, 9.6
mmol) was dissolved in dry dichloromethane, and the reaction mixture was cooled to -78
°C. 2,6-Lutidine (1.34 mL, 11.5 mmol) was added to the cooled reaction mixture. A
solution of trifluoromethanesulfonic anhydride (1.93 mL, 11.5 mmol) dissolved in dry
dichloromethane (50 mL) was added to the reaction mixture via cannula dropwise. Then
the reaction mixture was stirred at -78 °C for 4 hours. The reaction solvents were then
removed in vacuo. Under a stream of flowing N2, hexanes were added to the pale pink
residue and stirred vigorously. The biphasic mixture was separated via decanting, and the
hexane layer was retained. Hexanes were removed in vacuo to afford a colorless oil
product, Scheme 7.1 (2-1, 1.13 g, 50% yield). The product was used as obtained without
characterization.
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2,2',2'',2'''-((S)-2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-

1,4,7,10-tetrayl)(2S,2'S,2''S,2'''S)-tetrapropionate (S-SSSS Me4-NB-DOTMA)

Scheme 7.2. Synthesis of protected methyl ester ligand (Me4-NB-DOTMA S-SSSS, 2-2) via
alkylation of 2-1 onto NB-cyclen.

On a Schlenk line under inert conditions (N2) dry dichloromethane (100 mL) was
added to a mixture of (S)-2-(4-nitrobenzyl)-1, 4, 7, 10-tetraazacyclododecane (0.1 g, 0.325
mmol) and potassium carbonate (0.2841 g, 1.63 mmol), and the reaction mixture was
cooled to -78 °C. A mixture of 2-1 (1.13 g, 4.8 mmol) in dry dichloromethane (50 mL) was
added dropwise via cannula to the reaction mixture. The reaction was stirred from -78 °C
– RT under flowing N2 for 18 hours. The reaction was then heated at 40 °C under flowing
N2 for 48 hours. The reaction mixture was washed three times with a potassium carbonate
solution (pH 10), and the organic layer was dried in vacuo to afford a dark yellow oil crude
product, confirmed by MS (ESMS ESI(+) m/z: 652.36 ([M]+, 100%)), Scheme 7.2 (Me4NB-DOTMA S-SSSS). The product was used without further purification.
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7.2.1.3. (2S,2'S,2''S,2'''S)-2,2',2'',2'''-((S)-2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetrapropionic acid (S-SSSS H4-NB-DOTMA)

Scheme 7.3. Synthesis of ligand S-SSSS H4-NB-DOTMA via methyl ester hydrolysis of S-SSSS
Me4-NB-DOTMA.

The crude reaction mixture of Me4-NB-DOTMA S-SSSS was dissolved in THF (10
mL) and 8 equivalents of 1M KOH (5.2 mL) was added. The reaction was heated at 60 °C
for 48 hours, until the biphasic solution became monophasic. The solvents were removed
via lyophilization to yield a crude brown solid. The product was not isolated and used
without further purification, Scheme 7.3 (H4-NB-DOTMA S-SSSS).
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2,2',2'',2'''-((S)-2-(4-nitrobenzyl)-1,4,7,10-

tetraazacyclododecane-1,4,7,10-tetrayl)(2S,2'S,2''S,2'''S)-tetraacetate (S-SSSS TbNBDOTMA Corner and Side isomers)

Scheme 7.4. Synthesis of target chelate, S-SSSS TbNB-DOTMA via chelation of S-SSSS H4NB-DOTMA with TbCl3.

Terbium (III) chloride (2 equivalents) and the crude reaction mixture of H4-NBDOTMA S-SSSS and dissolved in water. The solution pH was adjusted to 5.5 with dilute
KOH and heated the reaction was at 60 °C for 48 hours, Scheme 7.4. The solvents were
removed via lyophilization to yield a crude waxy solid. The crude residue was subjected to
separation and purification via RP-HPLC utilizing the solvent system in Table 7.1.
Table 7.1. RP-HPLC purification method for LnNB-DOTMA chelates.
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The HPLC fractions were dried via lyophilization to yield two colorless solids, the
Corner (RT = 16.8 minutes, 10 mg, 4% yield) and Side (RT = 19.8 minutes, 8.7 mg, 4%
yield) (S-SSSS TbNB-DOTMA Corner and Side). Both chelates were verified by 1HNMR and the data consistent with previously published spectra.115 TbNB-DOTMA
Corner 400 MHz D2O; 1H (ppm): : -378.52 (1H), -350.98 (1H), -335.08 (1H), -321.02
(1H), -150.30 (1H), -103.06 (1H), -94.93 (1H), -91.47 (1H), -61.95 (1H), -56.60 (1H), 51.81 (1H), -49.36 (1H), -32.09 (1H), 1.3732 (1H), 1.60 (1H), 1.98 (1H), 3.61 (1H), 6.93
(1H), 7.75 (1H), 9.65 (1H), 11.08 (1H), 16.56 (1H), 17.08 (1H), 36.20 (1H), 51.99 (1H),
56.58 (1H), 60.78 (1H), 63.89 (1H), 68.36 (1H), 73.64 (1H), 85.57 (1H), 89.61 (1H), 93.84
(1H), 116.16 (1H), 121.89 (1H), 146.93 (1H), 197.62 (1H), 463.73 (1H). TbNB-DOTMA
Side 400 MHz D2O; 1H (ppm): : -470.91 (1H), -386.78 (1H), -347.39 (1H), -345.56
(1H), -112.14 (1H), -100.91 (1H), -95.26 (1H), -75.13 (1H), -72.66 (1H), -60.64 (1H), 59.85 (1H), -57.06 (1H), -54.52 (1H), -23.10 (1H), -15.77 (1H), -1.76 (1H), -1.39 (1H),
0.14 (1H), 0.91 (1H), 1.36 (1H), 1.59 (1H), 1.97 (1H), 2.75 (1H), 3.51 (1H), 7.50 (1H),
8.22 (1H), 53.31 (1H), 61.84 (1H), 64.72 (1H), 71.33 (1H), 98.24 (1H), 118.97 (1H),
169.96 (1H), 172.09 (1H), 243.33 (1H), 298.47 (1H), 319.85 (1H), 324.95 (1H).
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7.3. Synthesis, purification, and characterization of Chapter 3 Complexes
7.3.1. DO3A tert-Butyl Esters Synthesis (Used in Chapter 3 and Chapter 5 Complexes)

Scheme 7.5. Synthesis of DO3A-tert-butyl esters.

i. Alkylation. On a Schlenk line under inert conditions (N2 gas), 1, 4, 7, 10tetraazacyclododecane (cyclen, 25 g, 0.145 mol) was dissolved in dimethylacetamide (428
mL, 4.6 mol). Sodium acetate (37.8 g, 0.41 mol) was added to the stirring solution. tertButyl bromoacetate (63.9 mL, 0.41 mol) in dimethylacetamide (70 mL) was added
dropwise using a pressure equalized drop funnel, and the reaction mixture was stirred for
18 hours under nitrogen purge. After the addition of the tert-butyl bromoacetate solution,
the reaction flask was stoppered and left to stir at room temperature for 19 days.
The reaction mixture was then filtered through a sintered glass filter. The liquid
filtrate was reduced in vacuo to yield more solid, this solid was combined with the original
filter cake. The filter cake was dried under vacuum for 18 hours. The filter cake was then
washed with chloroform through the sintered glass filter into a separatory funnel. The
chloroform solution was washed with water (3  200 mL), and the organic solvents were
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dried (Na2SO4) and removed in vacuo. The residual solids were further dried on the
diaphragm pump for 18 hours.
ii. Neutralization of the HBr Salt. The dried solid was weighed to determine the
amount of potassium carbonate to add to neutralize the HBr salt product. The mass of
potassium carbonated needed was determined via Equation 6.1.
(g crude HBr Salt Solid × 276.42 g⁄mol)
g K 2 CO3 = [
]
676.52 g⁄mol
Equation 7.1. Determination of mass of potassium carbonate to add to the DO3AtBu ester
HBr salt to effectively neutralize.

The dried solid was dissolved in 100 mL acetonitrile, and potassium carbonate
(30.46 g, 0.11 mol) was added to the solution. The reaction mixture was stirred and heated
at 45°C for 48 hours. After the reaction time, the solution was filtered through a filtered
glass funnel, and organic solvents were removed in vacuo to yield a dark yellow residue.
The residue was extracted 3  200 mL diethyl ether to yield a bright orange oil (DO3Atert-butyl esters, 39.9 g, 53% yield). The orange oil was recrystallized out of hexanes and
dichloromethane via a slow evaporation of solvents to yield a colorless fluffy powder. 1HNMR and 13C-NMR spectra were consistent with previously published data (ESMS ESI(+)
m/z: 515.38 ([M + 1]+, 100%)).74

CHAPTER 7. Experimental

198

7.3.2. Synthesis of DO3A-NBAM derivatives
7.3.2.1. 2-Bromo-N-(4-nitrobenzyl) acetamide (3-1).

Scheme 7.6. Synthesis of 2-bromo-N-(4-nitrobenzyl) acetamide (3-1).

4-nitrobenzylamine (0.5 g, 2.7 mmol) was dissolved in 2M potassium carbonate
solution (20 mL) and cooled to 0C. Bromo acetylbromide (0.46 mL, 5.3 mmol) was
dissolved in dichloromethane (20 mL) and added dropwise to the 4-nitrobenzylamine
solution over the span of one hour. The reaction mixture stirred until it reached room
temperature for 18 hours, Scheme 7.6. The opaque solution was extracted with
dichloromethane (3 × 50 mL), and the organic layer was dried (Na2SO4) and solvents
removed in vacuo to afford a colorless solid product. The colorless solid was diluted with
methanol (15 mL) and heated at 70C until dissolved. The solution was heated until the
volume was reduced to <5 mL and then allowed to slowly cool to room temperature. After
cooling, colorless cubic-like crystals formed. The isolated and dried crystals were
characterized (3-1, 0.67 g, 77% yield). 600MHz CDCl3; 1H (ppm):  3.89 (s, 2H), 4.52
(d, J = 6.14 Hz, 2H), 6.92 (s, 1H), 7.38 (d, J = 8.42 Hz, 2H), 8.13 (d, J = 8.23 Hz, 2H); 13C
(ppm):  28.88, 43.41, 124.01, 128.31, 144.91, 147.51, 165.89. ESMS ESI(–) m/z:
271.08334 ([M]–, 100%), 273.08334 ([M+2]–, 98%). FT-IR max = 4000 cm-1 (cm-1):
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695.91 (C–Br), 1108.55 (ar N–O), 1317.98 (amide C–N), 1344.57 (ar N=O), 1513.74 (ar
sp2 C=C), 1630.07 (amide C=O), 3010.76 (ar sp2 C–H), 3261.45 (amide N–H).
7.3.2.2. Tris-tert-butyl 2, 2’, 2’’-(10-2((4-nitrobenzyl)amino)-2-oxoethyl)-1, 4, 7, 10tetraazacyclododecane-1, 4, 7 triyl)triacetate. (3-2)

Scheme 7.7. Synthesis of the protected ligand (3-2) via alkylation of 3-1 onto DO3A-tert-butyl
esters.

DO3A-tert-butyl ester (0.5 g, 0.97 mmol) was dissolved in acetonitrile (40 mL).
Potassium carbonate (0.67 g, 4.8 mmol) and 3-1 (0.32 g, 1.2 mmol) were added, and the
reaction mixture stirred at 40C for 18 hours, Scheme 7.7. After cooling to room
temperature, the solvents were removed in vacuo. The opaque brown residue was extracted
with dichloromethane (3 × 50 mL), and the organic layer was dried (Na2SO4) and solvents
removed in vacuo to afford a translucent yellow oil product, the protected ligand (3-2, 0.61
g, 87% yield). 400 MHz CD3CN; 1H (ppm): : 1.45 (27H, s, tBu), 2.01 – 2.88 (18H, m, CH2), 3.05 – 4.74 (8H, m, -CH2), 4.48 (2H, s, benzylic -CH2), 7.56 (2H, d, J = 9 Hz, ar CH), 8.16 (2H, d, J = 9 Hz, ar -CH). 13C (ppm): : 27.8 (9C, tBu), 41.6 (1C, -CH2), 49.4 –
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56.8 (8C, broad, NCH2CH2N), 57.9 (3C -CH2), 62.5 (1C, -CH2), 81.9 (2C, C(CH3)3),
82.1(1C, C(CH3)3), 124.0 (1C, ar C(CH)2), 128.6 (2C, ar C-H), 128.8 (2C, ar C-H), 147.4
(1C, ar CNO2), 173.0 (2C, C=O), 173.1 (1C, C=O), 173.4 (1C, C=O). ESMS ESI(+) m/z:
729.41348 ([M + Na]+, 100%). FT-IR max = 4000 cm-1 (cm-1): 1106.33 (ester C–O),
1155.36 (ar N=O), 1225.24 (amide C–N), 1342.91 (ar N–O), 1605.56 (ar sp2 C=C),
1667.13 (amide C=O), 1724.92 (ester C=O), 2824.42 (ar sp2 C–H), 2975.38 (amide C–H).
Rf = (Si2O2, (CH2CH3)2O) 0.125.
7.3.2.3. Synthesis of 2, 2’, 2’’-(10-2((4-nitrobenzyl)amino)-2-oxoethyl)-1, 4, 7, 10tetraazacyclododecane-1, 4, 7 triyl)triacetic acid. (DO3A-NBAM)

Scheme 7.8. Synthesis of the ligand DO3A-NBAM via tert-butyl ester hydrolysis of the
protected ligand (3-2) in acid.

3-2 (0.84 g, 1.19 mmol) was dissolved in 4M HCl (20 mL) and stirred for 18 hours,
Scheme 7.8. The acidic solution was neutralized with KOH to pH 6.5 and solvents were
removed by lyophilization to yield a solid product (DO3A-NBAM, 0.16 g, 24% yield).
400 MHz D2O; 1H (ppm):  2.69 – 3.58 (16H, m, NCH2CH2N), 3.69 – 4.30 (8H, m, CH2), 4.43 (2H, s, -CH2),  (2H, d, J = 9 Hz, ar -CH),  (2H, d, J = 9 Hz, ar -CH),C
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(ppm):  43.0 (1C, -CH2) 47.5 – 54.7 (8C, broad, NCH2CH2N), 60.9 (4C, -CH2), 123.7
(2C, ar -CH), 128.0 (2C, ar -CH), 145.7 (1C, ar -C(CH)2), 146.8 (1C, ar -CNO2), 173.9
(4C, C=O). ESMS-ESI(–) m/z: 537.2316 ([M – 1]-, 100%). FT-IR max = 4000 cm-1 (cm1):

aromatic N–O 1162.28 cm-1, amide C–N 1213.76 cm-1, aromatic N=O 1344.57 cm-1,

carboxylic acid C–O 1387.93 cm-1, aromatic sp2 C=C 1606.37 cm-1, amide C=O 1676.20
cm-1, carboxylic acid C=O 1724.58 cm-1, aromatic sp2 C–H 2967.79 cm-1, carboxylic acid
O–H 3084.30 cm-1, amide N–H 3356.83 cm-1. Rf = (Si2O2, (CH2CH3)2O) 0.075.
7.3.2.4. Ln(III)-(2,

2’,

2’’-(10-2((4-nitrobenzyl)amino)-2-oxoethyl)-1,

4,

7,

10-

tetraazacyclododecane-1, 4, 7 triyl)triacetate). (LnDO3A-NBAM)

Scheme 7.9. Chelation of the ligand DO3A-NBAM with lanthanide chlorides (EuCl3, GdCl3,
YbCl3) to produce target complexes.

DO3A-NBAM (0.049 g, 0.09 mmol) and GdCl3·6H2O (0.072 g, 0.19 mmol) were
dissolved in H2O (10 mL) and acetonitrile (2 mL). The pH was adjusted to 5.5 with KOH
and the reaction was stirred and heated at 60C for 48 hours, Scheme 7.9. The solution was
purified by RP-HPLC, with absorbance monitoring at  = 270 nm and 205 nm. The solvent
system utilized is described in Table 7.2. The RP-HPLC purification yielded a colorless
solid product (GdDO3A-NBAM, RT = 6.9 minutes, 8.5 mg, 14% yield). ESMS-ESI(–)
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m/z: 692.13 ([M]- with appropriate isotope distribution). EuDO3A-NBAM 1H-NMR 400
MHz D2O (ppm): : -18.14 (1H), -18.02 (1H), -17.08 (1H), -16.59 (1H), -16.25 (1H), 15.96 (1H), -13.88 (1H), -13.79 (1H), -12.32 (1H), -11.50 (1H), -8.93 (1H), -8.05 (1H), 7.64 (1H), -7.18 (1H), -5.67 (1H), -5.02 (1H), -3.49 (1H), -2.78 (1H), -1.91 (1H), -1.03
(1H), -0.39 (1H), -0.19 (1H), 2.88 (1H), 3.17 (1H), 4.40 (1H), 6.05 (1H), 6.33 (1H), 32.76
(1H), 33.48 (1H), 34.20 (1H).
Table 7.2. RP-HPLC purification method for LnDO3A-NBAM chelates.
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7.3.3. DO3A-BPAM Derivatives
7.3.3.1. 2,

2’,

2’’-(10-2((4-aminobenzyl)amino)-2-oxoethyl)-1,

4,

7,

10-

tetraazacyclododecane-1, 4, 7 triyl)triacetic acid. (DO3A-ABAM)

Scheme 7.10. Synthesis of DO3A-ABAM via hydrogenation of DO3A-NBAM with Pd/C.

DO3A-NBAM (0.8604 g, 1.6 mmol) dissolved in H2O (20 mL) in a 500 mL
hydrogenator vessel. A catalytic amount of 10% Pd/C was added, and the reaction mixture
was shaken on a Parr Hydrogenator under H2 at 10 PSI for three hours, Scheme 7.10. The
solution was subsequently filtered, and solvents were removed by lyophilization, to yield
an orange solid (DO3A-ABAM, 0.735 g, 87% yield). 400 MHz D2O; 1H (ppm):  2.92
– 3.95 (16H, m, NCH2CH2N), 3.51 – 3.95 (8H, m, -CH2), 4.34 (2H, s, -CH2), 7.32 (2H, d,
J = 8 Hz, ar -CH), 7.40 (2H, d, J = 8 Hz, 2H, d, ar -CH). C (ppm):  42.5 (1C, -CH2),
47.5 – 51.0 (8C, broad, NCH2CH2N), 55.1 (4C, -CH2), 122.9 (2C, ar -CH), 128.6 (2C, ar CH), 138.9 (1C, ar -CNH2), 141.4 (1C, ar -C(CH)2), 171.6 (4C, C=O). (ESMS-ESI(+) m/z:
509.4167 ([M + 1]+, 100%). FT-IR max = 4000 cm-1 (cm-1): 1214.07 (carboxylic acid C–
O), 1350.83 (amide C–N), 1550.43 (ar sp2 C=C), 1675.78 (amide C=O), 1718.80

CHAPTER 7. Experimental

204

(carboxylic acid C=O), 2591.12 (ar sp2 C–H), 2853.73 (carboxylic acid O–H), 3361.90 (ar
amine). Rf = (Si2O2, CH3OH) 0.25.
7.3.3.2. 2,

2’,

2’’-(10-2((4-isothiocyanatobenzyl)amino)-2-oxoethyl)-1,

4,

7,

10-

tetraazacyclododecane-1, 4, 7 triyl)triacetic acid. (DO3A-IBAM)

Scheme 7.11. Synthesis of DO3A-IBAM from DO3A-ABAM.

DO3A-ABAM (0.1093 g, 0.21 mmol) was dissolved in H2O (10 mL, pH = 2).
Thiophosgene (0.05 mL) was dissolved in chloroform (10 mL). The organic solution was
added to the aqueous mixture and stirred vigorously at room temperature for 18 hours,
Scheme 7.11. The mixture was then washed with chloroform (30 mL). The aqueous phase
was dried via lyophilization to afford a light orange solid product (DO3A-IBAM, 0.102 g,
86% yield). 400 MHz D2O; 1H (ppm):  2.82 – 3.43 (16H, m, NCH2CH2N), 3.52 – 3.92
(8H, m, -CH2), 4.32 (2H, s, -CH2), 7.23 (J = 8 Hz, 2H, d, ar -CH), 7.71 (J = 8 Hz, 2H, d,
ar -CH). C (ppm):  41.8 (1C, -CH2), 46.1 – 51.1 (8C, broad, NCH2CH2N), 52.4 (4C, CH2), 125.0 (2C, ar -CH), 127.7 (2C, ar -CH), 128.7 (1C, ar -C(CH)2), 133.0 (1C, ar C(CH)2), 136.4 (1C, NCS), 172.8 (4C, C=O). ESMS-ESI(+) m/z: 551.23 ([M + 1]+,
100%). FT-IR max = 4000 cm-1 (cm-1): 1161.44 (carboxylic acid C–O), 1214.71 (amide
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C–N), 1537.53 (ar sp2 C=C), 1673.14 (amide C=O), 1723.59 (carboxylic acid C=O),
2099.67 (ar N=C=S), 2971.58 (ar sp2 C–H), 3084.69 (carboxylic acid O–H).
7.3.3.3. 2, 2', 2''-(10-(2-((4-(3-([1, 1'-biphenyl]-4-ylmethyl)thioureido)benzyl)amino)-2oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl)triacetic acid (DO3A-BPAM)

Scheme 7.12. Synthesis of the target ligand, DO3A-BPAM from DO3A-IBAM.

DO3A-IBAM (0.1022 g, 0.19 mmol) was dissolved in H2O (5 mL). The pH was
adjusted to 8 with KOH. 4-phenylbenzylamine (0.0671 g, 0.4 mmol) dissolved in dioxane
(7 mL) was added to the aqueous reaction mixture and it was stirred at room temperature
for 18 hours, Scheme 7.12. The flocculent solution was adjusted to pH 7 with HCl and
solvents were removed via lyophilization to afford a crude fluffy colorless solid (DO3ABPAM, 0.051g, 48% yield). 400 MHz CD3CN; 1H (ppm):  1.19 (2H, s, -CH2), 1.49
(2H, s, -CH2), 1.74 (2H, s, -CH2), 1.76 (2H, s, -CH2), 1.91 – 2.03 (16H, NCH2CH2N), 4.07
(2H, s, CH2), 4.73 (2H, s, -CH2), 7.31 (2H, J = 8 Hz, d, ar -CH), 7.39 (4H, J = 8 Hz, d, ar
-CH), 7.49 (J = 8 Hz, 3H, t, ar -CH), 7.58 (2H, J = 8 Hz, d, ar -CH), 7.62 (2H, J = 8 Hz, d,
ar -CH), C (ppm): : 36.4 (4C, broad, -CH2), 41.6 (2C, -CH2), 51.6 – 62.3 (8C, broad,
NCH2CH2N), 111.4 – 125.0 (18C, broad, ar -C(CH)2), 166.2 (4C, C=O), 190.8 (1C, C=S)
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ESMS-ESI(+) m/z: 734.33 ([M + 1]+, 100%), 772.28 ([M + K]+, 50%). FT-IR max = 4000
cm-1 (cm-1): 733.60 (thiourea C=S), 1087.07 (carboxylic acid C–O), 1220.66 (amide C–
N), 1485.16 (thiourea C–N), 1599.83 (ar sp2 C=C), 1675.77 (amide C=O), 1718.81
(carboxylic acid C=O), 2963.55 (ar sp2 C–H), 3214.77 (amide N–H), 3372.74 (carboxylic
acid O–H). Rf = (Si2O2, CH3OH) 0.125.
7.3.3.4. Ln(III)-(2, 2', 2''-(10-(2-((4-(3-([1, 1'-biphenyl]-4-ylmethyl) thioureido) benzyl)
amino)-2-oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl) triacetate) (LnDO3ABPAM)

Scheme 7.13. Chelation of the ligand DO3A-BPAM with lanthanide chlorides (EuCl3, GdCl3)
to produce target complexes.

DO3A-BPAM (0.0592 g, 0.081 mmol), and EuCl3‧H2O (0.033 g, 0.091 mmol) were
dissolved in H2O (10 mL), the pH of the solution was adjusted to 7 with 1M KOH. The
reaction was heated and stirred at 70C for 24 hours, Scheme 7.13. The solution was
purified by RP-HPLC, with absorbance monitoring at  = 254 nm and 205 nm. The solvent
system utilized is outlined in Table 7.3. The fractions were lyophilized to yield a colorless
solid (EuDO3A-BPAM, RT = 22.3 minutes, 19.1 mg, 27% yield). 400 MHz D2O; 1H
EuDO3A-BPAM: : –16.438 (1H), –14.845 (1H), –12.683 (1H), –8.305 (1H), –6.796
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(1H), –6.293 (1H), –4.476 (1H), –1.067 (1H), 1.819 (4H), 2.758 (1H), 3.041 (1H), 3.593
(1H), 3.707 (1H), 4.165 (8H), 7.497 (5H), 7.692 (8H), 32.183 (1H), 32.641 (1H), 33.338
(1H), 34.313 (1H). GdDO3A-BPAM ESMS–ESI(-) m/z: 887.2176 ([M – 1]-, with
appropriate Gd isotope distribution).
Table 7.3. RP-HPLC purification method for LnDO3A-BPAM chelates.

7.3.4. Synthesis of DOTA-NF Derivatives
7.3.4.1. Ethyl 2-bromo-2-(4-nitrophenyl) acetate (3-3)

Scheme 7.14. Synthesis of ethyl 2-bromo-2-(4-nitrophenyl) acetate (3-3).

Ethyl 4-nitrophenylacetate (10.05 g, 48 mmol) and N-bromo succinimide (12.84 g,
72 mmol) were dissolved in acetonitrile (50 mL). The reaction mixture was equipped with
a condenser and was irradiated with a 72-watt UV (365 – 395 nm) light, and heated at 60
℃ for 15 days, Scheme 7.14. After the reaction time, the dark red liquid was filtered
through a sintered glass funnel with diethyl ether. The filtered solution was extracted 3 ×
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100 mL with diethyl ether, and the organic layer was dried in vacuo to afford a dark orange
oil product (3-3, 15.2 g, 86% yield). The spectra for 3-3 were consistent with previously
published literature (ESMS-ESI(–) m/z: 287.9700 ([M – 1]-, 100%), 285.9722 ([M – 2]-,
98%)).116,117 The resulting crude product was used without further purification.
7.3.4.2. tri-tert-butyl

2,2',2''-(10-(2-ethoxy-1-(4-nitrophenyl)

-2-oxoethyl)

-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate (3-4)

Scheme 7.15. Synthesis of the protected ligand (3-4) via alkylation of 3-3 onto DO3A-tert-butyl
esters.

Multiple reaction conditions were attempted to effectively alkylate DO3A-tertbutyl esters with 3-3. The various reaction attempts are discussed in Chapter 3. The reaction
that yielded the highest amount of the protected ligand, 3-4, is shown in Scheme 7.15.
DO3A-tert-butyl esters (0.104 g, 0.2 mmol), 3-3 (87 mg, 0.3 mmol), and potassium
carbonate (55 mg, 0.4 mmol) were dissolved in chloroform (10 mL). The reaction mixture
was stirred at ambient temperature (~20 °C) for 48 hours. The resulting reaction mixture
was extracted with water, to yield a dark red residue (3-4, 0.14 g, 94% yield). 600 MHz
CD3CN; 1H (ppm): : 1.48 (27H, s, tBu-CH3), 2.10 – 3.08 (16H, m, NCH2CH2N), 3.38
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(2H, s, -CH2), 3.74 (2H, q, -CH2CH3), 4.0 (1H, s, -CH), 4.19 (3H, t, -CH2CH3), 5.32 (4H,
s, -CH2), 8.20 (2H, J = 9 Hz, d, ar -CH), 8.28 (2H, J = 9 Hz, d, ar -CH). C (ppm): : 14.0
(1C, -CH2CH3), 28.7 (9C, tBu-CH3), 48.1 – 55.7 (8C, broad, NCH2CH2N), 62.7 (3C, -CH2),
71.1 (1C, -CH2CH3), 82.4 (1C, -CH), 95.5 (3C, C(CH3)3), 123.6 (4C, ar -CH), 131.1 (2C,
ar -C(CH)2), 173.1 (4C, C=O). ESMS-ESI(+) m/z: 744.42 ([M + Na]+, 100%), 722.43 ([M
+ 1]+, 12%). FT-IR max = 4000 cm-1 (cm-1): 1159.38 (nitro N=O), 1258.33 (ester C–O),
1347.10 (nitro N–O), 1597.90 (ar sp2 C=C), 1726.49 (ester C=O), 2979.61 (ar sp2 C–H).
Rf = (Si2O2, 50% (CH2CH3)2O / 50% hexanes) 0.53.
7.3.4.3. 2,2',2''-(10-(carboxy(4-nitrophenyl)methyl)-1,4,7,10-tetraazacyclododecane1,4,7-triyl)triacetic acid (DOTA-NF)

Scheme 7.16. Synthesis of the ligand DOTA-NF via ester hydrolysis of the protected ligand
(3-4) in base.

A crude sample of 3-4 (4.9 g, 6.8 mmol) was added to a solution of 1M KOH (44
mL) and acetonitrile (50 mL). The reaction mixture was heated at 60 °C for 48 hours,
Scheme 7.16. The crude reaction mixture was purified via RP-HPLC using the solvent
system described in Table 7.4, with absorbance monitoring at  = 270 nm and 254 nm. The
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fractions were freeze dried to yield a colorless solid (RT = 15.4 minutes, 0.111 g, 3% yield).
The NMR and MS spectra were consistent with previously published data (DOTA-NF,
ESMS-ESI(+) m/z: 526.21 ([M + 1]+, 100%)).73
Table 7.4. RP-HPLC method used for nitrophenyl containing ligands.

7.3.4.4. Ln(III)-(2,2',2''-(10-(carboxy(4-nitrophenyl)methyl)-1,4,7,10tetraazacyclododecane-1,4,7-triyl)triacetate) (LnDOTA-NF)

Scheme 7.17. Chelation of DOTA-NF with lanthanide chlorides (EuCl3, GdCl3).

DOTA-NF (0.102 g, 0.194 mmol) and GdCl3‧6H2O (0.148 g, 0.4 mmol) were
dissolved in water (10 mL) and acetonitrile (10 mL), the pH was adjusted to 5.5 with 1M
KOH. The reaction was heated at 60 °C for 48 hours, Scheme 7.17. The chelation mixture
was purified via RP-HPLC according to the method in Table 7.5. The fractions were
lyophilized to yield a colorless solid (GdDOTA-NF, RT = 15.7 minutes, 11 mg, 8% yield).
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The 1H-NMR spectrum of the europium complex is consistent with previously published
data (EuDOTA-NF 400 MHz, D2O, 1H (ppm) : -18.05 (1H), -17.57 (1H), -16.85 (1H),
-16.05 (1H), -15.16 (1H), -14.81 (1H), -11.24 (1H), -10.64 (1H), -10.10 (1H), -8.98 (1H),
-8.52 (1H), -7.90 (1H), -7.41 (1H), -6.45 (1H), -6.21 (1H), -5.89 (1H), -5.49 (1H), -5.21
(1H), -4.69 (1H), -4.25 (1H), -3.89 (1H), -3.54 (1H), -2.58 (1H), -2.36 (1H), -1.54 (1H), 0.94 (1H), -0.30 (1H), 0.46 (1H), 1.21 (1H), 1.40 (1H), 1.61 (1H), 1.92 (1H), 1.97 (1H),
2.17 (1H), 2.71 (1H), 3.22 (1H), 3.41 (1H), 3.60 (1H), 3.68 (1H), 5.92 (1H), 6.96 (1H),
7.56 (1H), 7.71 (1H), 7.84 (1H), 8.06 (1H), 8.79 (1H), 12.73 (1H), 13.71 (1H), 14.57 (1H),
16.32 (1H), 33.87 (1H), 35.11 (1H), 36.43 (1H), 37.30 (1H)).73
Table 7.5. RP-HPLC method for nitrophenyl containing chelates.
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7.3.5. Synthesis of DOTA-BP Derivatives
7.3.5.1. 2,2',2''-(10-((4-aminophenyl)(carboxy)methyl)-1,4,7,10-tetraazacyclododecane1,4,7-triyl)triacetic acid (DOTA-AF)

Scheme 7.18. Reduction of DOTA-NF to DOTA-AF utilizing Pd/C.

DOTA-NF (0.3 g, 0.57 mmol) dissolved in H2O (10 mL) and methanol (10 mL) in
a 500 mL hydrogenator vessel. A catalytic amount of 10% Pd/C was added, and the
reaction mixture was shaken on a Parr Hydrogenator under H2 at 20 PSI for three hours,
Scheme 7.18. The solution was subsequently filtered, and solvents were removed by
lyophilization, to yield an orange solid (DOTA-AF, 0.24 g, 85% yield). 400 MHz D2O;
1H

(ppm): : 2.93 – 3.67 (16H, m, NCH2CH2N), 3.94 (6H, s, -CH2), 5.25 (1H, s, -CH),

7.24 (2H, J = 8 Hz, d, ar -CH), 7.35 (2H, J = 8 Hz, ar -CH). ESMS-ESI(+) m/z: 519.1383
([M + Na]+, 100%). FT-IR max = 4000 cm-1 (cm-1): 1109.55 (carboxylic acid C–O),
1346.62 (amine C–N), 1599.75 (ar sp2 C=C), 1629.04 (carboxylic acid C=O), 2854.63 (ar
sp2 C–H), 3107.25 (carboxylic acid O–H), 3360.63 (amine N–H). Rf = (Si2O2, CH3OH)
0.125.
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7.3.5.2. 2,2',2''-(10-(carboxy(4-isothiocyanatophenyl)methyl)-1,4,7,10tetraazacyclododecane-1,4,7-triyl)triacetic acid (DOTA-IF)

Scheme 7.19. Synthesis of DOTA-IF from DOTA-AF.

DOTA-AF (0.2404 g, 0.49 mmol) was dissolved in H2O (15 mL). Thiophosgene
(0.13 mL) was dissolved in chloroform (10 mL). The organic solution was added to the
aqueous mixture and stirred vigorously at room temperature for 18 hours, Scheme 7.19.
The reaction mixture was washed with chloroform (50 mL). The aqueous phase was dried
via lyophilization to afford a light orange solid product (DOTA-IF, 0.12 g, 45% yield).
400 MHz D2O; 1H (ppm): : 2.61 (1H, s, -CH), 2.92 – 3.71 (16H, m, NCH2CH2N), 3.92
(2H, s, -CH2), 4.13 (4H, s, -CH2), 7.64 (2H, J = 10 Hz, d, ar -CH), 8.22 (2H, J = 10 Hz, d,
ar -CH). ESMS-ESI(-) m/z: 536.18 ([M – 1]-, 100%). FT-IR max = 4000 cm-1 (cm-1):
1192.33 (carboxylic acid C–O), 1655.23 (ar sp2 C=C), 1720.58 (carboxylic acid C=O),
2097.64 (ar N=C=S), 3050.17 (ar sp2 C–H), 3194.97 (carboxylic acid O–H).
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7.3.5.3. 2,2',2''-(10-((4-(3-([1,1'-biphenyl]-4-ylmethyl) thioureido) phenyl) (carboxy)
methyl) -1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid (DOTA-BP)

Scheme 7.20. Synthesis of the target ligand, DOTA-BP, from DOTA-IF.

DOTA-IF (0.1175 g, 0.22 mmol) was dissolved in H2O (10 mL) and the pH was
adjusted to 8 with 1M KOH, then tetrahydrofuran was added (10 mL). 4phenylbenzylamine (0.0867 g, 0.47 mmol) was added, and the reaction mixture was stirred
at ambient temperature (~20 °C) for 18 hours, Scheme 7.20. The reaction mixture was dried
via lyophilization to yield a light yellow solid (DOTA-BP potassium salt, 0.19 g). 400
MHz D2O; 1H (ppm): : 2.48 (2H, s, -CH2), 2.98 – 3.60 (16H, m, NCH2CH2N), 3.89 (1H,
s, -CH), 4.18 (6H, s, -CH2), 7.41 (1H, J = 8 Hz, t, ar -CH), 7.51 (4H, J = 8 Hz, t, ar -CH),
7.68 (4H, J = 8 Hz, dd, ar -CH). ESMS-ESI(+) m/z: 798.9275 ([M + 2K]+, 10%), 562.8433
([M – BP]+, 100%). FT-IR max = 4000 cm-1 (cm-1): 1155.92 (thiourea C=S), 1220.89
(thiourea C–N), 1388.29 (carboxylic C–O), 1596.00 (ar sp2 C=C), 1643.82 (carboxylic acid
C=O), 2915.24 (ar sp2 C–H), 3361.02 (carboxylic acid O–H).
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thioureido)

phenyl)

(carboxy) methyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetate) (LnDOTA-BP)

Scheme 7.21. Chelation of DOTA-BP with lanthanide chlorides (EuCl3, GdCl3).

DOTA-BP (0.0543 g, 0.075 mmol) and EuCl3‧6H2O (0.058 g, 0.16 mmol) were dissolved
in water (10 mL), and acetonitrile (5 mL). The pH was adjusted to 5.5 with 1M KOH and
the reaction mixture was stirred at 60 °C for 24 hours, Scheme 7.21. The reaction mixture
was purified via RP-HPLC utilizing the method in Table 7.6. The fractions were
lyophilized to yield a colorless solid (EuDOTA-BP RT = 21.0 minutes, 0.015 g, 23% yield)
600 MHz D2O; 1H EuDO3A-BPAM (ppm): : -18.26 (1H), -17.74 (1H), -17.06 (1H), 16.13 (1H), -15.13 (1H), -14.83 (1H), -11.26 (1H), -10.78 (1H), -10.13 (1H), -9.05 (1H), 8.53 (1H), -7.88 (1H), -7.47 (1H), -6.54 (1H), -6.26 (1H), -5.58 (1H), -5.24 (1H), -4.81
(1H), -4.19 (1H), -4.02 (1H), -3.72 (1H), -2.71 (1H), -2.43 (1H), -1.55 (1H), -1.0 (1H), 0.44 (1H), 0.01 (1H), 0.30 (1H), 0.81 (1H), 1.17 (1H), 1.34 (1H), 1.50 (1H), 1.98 (1H),
2.13 (1H), 2.58 (1H), 2.82 (1H), 3.04 (1H), 3.22 (1H), 3.37 (1H), 3.61 (1H), 4.15 (1H),
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5.79 (1H), 7.47 (1H), 7.67 (1H), 12.51 (1H), 13.49 (1H), 14.43 (1H), 16.11 (1H), 33.71
(1H), 34.92 (1H), 36.21 (1H), 37.19.
Table 7.6. RP-HPLC method to purify biphenyl containing chelates.

7.4. Synthesis, purification, and characterization of Chapter 4 Complexes
7.4.1. Methyl (R)-2-bromo-2-phenylacetate (4-1)

Scheme 7.22. Two-step synthesis of methyl (R)-2-bromo-2-phenylacetate (4-1).

i. D--phenylglycine (10 g, 0.066 mols) and sodium bromide (54 g, 0.53 mols)
were dissolved in 2M HBr (120 mL) and cooled to 0C. Sodium nitrite (5 g, 0.073 mol)
was added to the reaction mixture over the course of several hours, allowing for brown gas
to dissipate after each addition. Once the addition of the sodium nitrite was complete, the
diazotization reaction was stirred for 18 hours allowing the reaction mixture to come to
room temperature. The reaction mixture was extracted diethyl ether (3 × 60 mL) and water,
and the organic phase was dried in vacuo to yield a colorless oil, Scheme 7.22.
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ii. The crude reaction mixture from the diazotization reaction was dissolved in
methanol (50 mL) and sulfuric acid (1 mL) and heated at 60C for 18 hours. Once
completed, the solvents were removed in vacuo and the crude oil was extracted with diethyl
ether (3 × 60 mL) and potassium carbonate mixture in water (pH 10). The organic layer
was dried in vacuo to yield a crude, colorless oil. The crude product was purified via
gradient column chromatography (10% diethyl ether in hexanes – 100% diethyl ether, with
a MeOH wash), organic solvent removed in vacuo to yield a pure colorless oil (4-1, 7.87
g, 26% yield). NMR spectra were consistent with previously published data (400 MHz
CDCl3; 1H (ppm): : 3.76 (3H, s, -CH3), 5.43 (1H, s, -CH), 7.36 (3H, J = 7 Hz, t, ar -CH),
7.58 (2H, J = 7 Hz, d, 2H)).92
7.4.2. Tetramethyl 2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetrayl) (2
S, 2’S, 2’’S, 2’’’S)-tetrakis (2-phenylacetate) (Me4-DOTFA)

Scheme 7.23. Synthesis of Me4-DOTFA via alkylation of 4-1 onto cyclen.
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4-1 (5 g, 0.022 mols), 1, 4, 7, 10-tetraazacyclododecane (cyclen, 0.75 g, 0.0044
mols), and cesium carbonate (7.11 g, 0.022 mols) was dissolved in acetonitrile (50 mL)
and stirred at 60C for 24 hours, Scheme 7.23. After alkylation, the organic solvents were
removed in vacuo and was extracted with dichloromethane (3 × 60 mL) and water. The
organic solvents were removed in vacuo to yield a dark yellow oil (Me4-DOTFA, 3.30 g,
98% yield). 400 MHz CD3CN; 1H (ppm):  2.6 – 3.0 (16H, m, NCH2CH2N); 3.63 (12H,
s, -CH3); 4.42 (4H. s, -CH); 7.27 (4H, J = 10 Hz, m); 7.32 (8H, J = 10 Hz, t); 7.34 (8H, J
= 10 Hz. d). 13C (ppm):  51.5 (8C, NCH2CH2N), 68.5 (4C, -CH3), 128.3 (4C, ar -CH),
128.7 (8C, ar -CH), 129.6 (8C, ar -CH), 129.7 (4C, ar -C(CH)2), 137.6 (4C, -CH), 173.1
(4C, C=O). ESMS-ESI(+) m/z: 765.3854 ([M+1]+, 39%), 787.3673 ([M+Na]+, 100%).
FT-IR max = 4000 cm-1 (cm-1): 1152.46 (C–O, ester), 1599.43 (ar sp2 C=C), 1731.49
(C=O, ester), 2950.14 (ar sp2 C–H). MP: 74.5 – 76.4 °C.
7.4.3. (2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10tetrayl) tetrakis (2-phenylacetic acid) (H4-DOTFA)

Scheme 7.24. Synthesis of ligand H4-DOTFA from protected ligand Me4-DOTFA.
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Me4-DOTFA (0.5 g, 0.654 mmol) and sodium hydroxide (0.25 g, 0.621 mmols)
was dissolved in tetrahydrofuran (10 mL) and water (10 mL). The reaction mixture was
heated at 65C for 18 hours, Scheme 7.24. The pH of the solution was lowered to 3 with
hydrochloric acid and the aqueous solvent were removed via lyophilization to yield a
colorless solid (H4-DOTFA, 0.24 g, 55% yield). 400 MHz D2O; 1H (ppm):  2.33 – 2.59
(16H, m, NCH2CH2N), 4.22 (4H, s, -CH); 7.23 (8H, J = 13 Hz, m, ar -CH); 7.35 (8H, J =
13 Hz, m, ar -CH); 7.43 (4H, J = 13 Hz, d, ar -CH). 13C (ppm): : 58.5 (8C, NCH2CH2N),
95.2 (4C, -CH), 125.3 – 129.5 (24C, broad, ar C(CH)5), 176.4 (4C, C=O). FTMS ESI(-)
m/z: 707.3095 ([M-1]-, 100%), 729.2909 ([M+Na]-, 80%). FT-IR max = 4000 cm-1 (cm1):

1101.77 (carboxylic acid C–O), 1575.51 (ar sp2 C=C), 1589.47 (carboxylic acid C=O),

), 2976.45 (ar sp2 C–H), 3345.90 (carboxylic acid O–H).
7.4.4. Ln(III)-(2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1,
4, 7, 10-tetrayl) tetrakis (2-phenylacetate) from lanthanide chloride salts (LnDOTFA)

Scheme 7.25. Synthesis of target chelate LnDOTFA (Ln = Eu, Gd).

DOTFA (0.03 g, 0.034 mmol) and lanthanide chloride (EuCl3, or GdCl3) (0.1
mmol) were dissolved in water (10 mL). The pH of the solution was adjusted to 5.5 with
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potassium hydroxide and heated at 70C for 48 hours, Scheme 7.25. The chelates were
purified by RP-HPLC, with absorbance monitoring at  = 205 nm and 254 nm. The solvent
system utilized is described in Table 7.7. The fractions were freeze dried to yield a colorless
solid (RT = 22.3 minutes, 0.019 g, 27% yield). EuDOTFA 400 MHz D2O; 1H (ppm):  23.451 (1H); -10.439 (1H); -9.409 (2H); -5.584 (1H); -5.120 (1H); -4.808 (2H); -1.769
(1H); 1.503 (2H); 2.069 (1H); 5.768 (4H); 6.401 (2H); 6.724 – 6.982 (20H); 17.4519 (1H),
43.0135 (1H). GdDOTFA FTMS ESI(-) m/z: 862.2112 ([M]-, 100%).
Table 7.7. RP-HPLC purification method for LnDOTFA chelates.

7.5. Synthesis, purification, and characterization of Chapter 5 Complexes
7.5.1. General Remarks
The synthesis of the target ligand, H4-DOTFA is described in Section 7.4.
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7.5.2. Ln(III)-(2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1,
4, 7, 10-tetrayl) tetrakis(2-phenylacetate) (LnDOTFA)

Scheme 7.26. Synthesis of LnDOTFA from corresponding lanthanide triflates, chlorides, and
oxides. (Ln = Y, Sc, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb)

7.5.2.1. Ln(III)-(2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1,
4, 7, 10-tetrayl) tetrakis(2-phenylacetate) from lanthanide triflates (LnDOTFA, Ln = Sc)
DOTFA (0.03 g, 0.034 mmol) and scandium triflate (0.1 mmol) were dissolved in
water (10 mL). The pH of the solution was adjusted to 5.5 with potassium hydroxide and
heated at 70 C for 48 hours. The chelates were purified by RP-HPLC, with absorbance
monitoring at  = 205 nm and 254 nm. The solvent system utilized is described in Table
7.7. The fractions were freeze dried to yield a colorless solid (RT = 20.1 minutes).
The purified ScDOTFA chelate was recrystallized by adding the filtered
lyophilized solids in minimal volumes of water. These solutions were gently heated at 60
°C until complete dissolution, then the heat was turned off and they were partially covered
to facilitate crystal growth.
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7.5.2.2. Ln(III)-(2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1,
4, 7, 10-tetrayl) tetrakis(2-phenylacetate) from lanthanide chlorides (LnDOTFA, Ln = Ce,
Nd, Eu, Gd, Tb, Dy, Yb)
DOTFA (0.03 g, 0.034 mmol) and lanthanide chloride (Ln = Ce, Nd, Eu, Gd, Tb,
Dy, Yb, 0.1 mmol) were dissolved in water (10 mL). The pH of the solution was adjusted
to 5.5 with potassium hydroxide and heated at 70 C for 48 hours. The chelates were
purified by RP-HPLC, with absorbance monitoring at  = 205 nm and 254 nm. The solvent
system utilized is described in Table 7.7. The fractions were freeze dried to yield a colorless
solid (RT CeDOTFA = 21.2 minutes, 60% yield; RT NdDOTFA = 20.8 minutes, 41% yield;
RT EuDOTFA = 21.8 minutes, 54% yield; RT GdDOTFA = 21.3 minutes, 34% yield; RT
TbDOTFA = 21.8 minutes, 20% yield; RT DyDOTFA = 21.8 minutes, 30% yield; RT
YbDOTFA = 22.0 minutes, 22% yield).
The purified chelates were recrystallized by adding the filtered lyophilized solids
in minimal volumes of water. These solutions were gently heated at 60 °C until complete
dissolution, then the heat was turned off and they were partially covered to facilitate crystal
growth.
7.5.2.3. Ln(III)-(2 S, 2’S, 2’’S, 2’’’S)-2, 2’, 2’’, 2’’’-(1, 4, 7, 10-tetraazacyclododecane-1,
4, 7, 10-tetrayl) tetrakis(2-phenylacetate) from lanthanide oxides (LnDOTFA, Ln = Y, Pr,
Sm, Ho, Er, Tm)
DOTFA (0.03 g, 0.034 mmol) and lanthanide oxide (Ln = Y, Pr, Sm, Ho, Er, Tm,
0.1 mmol) were dissolved in water (10 mL) and heated at 70 C for 72 hours. The reaction
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mixture was pH adjusted to 7 with 1M KOH. The chelates were purified by RP-HPLC,
with absorbance monitoring at  = 205 nm and 254 nm. The solvent system utilized is
described in Table 7.7. The fractions were freeze dried to yield a colorless solid (RT
YDOTFA = 20.8 minutes; RT PrDOTFA = 21.1 minutes, 66% yield; RT SmDOTFA = 21.2
minutes, 49% yield; RT HoDOTFA = 21.7 minutes, 43% yield; RT ErDOTFA = 21.6
minutes, 46% yield; RT TmDOTFA = 21.9 minutes, 28% yield).
The purified chelates were recrystallized by adding the filtered lyophilized solids
in minimal volumes of water. These solutions were gently heated at 60 °C until complete
dissolution, then the heat was turned off and they were partially covered to facilitate crystal
growth.
7.5.3. Synthesis of Racemic EuDOTFA
7.5.3.1. DL-methyl 2-bromo-2-phenylacetate (6-1)

Scheme 7.27. Synthesis of DL-methyl 2-bromo-2-phenylacetate (6-1).
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Methyl DL-mandelate (5 g, 30 mmol) was added to chloroform (20 mL).
Phosphorus tribromide (5.7 mL, 60 mmol) was added to the reaction mixture. The reaction
was stirred at 20 °C for 96 hours, Scheme 7.27. The reaction mixture was extracted with
water (3 × 20 mL) to yield a colorless oil (6-1, 6.48 g, 93% yield).
7.5.3.2. DL-tetramethyl

2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-

tetrayl)tetrakis(2-phenylacetate) (Racemic Me4-DOTFA)

Scheme 7.28. Synthesis of the protected ligand Racemic Me4-DOTFA via alkylation of 6-1
onto cyclen.

6-1 (3.3 g, 15 mmols), 1, 4, 7, 10-tetraazacyclododecane (cyclen, 0.5 g, 5.8 mmols),
and cesium carbonate (4.7 g, 15 mmols) was dissolved in acetonitrile (50 mL) and stirred
at 60 C for 24 hours, Scheme 7.28. After alkylation, the organic solvents were removed
in vacuo and the remaining residue was extracted with dichloromethane (3 × 60 mL) and
water. The organic layer was dried (Na2SO4). The solvents were removed in vacuo to yield
a dark yellow crude oil. The crude product was purified via gradient column
chromatography (50% diethyl ether in hexanes, 100% MeOH, with a 10% NH4OH in
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MeOH wash), organic solvent removed in vacuo to yield a pure colorless oil (Racemic
Me4-DOTFA, 0.18 g, 8% yield). FTMS ESI(+) m/z: 765.39 ([M+1]+, 100%).
7.5.3.3. DL-2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(2phenylacetic acid) (Racemic H4-DOTFA)

Scheme 7.29. Synthesis of target ligand Racemic H4-DOTFA via methyl ester hydrolysis of
the protected ligand Racemic Me4-DOTFA in base.

Racemic Me4-DOTFA (0.18 g, 0.24 mmol) was added to tetrahydrofuran (5 mL).
1M KOH was added (4 equivalents, 0.94 mmol) and the reaction mixture was stirred at 60
°C for 48 hours, Scheme 7.29. The aqueous layer was dried by lyophilization to yield a
crude colorless salt that was used without further purification (Racemic DOTFA). FTMS
ESI(-) m/z: 707.31 ([M–1]-, 100%).
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7.5.3.4. DL-Eu(III)-2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10tetrayl)tetrakis(2-phenylacetate) (Racemic EuDOTFA)

Scheme 7.30. Synthesis of target chelate Racemic EuDOTFA.

Racemic DOTFA (0.17 g, 0.24 mmol) and europium chloride (0.18 g, 0.47 mmol)
was added to water and the pH was adjusted to 5.5 with 1M HCl. The reaction mixture was
stirred at 60 °C for 48 hours, Scheme 7.30. The reaction mixture solvents were removed
by lyophilization to yield a crude chelate (Racemic EuDOTFA). 400 MHz D2O; 1H
(ppm): : -25.46 (1H), -23.57 (1H), -23.41 (1H), -22.64 (1H), -22.01 (1H), -17.16 (1H), 15.86 (1H), -14.79 (1H), -14.01 (1H), -13.40 (1H), -13.12 (1H), -11.79 (1H), -11.54 (1H),
-11.30 (1H), -10.82 (1H), -10.12 (1H), -9.37 (1H), -9.0 (1H), -8.75 (1H), -7.98 (1H), -7.37
(1H), -7.14 (1H), -6.89 (1H), -6.35 (1H), -5.96 (1H), -5.62 (1H), -4.99 (1H), -4.71 (1H), 4.31 (1H), -3.81 (1H), -2.63 (1H), -1.72 (1H), -1.24 (1H), -0.78 (1H), -0.36 (1H), 1.08
(1H), 1.93 (1H), 2.65 (1H), 3.00 (1H), 3.27 (1H), 3.60 (1H), 5.69 (1H), 5.85 (1H), 6.21
(1H), 6.43 (1H), 6.76 (1H), 7.06 (1H), 7.25 (1H), 7.35 (1H), 17.46 (1H), 22.46 (1H), 23.94
(1H), 37.64 (1H), 39.30 (1H), 42.08 (1H), 43.25 (1H), 44.36 (1H), 49.67 (1H), 51.21 (1H).
7.6. Synthesis, purification, and characterization of Chapter 6 Complexes
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7.6.1. General Remarks
The synthesis of the starting ligand, DO3AtBu esters, is described in Section 6.3.1
and Scheme 6.5. The RP-HPLC purification method for all chelates described is shown in
Table 7.8.
Table 7.8. RP-HPLC purification method of LnDO3A-Monoamide Chelates.

7.6.2. Synthesis of Aniline Derived Monoamides
7.6.2.1. 2-bromo-N-phenylacetamide (6-1)

Scheme 7.31. Synthesis of 2-bromo-N-phenylacetamide (6-1).

Aniline (2 g, 21.5 mmol) was dissolved in 2M potassium carbonate solution (20
mL) and cooled to 0C. Bromo acetylbromide (5.2 mL, 43 mmol) was dissolved in
dichloromethane (20 mL), and added dropwise to the aniline solution over the span of one
hour. The reaction mixture was allowed to stir to room temperature for 18 hours, Scheme
7.31. The reaction mixture was extracted with dichloromethane (3 × 50 mL), and the
organic layer was dried (Na2SO4). Solvents were removed in vacuo to afford a colorless
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fluffy solid (6-1, 4.4 g, 96% yield). Spectra were consistent with previously published data
(400 MHz CDCl3; 1H (ppm): : 1.63 (2H, s, -CH2), 7.20 (1H, J = 8 Hz, t, ar -CH), 7.39
(2H, J = 8 Hz, t, -CH), 7.56 (2H, J = 8 Hz, d, ar -CH)).118
7.6.2.2. Tris-tert-butyl

2,2',2''-(10-(2-oxo-2-(phenylamino)

ethyl)-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate (6-2)

Scheme 7.32. Synthesis of the protected ligand (6-2) via alkylation of 6-1 onto DO3A-tert-butyl
esters.

A mixture of DO3A-tert-butyl esters (0.3 g, 0.583 mmol) and cesium carbonate
(0.38 g, 1.17 mmol) was added to acetonitrile (15 mL). 6-1 (0.187 g, 0.87 mmol) was
added, and the reaction mixture was stirred at 60C for 18 hours, Scheme 7.32. The reaction
mixture was extracted with dichloromethane (3 × 15 mL), and the organic layer was dried
(Na2SO4). Solvents were removed in vacuo to afford a waxy yellow solid (6-2, 0.38 g, 90%
yield). FTMS ESI(+) m/z: 648.4322 ([M+1]+, 10%), 670.4138 ([M+Na]+, 100%).
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7.6.2.3. 2,2',2''-(10-(2-oxo-2-(phenylamino) ethyl)-1,4,7,10-tetraazacyclododecane-1,4,7triyl) triacetic acid (DO3A-Phenylamide)

Scheme 7.33. Synthesis of the ligand DO3A-Phenylamide via tert-butyl ester hydrolysis of the
protected ligand (6-2) in acid.

6-2 (0.3755 g, 0.58 mmol) was dissolved in 1M HCl (3.5 eq) and acetonitrile (10
mL). The reaction mixture was stirred and heated at 60°C for 18 hours, Scheme 7.33. Once
reaction was complete, solvents were removed by lyophilization affording a crude salt
product. The product was confirmed by ESI-MS and consistent with previously published
data (DO3A-Phenylamide). (FTMS ESI(+) m/z: 480.2448 ([M+1]+, 100%), 502.2265
[M+Na]+, 30%)).110
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ethyl)-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate Chelates (Ln-DO3A Phenylamide)

Scheme 7.34. Synthesis of target chelates LnDO3A-Phenylamide (Ln = Eu, Gd, Yb).

DO3A-Phenylamide (0.1778 g, 0.371 mmol) and lanthanide chlorides (0.737
mmol) were dissolved in H2O (10 mL) and acetonitrile (2 mL). The pH was adjusted to 5.5
with 1M KOH and the reaction was stirred and heated at 60C for 24 hours, Scheme 7.34.
The solution was purified by RP-HPLC, with absorbance monitoring at  = 254 nm and
205 nm. The solvent system utilized is shown in Table 7.8. RP-HPLC purification yielded
a colorless solid product (EuDO3A-Phenylamide RT = 4.8 minutes, 79% yield;
GdDO3A-Phenylamide RT = 4.9 minutes, 78% yield; YbDO3A-Phenylamide RT = 5.7
minutes, 31% yield). 1H-NMR spectra of the Yb and Eu products were consistent with
previously published data (YbDO3A-Phenylamide 400 MHz D2O; 1H (ppm): : -51.67
(1H), -50.60 (1H), -50.15 (1H), -49.52 (1H), -47.18 (1H), -44.86 (1H), -40.06 (1H), -39.47
(1H), -38.49 (1H), -37.41 (1H), -36.24 (1H), -35.79 (1H), -34.83 (1H), -31.41 (1H), -30.57
(1H), -29.80 (1H), -26.54 (1H), -26.09 (1H), -24.38 (1H), -22.51 (1H), -21.20 (1H), -17.78
(1H), -16.19 (1H), -13.96 (1H), -7.33 (1H), -4.76 (1H), -3.14 (1H), -1.83 (1H), 0.61 (1H),
0.73 (1H), 0.96 (1H), 1.55 (1H), 1.69 (1H), 1.94 (1H), 2.41 (1H), 2.83 (1H), 3.02 (1H),
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4.01 (1H), 4.22 (1H), 6.86 (1H), 7.94 (1H), 9.09 (1H), 9.35 (1H), 12.64 (1H), 14.75 (1H),
16.33 (1H), 17.35 (1H), 18.79 (1H), 20.71 (1H), 23.16 (1H), 28.95 (1H), 62.32 (1H), 82.55
(1H), 107.31 (1H), 109.89 (1H), 112.80 (1H), 117.10 (1H)).110
7.6.3. Synthesis of Benzylamine Derived Monoamides
7.6.3.1. N-benzyl-2-bromoacetamide (6-3)

Scheme 7.35. Synthesis of N-benzyl-2-bromoacetamide (6-3).

Benzylamine (2 g, 18.7 mmol) was dissolved in 2M potassium carbonate solution
(20 mL) and cooled to 0 C. Bromo acetylbromide (4.5 mL, 37 mmol) was dissolved in
dichloromethane (20 mL), and added dropwise to the benzylamine solution over the span
of one hour. The reaction mixture was allowed to stir to room temperature for 18 hours,
Scheme 7.35. The reaction mixture was extracted with diethyl ether (3 × 50 mL), and the
organic layer was dried (Na2SO4). The solvents were removed in vacuo to afford a colorless
solid product (6-3, 3.9 g, 91% yield). NMR spectra were consistent with previously
published data (400 MHz CDCl3; 1H (ppm): : 3.97 (2H, s, -CH2), 4.51 (2H, d, -CH2),
7.31 (1H, J = 8 Hz, t, ar -CH), 7.35 (2H, J = 8 Hz, t, -CH), 7.39 (2H, J = 8 Hz, d, ar CH)).119
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-2-oxoethyl)

-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate (6-4)

Scheme 7.36. Synthesis of the protected ligand (6-4) via alkylation of 6-3 onto DO3A-tert-butyl
esters.

A mixture of DO3A-tert-butyl ester (0.3 g, 0.583 mmol) and cesium carbonate
(0.38 g, 1.17 mmol) was added to acetonitrile (15 mL). 6-3 (0.199 g, 0.87 mmol) was
added, and the reaction mixture was stirred at 60 C for 18 hours, Scheme 7.36. The
reaction mixture was extracted with dichloromethane (3 × 15 mL), and the organic layer
was dried (Na2SO4). The solvents were removed in vacuo to afford a dark orange oil (6-4,
0.39 g, 99% yield). FTMS ESI(+) m/z: 662.4480 ([M+1]+, 100%), 684.6296 ([M+Na]+,
15%).

CHAPTER 7. Experimental

233

7.6.3.3. 2,2',2''-(10-(2-(benzylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7triyl)triacetic acid (DO3A-Benzylamide)

Scheme 7.37. Synthesis of the ligand DO3A-Benzylamide via tert-butyl ester hydrolysis of the
protected ligand (6-4) in acid.

6-4 (0.3894 g, 0.59 mmol) was dissolved in 1M HCl (3.5 eq) and acetonitrile (10
mL). The reaction mixture was stirred and heated at 60 °C for 18 hours, Scheme 7.37. Once
reaction was complete, solvents were removed by lyophilization to yield a crude salt
product (DO3A-Benzylamide). FTMS ESI(+) m/z: 494.2606 ([M+1]+, 100%).
7.6.3.4. Ln

(III)

-2,2',2''-(10-(2-(benzylamino)-2-oxoethyl)-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate Chelates (LnDO3A-Benzylamide Chelates)

Scheme 7.38. Synthesis of target chelates LnDO3A-Benzylamide (Ln = Eu, Gd, Yb).
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DO3A-Benzylamide (0.1788 g, 0.362 mmol) and lanthanide chloride (0.727 mmol) were
dissolved in H2O (10 mL) and acetonitrile (2 mL). The pH was adjusted to 5.5 with 1M
KOH and the reaction was stirred and heated at 60C for 48 hours, Scheme 7.38. The
solution was purified by RP-HPLC, with absorbance monitoring at  = 254 nm and 205
nm. The solvent system utilized is described in Table 7.8. RP-HPLC purification yielded a
colorless solid product (EuDO3A-Benzylamide RT = 6.1 minutes, 39% yield; GdDO3ABenzylamide RT = 6.4 minutes, 40% yield; YbDO3A-Benzylamide RT = 5.7 minutes,
20% yield). 1H-NMR spectra of the europium and ytterbium product complexes was
consistent with previously published data (YbDO3A-Benzylamide 400 MHz D2O; 1H
(ppm): : -69.03 (1H), -68.64 (1H), -68.21 (1H), -67.05 (1H), -63.77 (1H), -51.13 (1H), 47.54 (1H), -45.03 (1H), -39.15 (1H), -37.80 (1H), -36.87 (1H), -35.40 (1H), -31.31 (1H),
-28.99 (1H), -26.86 (1H), -25.47 (1H), -21.40 (1H), -19.32 (1H), -18.32 (1H), -17.62 (1H),
-16.03 (1H), -14.59 (1H), -12.41 (1H), -11.89 (1H), -9.17 (1H), -7.75 (1H), -5.54 (1H), 5.05 (1H), -4.71 (1H), -3.47 (1H), -3.10 (1H), -1.88 (1H), 0.81 (1H), 1.12 (1H), 1.36 (1H),
2.01 (1H), 2.91 (1H), 3.19 (1H), 3.75 (1H), 4.04 (1H), 4.21 (1H), 6.94 (1H), 8.10 (1H),
9.22 (1H), 12.01 (1H), 14.35 (1H), 15.53 (1H), 16.62 (1H), 17.73 (1H), 18.40 (1H), 19.13
(1H), 20.32 (1H), 21.84 (1H), 22.94 (1H), 23.41 (1H), 26.99 (1H), 28.32 (1H), 65.09 (1H),
73.52 (1H), 110.63 (1H), 112.48 (1H)).120
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7.6.4. Synthesis of Dibenzylamine Derived Monoamides
7.6.4.1. N,N-dibenzyl-2-bromoacetamide (6-5)

Scheme 7.39. Synthesis of N,N-dibenzyl-2-bromoacetamide (6-5).

Dibenzylamine (5 g, 25.2 mmol) was dissolved in 2M potassium carbonate solution
(40 mL) and cooled to 0 C. Bromo acetylbromide (4.6 mL, 38 mmol) was dissolved in
dichloromethane (20 mL), and added dropwise to the dibenzylamine solution over the span
of one hour. The reaction mixture was allowed to stir to room temperature for 18 hours,
Scheme 7.39. The reaction mixture was extracted with dichloromethane (3 × 50 mL) and
K2CO3 solution (pH 10). The organic layer was dried (Na2SO4). The solvents were
removed in vacuo to afford a pale-yellow oil (6-5, 7.7 g, 95% yield). 1H-NMR spectra were
consistent with previously published data (400 MHz CDCl3; 1H (ppm): : 3.95 (2H, s, CH2), 4.56 (2H, s, -CH2), 4.65 (2H, s, -CH2), 7.23 (4H, J = 8 Hz, dd, ar -CH), 7.35 (4H, J
= 8 Hz, m, -CH), 7.41 (2H, J = 8 Hz, t, ar -CH)).121
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-2-oxoethyl)

-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl) triacetate (6-6)

Scheme 7.40. Synthesis of the protected ligand (6-6) via alkylation of 6-5 onto DO3A-tert-butyl
esters.

A mixture of DO3A-tert-butyl ester (0.1187 g, 0.231 mmol) and cesium carbonate
(0.1282 g, 0.393 mmol) was added to acetonitrile (15 mL). 6-5 (0.1051 g, 0.330 mmol)
was added, and the reaction mixture was stirred at 60 C for 18 hours. The reaction mixture
was extracted with dichloromethane (3 × 15 mL), and the organic layer was dried
(Na2SO4). The solvents were removed in vacuo to afford a crude dark orange oil, Scheme
7.40. The crude product was purified via gradient column chromatography (10% methanol
in dichloromethane), organic solvent removed in vacuo to yield a pure colorless oil (6-6,
0.12 g, 75% yield). 400 MHz CD3CN; 1H:  1.45 (27H, m, tBu -CH3), 2.05 – 2.98 (16H,
m, NCH2CH2N), 3.29 (6H, s, -CH2), 4.48 (4H, s, -CH2), 5.48 (2H, s, -CH2), 7.22 – 7.40
(10H, J = 8 Hz, m, ar -CH). 13C: : 27.8 (9C, tBu -(CH3)3), 49.3 (1C, -CH2), 49.5 (1C, CH2), 52.0 – 56.1 (8C, NCH2CH2N), 81.9 (1C, -CH2), 82.1 (1C, -CH2), 127.1 (2C, ar -CH),
127.8 (1C, ar -CH), 128.0 (1C, ar -CH), 128.8 (1C, ar -CH), 129.3 (2C, ar -CH), 137.0 (1C,
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ar -C(CH)2), 138.0 (1C, ar -C(CH)2), 139.1 (2C, ar -CH), 172.8 (1C, C=O) 173.4 (1C,
C=O), 173.6 (2C, C=O). FTMS ESI(+) m/z: 752.4942 ([M+1]+, 49%), 774.4760
([M+Na]+, 100%). FT-IR max = 4000 cm-1 (cm-1): 1160.57 (ester C–O), 1226.16 (amide
C–N), 1495.27 (ar sp2 C=C), 1645.94 (amide C=O), 1726.57 (ester C=O), 2975.45 (ar sp2
C–H). Rf = (Si2O2, 90% CH2Cl2 / 10% CH3OH) 0.7.
7.6.4.3. 2,2',2''-(10-(2-(dibenzylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane1,4,7-triyl) triacetic acid (DO3A-Dibenzylamide)

Scheme 7.41. Synthesis of the ligand DO3A-Dibenzylamide via tert-butyl ester hydrolysis of
the protected ligand (6-6) in acid.

6-6 (0.39 g, 0.59 mmol) was dissolved in 1M HCl (3.5 eq) and acetonitrile (10 mL).
The reaction mixture was stirred and heated at 60 °C for 18 hours, Scheme 7.41. Once
reaction was complete, solvents were removed by lyophilization (DO3A-Dibenzylamide,
0.44 g, 40% yield). 400 MHz D2O; 1H:  2.71 – 3.52 (16H, m, NCH2CH2N), 3.75 (4H, s,
-CH2), 4.15 (4H, m, -CH2), 4.41 (2H, s, -CH2), 4.51 (2H, s, -CH2), 7.13 (4H, J = 11 Hz, m,
ar -CH), 7.25 (4H, J = 11 Hz, m, ar -CH), 7.37 (2H, J = 11 Hz, m, ar -CH). 13C: d: 42.3
(2C, -CH2), 47.6 – 49.8 (8C, broad, NCH2CH2N), 51.5 (1C, -CH2), 52.1(1C, -CH2),
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53.0(1C, -CH2), 126.8 (2C, ar -CH), 128.2 (4C, ar -CH), 128.9 (4C, ar -CH), 129.2 (2C, ar
-C(CH)2), 173.5 (1C, C=O), 174.4 (43C, C=O). FTMS ESI(+) m/z: 584.3076 ([M+1]+,
100%). FT-IR max = 4000 cm-1 (cm-1): 1112.35 (carboxylic acid C–O), 1223.09 (amide
C–N), 1604.33 (ar sp2 C=C), 1646.72 (amide C=O), 1733.68 (carboxylic acid C=O),
2973.47 (ar sp2 C–H), 3366.45 (carboxylic acid O–H).
7.6.4.4. Ln

(III)

-2,2',2''-(10-(2-(dibenzylamino)-2-oxoethyl)-1,4,7,10-

tetraazacyclododecane-1,4,7-triyl)triacetate Chelates (LnDO3A-Dibenzylamide)

Scheme 7.42. Synthesis of target chelates LnDO3A-Dibenzylamide (Ln = Eu, Gd, Yb).

DO3A-Dibenzylamide (0.22 g, 0.377 mmol) and lanthanide chloride (0.75 mmol)
were dissolved in H2O (10 mL) and acetonitrile (5 mL). The pH was adjusted to 5.5 with
1M KOH and the reaction was stirred and heated at 60C for 48 hours, Scheme 7.42. The
solution was purified by RP-HPLC, with absorbance monitoring at  = 254 nm and 205
nm. The solvent system utilized is described in Table 7.8. RP-HPLC purification yielded a
colorless solid product (EuDO3A-Dibenzylamide RT = 6.8 minutes, 0.024 g, 9% yield;
GdDO3A-Dibenzylamide RT = 6.1 minutes, 0.11 g, 39% yield; YbDO3ADibenzylamide RT = 10.3 minutes, 0.080 g, 31% yield). YbDO3A-Dibenzylamide 400
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MHz D2O; 1H (ppm): : -65.03 (1H), -64.44 (1H), -63.33 (1H), -61.72 (1H), -47.56 (1H),
-45.92 (1H), -44.85 (1H), -43.30 (1H), -41.41 (1H), -33.93 (1H), -32.40 (1H), -31.55 (1H),
-28.00 (1H), -27.34 (1H), -25.60 (1H), -18.07 (1H), -11.27 (1H), -9.86 (1H), -9.31 (1H), 0.98 (1H), 0.46 (1H), 0.58 (1H), 1.37 (1H), 2.68 (1H), 2.88 (1H), 3.34 (1H), 3.54 (1H),
3.96 (1H), 4.48 (1H), 5.16 (1H), 6.70 (1H), 6.75 (1H), 7.31 (1H), 7.98 (1H), 11.22 (1H),
13.02 (1H), 14.23 (1H), 15.80 (1H), 16.54 (1H), 18.14 (1H), 18.45 (1H), 20.30 (1H), 24.15
(1H), 28.67 (1H), 61.70 (1H), 64.09 (1H), 79.77 (1H), 103.20 (1H), 105.54 (1H), 108.33
(1H), 110.28 (1H).
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APPENDIX: CHAPTER 2 STERN-VOLMER LUMINESCENCE SPECTRA
A1.1. Stern-Volmer Emission Spectra for GdNB-DOTA Corner and Side

Figure A.1. Emission spectra at various concentrations for GdNB-DOTA Corner (left) and
Side (right) at ex = 270 nm (top), 297 nm (middle), and 340 nm (bottom).
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A1.2. Stern-Volmer Excitation Spectra for GdNB-DOTA Corner and Side

Figure A.2. Excitation spectra at various concentrations for GdNB-DOTA Corner (left) and
Side (right) at em = 400 nm (top), 535 nm (middle), and 590 nm (bottom).

